Processing 00000000.tx.1: Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies Katrin U. 

Phrase: "Therapeutic effect of idiotype-specific CD4+ T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1527144:Therapeutic Effect [Health Care Activity]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "against B-cell lymphoma"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   901   C0004561:B-cell [Cell]
   901   C0883208:cell lymphoma [Cell]
   827   C0007634:Cell [Cell]
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of anti-idiotypic antibodies Katrin U."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0003242:Antibodies, Anti-Idiotypic [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Lundin, Peter O. 

Phrase: "Lundin,"

Phrase: "Peter O."
Processing 00000000.tx.3: Hofgaard, Hilde Omholt, Ludvig A. 

Phrase: "Hofgaard,"

Phrase: "Hilde Omholt,"

Phrase: "Ludvig A."
Processing 00000000.tx.4: Munthe, Alexandre Corthay, and Bjarne Bogen From the Institute of Immunology, University of Oslo, Rikshospitalet University Hospital, Oslo, Norway  Abstract Top Abstract Introduction Materials and methods Results Discussion References  Immunoglobulin (Ig) variable (V) region idiotypes (Id's) are highly tumor-specific antigens produced by B-lymphoma cells and are promising targets for immunotherapy. 

Phrase: "Munthe,"

Phrase: "Alexandre Corthay,"

Phrase: "and"

Phrase: "Bjarne Bogen From the Institute of Immunology,"

Phrase: "University of Oslo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Rikshospitalet University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Oslo,"

Phrase: "Norway  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Immunoglobulin (Ig) variable (V) region idiotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0021013:Immunoglobulin Idiotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]
           idiotypes
   756   C0877857:Immunoglobulin Variable Region [Amino Acid, Peptide, or Protein,Immunologic Factor]
   708   C1302678:Immunoglobulin region [Amino Acid, Peptide, or Protein]

Phrase: "(Id's)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "are"

Phrase: "highly tumor-specific antigens"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   906   C0041361:tumor-specific antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumor Antigens
   861   C0456981:Specific antigens [Immunologic Factor]
   812   C0003320:Antigens [Immunologic Factor]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0205369:Specific [Qualitative Concept]
   812   C1552740:specific [Intellectual Product]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   706 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "produced by B-lymphoma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0079731:cell b lymphoma [Neoplastic Process]
   806   C0883208:Lymphoma cells [Cell]
   806   C2697951:Lymphoma Cells [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0024299:Lymphoma [Neoplastic Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "promising targets for immunotherapy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.5: Id vaccination has proven effective in experimental mouse models and may possibly prevent recurrence of B lymphomas in humans. 

Phrase: "Id vaccination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "proven effective in experimental mouse models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "recurrence of B lymphomas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034897:Recurrence [Phenomenon or Process]
   770   C1458156:recurrence [Neoplastic Process]
   770   C2825055:Recurrence [Pathologic Function]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.6: It has previously been shown that anti-Id antibodies protect against B-cell lymphoma in the absence of T cells. 

Phrase: "It"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that anti-Id antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0600091:ID [Intellectual Product]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "protect against B-cell lymphoma"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   806   C0004561:B-cell [Cell]
   806   C0883208:cell lymphoma [Cell]
   760   C0007634:Cell [Cell]
   760   C0024299:Lymphoma [Neoplastic Process]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of T cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: We here demonstrate in a T-cellreceptor transgenic mouse model that the contrary is also true: Id-specific CD4+ T cells can protect against Id+ B-lymphoma cells in the absence of B cells, antibodies, and CD8+ T cells. 

Phrase: "We here"

Phrase: "demonstrate in a T-cellreceptor transgenic mouse model"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0025936:Mouse, Transgenic [Mammal]
   770   C2986594:Mouse Model [Experimental Model of Disease]
   767   C1519606:Transgenic Model [Experimental Model of Disease]
   744   C0003069:Transgenic [Animal]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "the contrary"

Phrase: "is"

Phrase: "also true"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205238:True [Qualitative Concept]

Phrase: ":"

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "protect against Id+ B-lymphoma cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   809   C0079731:cell b lymphoma [Neoplastic Process]
   790   C0883208:Lymphoma cells [Cell]
   790   C2697951:Lymphoma Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0024299:Lymphoma [Neoplastic Process]
   753   C0600091:ID [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "CD8+ T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: Moreover, Id-specific CD4+ T cells have a curative potential since they could be transferred as late as 17 days after subcutaneous tumor cell injection of severe combined immunodeficiency (SCID) mice and still abrogate tumor development in about 50% of mice. 

Phrase: "Moreover,"

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a curative potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "since"

Phrase: "they"

Phrase: "could"

Phrase: "be"

Phrase: "transferred as late"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205087:Late [Temporal Concept]
   790   C0348011:transferred [Functional Concept]
   756 E C0040671:Transfer [Mental Process]
   756 E C1705822:Transfer [Activity]

Phrase: "as 17 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "after subcutaneous tumor cell injection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0021499:Subcutaneous injection [Functional Concept]
   812   C0021485:injection [Therapeutic or Preventive Procedure]
   812   C1272883:Injection [Biomedical or Dental Material]
   812   C1533685:Injection [Therapeutic or Preventive Procedure]
   812   C1828121:Injection [Functional Concept]

Phrase: "of severe combined immunodeficiency (SCID) mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "and"

Phrase: "still"

Phrase: "abrogate"

Phrase: "tumor development in about 50% of mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.9: Such mice undergo an acute inflammatory swelling with infiltration of neutrophils at the site of tumor injection, which subsides over weeks, with some mice cured and delayed emergence of lymphomas in other mice. 

Phrase: "Such mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "undergo"

Phrase: "an acute inflammatory swelling with infiltration of neutrophils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234939:INFLAMMATORY SWELLING [Finding]
   744   C0013604:SWELLING [Pathologic Function]
   744   C0038999:Swelling [Finding]

Phrase: "at the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of tumor injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "which"

Phrase: "subsides over weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0439230:weeks [Temporal Concept]
   756 E C0332174:/week [Temporal Concept]

Phrase: "with some mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "cured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880198:Cured [Conceptual Entity]

Phrase: "and"

Phrase: "delayed emergence of lymphomas"

Phrase: "in other mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.10: Adoptively transferred CD4+ T cells accumulated in the tumor and were activated (CD69+). 

Phrase: "Adoptively transferred CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "accumulated in the tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027651:Tumor [Neoplastic Process]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "were"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "(CD69+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540471:CD69 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.11: In vitro experiments demonstrated that memory, but not naive, Id-specific CD4+ T cells kill Id+ B-lymphoma cells. 

Phrase: "In vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that memory,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "but"

Phrase: "not naive, Id-specific CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   884   C3641721:Naive T Cells [Cell]
   829   C0039215:cd4 cells [Cell]
   818   C0039194:T-Cells [Cell]
   813 E C3251824:CD4+ cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "Id+ B-lymphoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.12: The results show that Id-specific CD4+ T cells, in the absence of antibodies home to subcutaneous Id+ B lymphoma, become activated, induce inflammation, and prevent tumor development.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Id-specific CD4+ T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of antibodies home"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442519:Home [Conceptual Entity]

Phrase: "to subcutaneous Id+ B lymphoma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024299:Lymphoma [Neoplastic Process]

Phrase: "become"

Phrase: "activated,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "inflammation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "tumor development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.13: Introduction Top Abstract Introduction Materials and methods Results Discussion References  Idiotypes (Id's) are antigenic determinants localized to the variable (V) regions of immunoglobulin (Ig). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Idiotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:idiotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Id's)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "are"

Phrase: "antigenic determinants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003316:Antigenic Determinants [Immunologic Factor]
   827   C1521761:Determinant [Functional Concept]
   789   C0003320:Antigen [Immunologic Factor]
   789   C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "localized to the variable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392752:Localized [Spatial Concept]
   770   C0439828:Variable [Qualitative Concept]

Phrase: "(V) regions of immunoglobulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C0877857:Variable Regions, Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   802   C1302678:Immunoglobulin region [Amino Acid, Peptide, or Protein]
   770   C0439828:Variable [Qualitative Concept]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "(Ig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1621846:immunoglobulin [Molecular Function]

Phrase: ")."
Processing 00000000.tx.14: Because Ig V regions are extremely diverse, the monoclonal Ig produced by a malignant B-cell clone express unique Id's that may function as highly tumor-specific antigens. 

Phrase: "Because"

Phrase: "Ig V regions"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0877857:Variable Regions, Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896   C1302678:Immunoglobulin region [Amino Acid, Peptide, or Protein]
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0439828:Variable [Qualitative Concept]
   827   C1621846:immunoglobulin [Molecular Function]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "extremely diverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880371:Diverse [Qualitative Concept]

Phrase: "the monoclonal Ig"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0443737:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0700271:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "produced by a malignant B-cell clone"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0004561:B-cell [Cell]
   778   C0009013:Cell Clone [Cell]
           Clone
   774   C0334227:Malignant Cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0205282:Malignant [Qualitative Concept]
   748   C0334590:MALIGNANT [Neoplastic Process]
   748   C1269647:Cell [Cell]
   748   C1522642:Clone [Tissue]
   748   C1533592:MALIGNANT [Neoplastic Process]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "unique Id's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "function as highly tumor-specific antigens."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   816   C0041361:tumor-specific antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumor Antigens
   790   C0456981:Specific antigens [Immunologic Factor]
   753   C0003320:Antigens [Immunologic Factor]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0031843:function [Physiologic Function]
   753   C0205250:Highly [Qualitative Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1552740:specific [Intellectual Product]
   753   C1578706:Tumor [Intellectual Product]
   753   C1705273:Function [Intellectual Product]
   753   C3273930:Tumor [Finding]
Processing 00000000.tx.15: Immunization with monoclonal Ig can induce Id-specific antibodies1 and Id-specific T cells,2 and early animal experiments suggested that both these humoral and cellular arms of adaptive immunity may have an antilymphoma effect.3-10 Id-vaccination has moved into phase 1 and 2 trials of follicular B-lymphoma patients with encouraging results.11-13 It has, however, been difficult to establish the relative contribution of antibodies and T cells to Id-specific protection against B lymphoma. 

Phrase: "Immunization with monoclonal Ig"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   770   C0042196:immunisation [Therapeutic or Preventive Procedure]
   770   C3244291:immunization [Functional Concept]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Id-specific antibodies1"

Phrase: "and"

Phrase: "Id-specific T cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "early animal experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0205664:Animal Experiments [Research Activity]
   827   C0003062:Animal [Animal]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both these humoral"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   928   C0020168:Humor [Intellectual Product]
   928   C0597811:humor [Therapeutic or Preventive Procedure]
   884 E C0683242:humorousness [Individual Behavior]

Phrase: "and"

Phrase: "cellular arms of adaptive immunity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0206655:ARMS [Neoplastic Process]
   760   C0446516:Arm [Body Location or Region]
   760   C1269078:Arm [Body Part, Organ, or Organ Component]
   760   C1269612:Arm [Body Location or Region]
   760   C2681631:ARMS [Gene or Genome]
   704 E C0445456:Brachial [Spatial Concept]

Phrase: "may"

Phrase: "have"

Phrase: "an antilymphoma effect.3-10 Id-vaccination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "moved into phase 1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0439559:Phase 1 [Temporal Concept]
   770   C0205390:Phase [Temporal Concept]
   770   C1269909:moved [Functional Concept]
   770   C1299988:moved [Functional Concept]
   770   C2699029:Moved [Activity]
   737 E C0560560:move [Organism Function]
   737 E C0578671:move [Finding]

Phrase: "and"

Phrase: "2 trials of follicular B-lymphoma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0008976:Trial [Research Activity]

Phrase: "with encouraging results.11-13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "It"

Phrase: "has"

Phrase: ","

Phrase: "however,"

Phrase: "been"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the relative contribution of antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "T cells to Id-specific protection"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0039194:T-Cells [Cell]
   767   C0524828:Cell Protection [Physiologic Function]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "against B lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.16: Supporting a role of antibodies, passive treatment of patients with Id-specific antibodies (Abs) may have an antiB-lymphoma effect,14 possibly due to signaling through lymphoma B-cell receptors (BCRs) and induction of apoptosis.15 Recently, it was shown that Id-specific antibodies alone protected mice against the mouse 38C13 B-cell lymphoma in the absence of T cells.16 The converse (ie, effect of Id-specific T cells in the absence of antibodies) has been shown in a myeloma model,17 but there is no conclusive evidence for B lymphomas. 

Phrase: "Supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a role of antibodies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "passive treatment of patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1704535:Passive Treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with Id-specific antibodies (Abs)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "may"

Phrase: "have"

Phrase: "an antiB-lymphoma effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "14 possibly due to signaling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0037083:Signaling [Cell Function]
   760   C2362652:Possibly [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]
   760   C3537152:signaling [Biologic Function]

Phrase: "through lymphoma B-cell receptors (BCRs)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0079731:lymphoma b-cell [Neoplastic Process]
   890   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0004561:B-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "induction of apoptosis.15 Recently,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Id-specific antibodies alone protected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "against the mouse 38C13 B-cell lymphoma"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1522021:Mouse Lymphoma [Neoplastic Process]
   888   C1522109:Mouse B Cell [Cell]
   884   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   840   C0004561:B-cell [Cell]
   840   C0883208:cell lymphoma [Cell]
   804   C0007634:Cell [Cell]
   804   C0024299:Lymphoma [Neoplastic Process]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of T cells.16"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "The converse"

Phrase: "("

Phrase: "ie"

Phrase: ","

Phrase: "effect of Id-specific T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "shown in a myeloma model,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026764:Myeloma [Neoplastic Process]
   760   C3161035:Model [Intellectual Product]
   760   C3538749:Myeloma [Intellectual Product]
   726   C1547282:Show [Intellectual Product]

Phrase: "17"

Phrase: "but"

Phrase: "there"

Phrase: "is"

Phrase: "no conclusive evidence for B lymphomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.17: This is not a trivial distinction as B-cell lymphomas generally express major histocompatibility complex (MHC) class II molecules and surface Ig, both of which myeloma cells lack. 

Phrase: "This"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a trivial distinction as B-cell lymphomas generally"

Phrase: "express"

Phrase: "major histocompatibility complex (MHC) class II molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0567416:molecules [Substance]
   780   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]
   716 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "surface Ig,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034789:Surface immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0205148:Surface [Spatial Concept]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "both of which myeloma cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0333843:cells myeloma [Cell]
   760   C0007634:Cells [Cell]
   760   C0026764:Myeloma [Neoplastic Process]
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]
   760   C3282337:Cells [Cell]
   760   C3538749:Myeloma [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "lack."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]
Processing 00000000.tx.18: Thus, B lymphomas could, in contrast to myeloma cells, be direct targets for both Id-specific CD4+ T cells and antibodies. 

Phrase: "Thus,"

Phrase: "B lymphomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024299:Lymphomas [Neoplastic Process]

Phrase: "could"

Phrase: ","

Phrase: "in contrast to myeloma cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "be"

Phrase: "direct targets for both Id-specific CD4+ T cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C1550500:direct target [Idea or Concept]
   745   C0221284:Target cells [Cell]
   745   C3272919:Target Cells [Laboratory Procedure]
   708   C1521840:Target [Functional Concept]
   708   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.19: Id-specific T cells can be of the CD4+ type, recognizing Id-peptide on MHC class II molecules,18,19 or the CD8+ type, recognizing Id-peptide on class I molecules.20,21 However, the role of either of these 2 types of Id-specific T cells in fighting B lymphoma in vivo is poorly understood. 

Phrase: "Id-specific T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be of the CD4+ type,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3541261:CD4 [Laboratory Procedure]

Phrase: "recognizing"

Phrase: "Id-peptide on MHC class II molecules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "18,"

Phrase: "19"

Phrase: "or"

Phrase: "the CD8+ type,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "recognizing"

Phrase: "Id-peptide on class I molecules.20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0136026:peptide I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "21 However,"

Phrase: "the role of either of these 2 types of Id-specific T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0035820:Role [Social Behavior]
   735   C1705810:Role [Conceptual Entity]

Phrase: "in fighting B lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024299:Lymphoma [Neoplastic Process]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.20: In a BALB/c mouse model, Id-specific CD4+ T cells have been shown to recognize a CDR3 peptide spanning residues 91 to 101 of a 2 Ig light (L) chain. 

Phrase: "In a BALB/c mouse model,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]
   756   C0025919:BALB/c Mouse [Mammal]

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recognize"

Phrase: "a CDR3 peptide spanning residues 91 to 101"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0604154:A-91 [Organic Chemical,Pharmacologic Substance]
   767   C0608016:A-101 [Organic Chemical,Pharmacologic Substance]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C1865782:CDR3 [Gene or Genome]
   711   C1709915:Residue [Conceptual Entity]
   711   C1711300:Span [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
   711   C2700613:Span [Quantitative Concept]

Phrase: "of a 2 Ig light (L) chain."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0021038:Immunoglobulin Light-Chain [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1302674:Immunoglobulin chain [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0337112:Chain [Manufactured Object]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1621846:immunoglobulin [Molecular Function]
   812   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.21: The particular 2 chain is called 2315 because it is derived from the MOPC315 plasmacytoma. 

Phrase: "The particular 2 chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "is"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "2315"

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "derived from the MOPC315 plasmacytoma."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0032131:Plasmacytoma [Neoplastic Process]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
   704 E C1136084:PLASMA CELL TUMOR [Neoplastic Process]
   704 E C1959632:Plasma Cell Tumor [Neoplastic Process]
Processing 00000000.tx.22: The 2315 contains unique amino acids in positions 94, 95, and 96, due to somatic mutations in the V-gene segment of MOPC315. 

Phrase: "The 2315"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "unique amino acids in positions 94,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "95,"

Phrase: "and"

Phrase: "96,"

Phrase: "due to somatic mutations"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0544886:somatic mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C2986476:Somatic [Qualitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
   768 E C0599444:soma [Cell Component]
   768 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   755 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "in the V-gene segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   755 E C0205122:Segmental [Spatial Concept]

Phrase: "of MOPC315."
Processing 00000000.tx.23: T-cell recognition of the 2315 Id heavily depends on these 3 CDR3 amino acids, and recognition is MHC class II (I-Ed) restricted.18,22,23 In order to establish a lymphoma model, the 2315 gene was transfected into the BALB/c A20 B-lymphoma cells. 

Phrase: "T-cell recognition of the 2315 Id heavily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0678836:cell recognition [Cell Function]
   744   C0524637:Recognition [Mental Process]

Phrase: "depends on these 3 CDR3 amino acids,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   748   C0725813:depend [Medical Device]
   748   C1865782:CDR3 [Gene or Genome]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "is"

Phrase: "MHC class II"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2263441:complex II [Molecular Function]
   840   C0441886:Class II [Intellectual Product]
   840   C2698968:Class II [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0205164:Major [Qualitative Concept]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "(I-Ed)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "restricted.18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443288:Restricted [Functional Concept]

Phrase: "22,"

Phrase: "23 In order to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0450348:23 [Quantitative Concept]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a lymphoma model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "the 2315 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "transfected into the BALB/c A20 B-lymphoma cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   773   C0079731:cell b lymphoma [Neoplastic Process]
   764   C0025919:BALB/C [Mammal]
   764   C0883208:Lymphoma cells [Cell]
   764   C2697951:Lymphoma Cells [Laboratory Procedure]
   742   C0007634:Cells [Cell]
   742   C0024299:Lymphoma [Neoplastic Process]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.24: Transfected cells (F9) expressed the 2315 L chain together with the endogenous heavy (H) chain in the cell surface BCR. 

Phrase: "Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(F9)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1366464:F9 [Gene or Genome]

Phrase: "expressed"

Phrase: "the 2315 L chain together with the endogenous heavy (H) chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0023693:Light [Natural Phenomenon or Process]
   739   C0337112:Chain [Manufactured Object]
   739   C1306462:Light [Functional Concept]
   739   C1524075:Chain [Idea or Concept]
   739   C1881376:Light [Qualitative Concept]

Phrase: "in the cell surface BCR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0699040:Cell surface [Cell Component]
Processing 00000000.tx.25: Moreover, F9 cells spontaneously processed 2315 and presented the Id-peptide on their class II molecules to cloned Id-specific CD4+ cells.24,25 This finding was corroborated by elution of V-region peptides from B-lymphoma class II molecules.26 Thus, B-lymphoma cells constitutively express both serologically defined Id's (ie, surface Ig) and T-celldefined Id's (ie, Id-peptides on class II molecules), each of which could be targets for Id-specific antibodies and CD4+ T cells, respectively. 

Phrase: "Moreover,"

Phrase: "F9 cells spontaneously"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "2315"

Phrase: "and"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "the Id-peptide on their class II molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "to cloned Id-specific CD4+ cells.24,"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   859   C0009013:Clone Cells [Cell]
           cloned
   827   C0039215:cd4 cells [Cell]
   810 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C0205369:Specific [Qualitative Concept]
   799   C0600091:ID [Intellectual Product]
   799   C1552740:specific [Intellectual Product]
   799   C3282337:Cells [Cell]
   799   C3541261:CD4 [Laboratory Procedure]
   766 E C1269647:Cell [Cell]
   766 E C1522642:Clone [Tissue]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "25"

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "corroborated by elution of V-region peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017446:Region [Geographic Area]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0205147:Region [Spatial Concept]
   748   C0439828:Variable [Qualitative Concept]
   748   C1441565:Elution [Laboratory Procedure]

Phrase: "from B-lymphoma class II molecules.26 Thus,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0441886:Class II [Intellectual Product]
   818   C2698968:Class II [Finding]
   795   C0024299:Lymphoma [Neoplastic Process]
   795   C0456387:Class [Intellectual Product]
   795   C0567416:molecules [Substance]
   795   C1705943:Class [Classification]
   795   C2347469:/B [Quantitative Concept]
   712 E C1521991:Molecular [Qualitative Concept]

Phrase: "B-lymphoma cells constitutively"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   875   C0004561:B-Cells [Cell]
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "both serologically defined Id's ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0600091:ID [Intellectual Product]
   827   C1704788:Defined [Conceptual Entity]
   827   C3539106:Defined [Intellectual Product]

Phrase: "ie"

Phrase: ","

Phrase: "surface Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034789:Surface immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0205148:Surface [Spatial Concept]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "T-celldefined Id's ("

Phrase: "ie"

Phrase: ","

Phrase: "Id-peptides on class II molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "each of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "targets for Id-specific antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "CD4+ T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.26: Id+ F9 B-lymphoma cells were rejected by cloned Id-specific T cells in vivo in a Winn-type assay.6 Moreover, Id-specific T-cellreceptor (TCR) transgenic mice were protected against challenges with the Id+ B lymphoma.27 However, a role of antibodies or CD8+ T cells was not ruled out in these experiments. 

Phrase: "Id+ F9 B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0883208:Lymphoma cells [Cell]
   840   C2697951:Lymphoma Cells [Laboratory Procedure]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rejected by cloned Id-specific T cells"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   778   C0039194:T-Cells [Cell]
   757   C0009013:Clone Cells [Cell]
           cloned
   748   C0007634:Cells [Cell]
   748   C0205369:Specific [Qualitative Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1548437:Rejected [Idea or Concept]
   748   C1552740:specific [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1522642:Clone [Tissue]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2700401:Reject [Activity]

Phrase: "in vivo in a Winn-type assay.6 Moreover,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "Id-specific T-cellreceptor (TCR) transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "protected against challenges"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0805586:challenges [Health Care Activity]
   756 E C0798503:Challenge [Clinical Attribute]
   756 E C3274764:Challenge [Conceptual Entity]

Phrase: "with the Id+ B lymphoma.27 However,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0024299:Lymphoma [Neoplastic Process]
   804   C0600091:ID [Intellectual Product]

Phrase: "a role of antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "CD8+ T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out in these experiments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0681814:Experiments [Research Activity]
   770   C0849355:Out [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.27: Moreover, as rearrangements of endogenous TCR chains are common in TCR-transgenic mice, a considerable TCR repertoire for other antigens than Id's could have contributed to this protection. 

Phrase: "Moreover,"

Phrase: "as"

Phrase: "rearrangements of endogenous TCR chains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511695:Rearrangements [Genetic Function]

Phrase: "are"

Phrase: "common in TCR-transgenic mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "a considerable TCR repertoire for other antigens"

Phrase: "than Id's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "could"

Phrase: "have"

Phrase: "contributed to this protection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1545588:Protection [Finding]
   737   C1880177:Contribute [Activity]
Processing 00000000.tx.28: To overcome these previous limitations, we have now used recombination-deficient Id-specific TCR transgenic mice that have CD4+ T cells that express only the transgenic Id-specific TCR but lack B cells and antibodies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "these previous limitations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:limitations [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "now used recombination-deficient Id-specific TCR transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025936:Mice, Transgenic [Mammal]
   790   C0003069:Transgenic [Animal]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "have"

Phrase: "CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "express"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the transgenic Id-specific TCR"

Phrase: "but"

Phrase: "lack B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.29: We show that CD4+ Id-specific cells protect against challenges with B-lymphoma cells, moreover, we demonstrate that Id-specific CD4+ T cells have a therapeutic effect since they can prevent tumor occurrence in mice previously injected with lymphoma cells.  

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CD4+ Id-specific cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   902   C0039215:cd4 cells [Cell]
   886 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "protect against challenges"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0805586:challenges [Health Care Activity]
   756 E C0798503:Challenge [Clinical Attribute]
   756 E C3274764:Challenge [Conceptual Entity]

Phrase: "with B-lymphoma cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0883208:Lymphoma cells [Cell]
   901   C2697951:Lymphoma Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "moreover,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a therapeutic effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1527144:Therapeutic Effect [Health Care Activity]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "since"

Phrase: "they"

Phrase: "can"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "tumor occurrence in mice previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "injected with lymphoma cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0883208:Lymphoma cells [Cell]
   833   C2697951:Lymphoma Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0024299:Lymphoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1720154:Inject [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.30: Materials and methods Top Abstract Introduction Materials and methods Results Discussion References  Mice Mice transgenic for an Id-specific TCR on a BALB/c background have been described,28 as have Id-specific TCR-transgenic mice homozygous for the scid mutation on a BALB/c IgH-congenic C.B-17 background.17 Recombinase activating 2 gene deficient (Rag2-/-) BALB/c mice were from Taconic (Bomholt, Ry, Denmark). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mice Mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   983   C0025914:mouse, mice [Mammal]

Phrase: "transgenic for an Id-specific TCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003069:Transgenic [Animal]

Phrase: "on a BALB/c background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706907:Background [Conceptual Entity]
   734   C0025919:BALB/C [Mammal]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "28"

Phrase: "as"

Phrase: "have"

Phrase: "Id-specific TCR-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "homozygous for the scid mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "on a BALB/c IgH-congenic C.B-17 background.17 Recombinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "2 gene deficient (Rag2-/-) BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025919:Mice, BALB C [Mammal]
           BALB/C
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "were from Taconic"

Phrase: "(Bomholt,"

Phrase: "Ry,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.31: Rag2 expression is necessary for recombination of endogenous TCR and Ig genes, therefore, Rag2-/- mice have a nonleaky severe combined immunodeficiency (SCID) phenotype. 

Phrase: "Rag2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "necessary for recombination of endogenous TCR"

Phrase: "and"

Phrase: "Ig genes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017350:Genes, Immunoglobulin [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "therefore,"

Phrase: "Rag2-/- mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "a nonleaky severe combined immunodeficiency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   861   C0494261:combined immunodeficiency [Disease or Syndrome]
   812   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   812   C0205082:Severe [Qualitative Concept]
   812   C0205195:Combined [Qualitative Concept]
   779 E C0336789:Combine [Manufactured Object]

Phrase: "(SCID"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   901   C0494261:combined immunodeficiency [Disease or Syndrome]
   827   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   827   C0205082:Severe [Qualitative Concept]
   827   C0205195:Combined [Qualitative Concept]
   793 E C0336789:Combine [Manufactured Object]

Phrase: ")"

Phrase: "phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.32: Hemizygous TCR-transgenic Rag2-/- were established in our animal facility by backcrossing homozygous TCR-transgenic BALB/c mice 2 times against Rag2-/- BALB/c. 

Phrase: "Hemizygous TCR-transgenic Rag2-/-"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   791   C0003069:Transgenic [Animal]
   791   C0011155:Deficient [Functional Concept]
   791   C0017337:Gene [Gene or Genome]
   791   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1636779:% deficient [Quantitative Concept]
   791   C1879547:activating [Activity]
   791   C1881036:Hemizygous [Qualitative Concept]
   758 E C1515877:Activate [Functional Concept]

Phrase: "were"

Phrase: "established in our animal facility"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0872329:animal facility [Manufactured Object]
   760   C0003062:Animal [Animal]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1547538:Facility [Idea or Concept]

Phrase: "by backcrossing homozygous TCR-transgenic BALB/c mice 2 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:times [Temporal Concept]
   790   C1632851:Times [Quantitative Concept]
   756 E C3541383:Time [Temporal Concept]
   718 E C0442043:Temporal [Spatial Concept]
   718 E C2362314:Temporal [Temporal Concept]

Phrase: "against Rag2-/- BALB/c."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0025919:BALB/C [Mammal]
   793   C0011155:Deficient [Functional Concept]
   793   C0017337:Gene [Gene or Genome]
   793   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0521124:Against [Qualitative Concept]
   793   C1636779:% deficient [Quantitative Concept]
   793   C1879547:activating [Activity]
   760 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.33: TCR-transgenic Rag2-/- mice expressed the transgenic TCR but not other TCR or Ig genes. 

Phrase: "TCR-transgenic Rag2-/- mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   866   C0025936:Mice, Transgenic [Mammal]
   866   C1420562:T gene [Gene or Genome]
   791   C0003069:Transgenic [Animal]
   791   C0011155:Deficient [Functional Concept]
   791   C0017337:Gene [Gene or Genome]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1636779:% deficient [Quantitative Concept]
   791   C1879547:activating [Activity]
   791   C2603360:T' [Clinical Attribute]
   758 E C1515877:Activate [Functional Concept]

Phrase: "expressed"

Phrase: "the transgenic TCR"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "other TCR"

Phrase: "or"

Phrase: "Ig genes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017350:Genes, Immunoglobulin [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]
Processing 00000000.tx.34: TCR-transgenic SCID (or TCR-transgenic Rag2-/-) mice hemizygous for the TCR transgenes were bred by (SCID [or Rag2-/-] x TCR-transgenic SCID [or TCR-transgenic Rag2-/-]) crosses. 

Phrase: "TCR-transgenic SCID"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   827   C0494261:combined immunodeficiency [Disease or Syndrome]
   799   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   799   C0205082:Severe [Qualitative Concept]
   799   C0205195:Combined [Qualitative Concept]
   766 E C0336789:Combine [Manufactured Object]

Phrase: "("

Phrase: "or"

Phrase: "TCR-transgenic Rag2-/-"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   878   C1420562:T gene [Gene or Genome]
   793   C0003069:Transgenic [Animal]
   793   C0011155:Deficient [Functional Concept]
   793   C0017337:Gene [Gene or Genome]
   793   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1636779:% deficient [Quantitative Concept]
   793   C1879547:activating [Activity]
   793   C2603360:T' [Clinical Attribute]
   760 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "hemizygous for the TCR transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1881036:Hemizygous [Qualitative Concept]

Phrase: "were"

Phrase: "bred by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0006159:breed [Organism Function]
   799   C1704650:Breed [Classification]

Phrase: "(SCID"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   901   C0494261:combined immunodeficiency [Disease or Syndrome]
   827   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   827   C0205082:Severe [Qualitative Concept]
   827   C0205195:Combined [Qualitative Concept]
   793 E C0336789:Combine [Manufactured Object]

Phrase: "["

Phrase: "or"

Phrase: "Rag2-/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "] x TCR-transgenic SCID"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   845   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   818   C0494261:combined immunodeficiency [Disease or Syndrome]
   795   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   795   C0205082:Severe [Qualitative Concept]
   795   C0205195:Combined [Qualitative Concept]
   762 E C0336789:Combine [Manufactured Object]

Phrase: "["

Phrase: "or"

Phrase: "TCR-transgenic Rag2-/-"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   878   C1420562:T gene [Gene or Genome]
   793   C0003069:Transgenic [Animal]
   793   C0011155:Deficient [Functional Concept]
   793   C0017337:Gene [Gene or Genome]
   793   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1636779:% deficient [Quantitative Concept]
   793   C1879547:activating [Activity]
   793   C2603360:T' [Clinical Attribute]
   760 E C1515877:Activate [Functional Concept]

Phrase: "]"

Phrase: ")"

Phrase: "crosses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828360:Cross [Conceptual Entity]
Processing 00000000.tx.35: Offspring (50% transgenic, 50% non-transgenic) were typed by staining of blood CD4+ lymphocytes using the clonotype-specific monoclonal antibody (mAb) GB113. 

Phrase: "Offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "(50% transgenic, 50% non-transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "typed by staining of blood CD4+ lymphocytes"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0039215:cd4 lymphocytes [Cell]
   778   C3641616:CD4/Lymphocytes [Laboratory Procedure]
   774   C0005835:blood staining [Body Substance]
   757   C0005810:blood type [Classification]
   757   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   757   C1383165:Blood Type [Clinical Attribute]
   757   C3274467:Blood Type [Diagnostic Procedure]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0229664:Blood [Body Substance]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]
   748   C3541261:CD4 [Laboratory Procedure]
   714   C0332307:Type [Qualitative Concept]
   714   C1547052:*Type [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the clonotype-specific monoclonal antibody (mAb) GB113."
Processing 00000000.tx.36: Mice were of specific pathogen free (SPF) standard and bred behind a barrier. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were of specific pathogen free (SPF) standard"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0162470:Specific Pathogen Free [Organism]
   753   C0205369:Specific [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C0450254:Pathogen [Organism]
   753   C1442989:Standard [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "bred behind a barrier."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1706912:BARRIER [Medical Device]
   737   C0006159:breed [Organism Function]
   737   C1704650:Breed [Classification]
Processing 00000000.tx.37: Experiments were performed according to governmental and institutional guidelines. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed according to governmental"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0680240:according [Social Behavior]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "institutional guidelines."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0162791:Guidelines [Intellectual Product]
   861   C0220845:guidelines [Intellectual Product]
   861   C0282423:guidelines [Intellectual Product]
Processing 00000000.tx.38: Adoptive transfer CD4+ T cells and CD4- cells were purified from lymph nodes (LNs) of TCR-transgenic mice, or spleen and LNs of TCR-transgenic SCID mice, and transferred to SCID recipients. 

Phrase: "Adoptive transfer CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CD4- cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0039215:cd4 cells [Cell]
   983 E C3251824:CD4+ cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified from lymph nodes (LNs) of TCR-transgenic mice,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   764   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   764   C0025936:Mice, Transgenic [Mammal]
   751   C1518047:Mouse Lymph Node [Tissue]
   742   C0003069:Transgenic [Animal]
   742   C0024202:Lymph [Body Substance]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0746922:nodes [Body Part, Organ, or Organ Component]
   742   C1998793:Purified [Functional Concept]
   731 E C0440747:LYMPH NODE [Tissue]
   731 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   708 E C1706163:Node [Conceptual Entity]
   708 E C2697524:Node [Conceptual Entity]
   708 E C2700445:Node [Plant]

Phrase: "or"

Phrase: "spleen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "LNs of TCR-transgenic SCID mice,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   744   C1518047:Mouse Lymph Node [Tissue]
   739   C0024202:Lymph [Body Substance]
   739   C0746922:nodes [Body Part, Organ, or Organ Component]
   726 E C0440747:LYMPH NODE [Tissue]
   726 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   706 E C1706163:Node [Conceptual Entity]
   706 E C2697524:Node [Conceptual Entity]
   706 E C2700445:Node [Plant]

Phrase: "and"

Phrase: "transferred to SCID recipients."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   790   C0494261:combined immunodeficiency [Disease or Syndrome]
   753   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   753   C0205082:Severe [Qualitative Concept]
   753   C0205195:Combined [Qualitative Concept]
   753   C0348011:transferred [Functional Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C0336789:Combine [Manufactured Object]
   719 E C1705822:Transfer [Activity]
   719   C1709854:Recipient [Human]
Processing 00000000.tx.39: Purification of CD4+ T cells (> 95% pure) was done by positive selection using magnetic beads conjugated with an IgM anti-CD4 mAb and released from beads by use of an anti-Fab reagent (Dynabeads and Detachabead; Dynal, Oslo, Norway).17 The negatively selected cells from this procedure were used as a source of CD4- T cells.17 In protection-type experiments, the indicated number of purified cells was transferred intravenously to SCID recipients that were challenged 3 days later with the indicated number of tumor cells. 

Phrase: "Purification of CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "("

Phrase: "> 95% pure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2247561:PurE [Molecular Function]
   789 E C1882508:Purity [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "done by positive selection"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C2347644:Positive Selection [Laboratory Procedure]
   770   C0036576:selection [Genetic Function]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1272695:Done [Qualitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2746065:Done [Temporal Concept]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "magnetic beads"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1328924:magnetic beads [Medical Device]
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "conjugated with an IgM anti-CD4 mAb"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0051980:anti-IgM [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0369518:IgM.monoclonal [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C2754997:IgM antibody [Cell Component]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0522529:Conjugated [Spatial Concept]
   744   C0746619:monoclonal [Finding]
   744   C3541261:CD4 [Laboratory Procedure]
   711 E C0301869:Conjugate [Immunologic Factor]

Phrase: "and"

Phrase: "released from beads"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0391871:Released [Functional Concept]
   790   C0991566:Beads [Biomedical or Dental Material]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]
   756 E C2346972:Bead [Spatial Concept]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of an anti-Fab reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Dynabeads"

Phrase: "and"

Phrase: "Detachabead"

Phrase: "; Dynal,"

Phrase: "Oslo,"

Phrase: "Norway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028423:Norway [Geographic Area]

Phrase: ").17"

Phrase: "The negatively selected cells from this procedure"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used as a source of CD4- T cells.17"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   764   C0039194:T-Cells [Cell]
   762   C0039215:cd4 cells [Cell]
   762   C3251824:Cells.CD4 [Cell]
   745   C1524063:Use of [Functional Concept]
   742   C0007634:Cells [Cell]
   742   C0449416:Source [Finding]
   742   C1273517:used [Finding]
   742   C1705919:Source [Idea or Concept]
   742   C3282337:Cells [Cell]
   742   C3541261:CD4 [Laboratory Procedure]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1947944:Use [Intellectual Product]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "In protection-type experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "the indicated number of purified cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "intravenously to SCID recipients"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   790   C0494261:combined immunodeficiency [Disease or Syndrome]
   753   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   753   C0205082:Severe [Qualitative Concept]
   753   C0205195:Combined [Qualitative Concept]
   719 E C0336789:Combine [Manufactured Object]
   719   C1709854:Recipient [Human]

Phrase: "that"

Phrase: "were"

Phrase: "challenged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0798503:Challenge [Clinical Attribute]
   966   C0805586:Challenge [Health Care Activity]
   966   C3274764:Challenge [Conceptual Entity]

Phrase: "3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "later with the indicated number of tumor cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0205087:Late [Temporal Concept]
Processing 00000000.tx.40: In immunotherapy type experiments, SCID mice were first injected subcutaneously with tumor cells and then intravenously with purified CD4+ T cells at the indicated time points. 

Phrase: "In immunotherapy type experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "subcutaneously with tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0431085:Tumor cells [Cell]
   799 E C0597032:Tumor Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027651:Tumor [Neoplastic Process]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "then intravenously with purified CD4+ T cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0039194:T-Cells [Cell]
   774   C0039215:cd4 cells [Cell]
   774   C3251824:Cells.CD4 [Cell]
   748   C0007634:Cells [Cell]
   748   C1883708:Then [Temporal Concept]
   748   C1998793:Purified [Functional Concept]
   748   C3282337:Cells [Cell]
   748   C3541261:CD4 [Laboratory Procedure]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "at the indicated time points."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.41: Tumor challenges, survival curves, and statistics Adult (6-16 weeks old) mice were injected subcutaneously between the shoulder blades with the indicated number of tumor cells and monitored weekly for tumor development. 

Phrase: "Tumor challenges,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0805586:challenges [Health Care Activity]
   827 E C0798503:Challenge [Clinical Attribute]
   827 E C3274764:Challenge [Conceptual Entity]

Phrase: "survival curves,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   827   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "statistics Adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001675:Adult [Age Group]
   861   C1706450:Adult [Human]

Phrase: "(6-16 weeks old) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "subcutaneously between the shoulder blades"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C0036277:Shoulder blade [Body Part, Organ, or Organ Component]
   760   C0037004:Shoulder [Body Location or Region]
   760   C0179323:blades [Medical Device]
   760   C1283792:Shoulder [Body Location or Region]
   726 E C2700402:Blade [Plant]
   726 E C2948008:Blade [Pharmacologic Substance]

Phrase: "with the indicated number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "weekly for tumor development."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0243107:development [Physiologic Function]
   770   C0332174:Weekly [Temporal Concept]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
Processing 00000000.tx.42: Tumor sizes (diameter) were estimated by palpation and use of a caliper. 

Phrase: "Tumor sizes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0475440:Tumour size [Spatial Concept]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0456389:SIZES [Spatial Concept]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: "(diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "estimated by palpation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2737251:Estimated by palpation [Finding]
   790   C0030247:Palpation [Diagnostic Procedure]
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "and"

Phrase: "use of a caliper."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
Processing 00000000.tx.43: A tumor of 3 mm in diameter was scored as a tumor take. 

Phrase: "A tumor of 3 mm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "in diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: "was"

Phrase: "scored as a tumor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0449820:scored [Quantitative Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "take."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]
Processing 00000000.tx.44: Mice were killed when tumor size reached 20 mm. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "when"

Phrase: "tumor size"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0475440:Tumor size [Spatial Concept]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0456389:size [Spatial Concept]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "20 mm."
Processing 00000000.tx.45: Tumor avoidance or survival curves and statistical comparison (log-rank test) were calculated by use of Graph Pad Prism 3.0 software (San Diego, CA). 

Phrase: "Tumor avoidance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870186:Avoidance [Mental Process]

Phrase: "or"

Phrase: "survival curves"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   827   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "statistical comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "(log-rank test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C0699794:Rank [Intellectual Product]
   827   C1708728:Log [Intellectual Product]
   827   C2986775:log [Occupational Activity]

Phrase: ")"

Phrase: "were"

Phrase: "calculated by use of Graph Pad Prism 3.0 software"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C1524063:Use of [Functional Concept]
   739   C0037585:Software [Intellectual Product,Manufactured Object]
   739   C0042153:use [Functional Concept]
   739   C0182158:pad [Medical Device]
   739   C0332568:Pad [Neoplastic Process]
   739   C0444686:Calculated [Functional Concept]
   739   C0457083:Use [Functional Concept]
   739   C0681493:Graph [Intellectual Product]
   739   C0814195:PRISM [Intellectual Product]
   739   C1441506:Calculated [Activity]
   739   C1443182:Calculated [Laboratory Procedure]
   739   C1947944:Use [Intellectual Product]
   739   C2698021:Graph [Conceptual Entity]
   739   C3540603:PAD [Gene or Genome]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.46: B-lymphoma cell lines and ex vivo single-cell suspensions from tumors F9A.15.3.19 (abbreviated F9) is a cell line derived from BALB/c (H-2d) A20 B-lymphoma cells transfected with the 2315 gene.24 F9 cells express the 2315 L chain together with the endogenous 2a in the cell membrane, easily detectable by surface iodination and immunoprecipitation and by flow cytometry. 

Phrase: "B-lymphoma cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C0004561:B-cell [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "ex vivo single-cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0038960:Suspensions [Biomedical or Dental Material]
   771 E C1382107:Suspension [Substance]
   771 E C1705537:Suspension [Functional Concept]

Phrase: "from tumors F9A.15.3.19"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0027651:Tumors [Neoplastic Process]
   771 E C1578706:Tumor [Intellectual Product]
   771 E C3273930:Tumor [Finding]

Phrase: "(abbreviated F9)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1366464:F9 [Gene or Genome]

Phrase: "is"

Phrase: "a cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "derived from BALB/c (H-2d"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025919:BALB/C [Mammal]
   753   C0439539:Heavy [Qualitative Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1705052:2D [Spatial Concept]
   753   C2986796:2D [Functional Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "A20 B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the 2315 gene.24 F9 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C1366464:F9 gene [Gene or Genome]
           F9
   750   C1861886:CELL Gene [Gene or Genome]
   744   C0007634:Cells [Cell]
   744   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "the 2315 L chain together with the endogenous 2a"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0023693:Light [Natural Phenomenon or Process]
   742   C0337112:Chain [Manufactured Object]
   742   C1306462:Light [Functional Concept]
   742   C1524075:Chain [Idea or Concept]
   742   C1881376:Light [Qualitative Concept]

Phrase: "in the cell membrane,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "easily detectable by surface iodination"

Phrase: "and"

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and by flow cytometry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.47: It secretes small amounts (150-500 ng/mL in dense cultures) of 2315 into supernatant (SN). 

Phrase: "It"

Phrase: "secretes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "small amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "(150-500 ng/mL in dense cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0439275:ng/mL [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "of 2315"

Phrase: "into supernatant (SN)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.48: It expresses Fas (CD95) as detected by the JO-2 mAb in flow cytometry and is readily killed by FasLigand (K.U.L. and B.B., unpublished data, June 2000). 

Phrase: "It"

Phrase: "expresses"

Phrase: "Fas (CD95"

Phrase: ")"

Phrase: "as"

Phrase: "detected by the JO-2 mAb in flow cytometry"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0016263:Flow Cytometry [Laboratory Procedure]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0022418:JO [Geographic Area]
   739   C0442726:Detected [Finding]
   739   C0746619:monoclonal [Finding]
   739   C0806140:Flow [Natural Phenomenon or Process]
   739   C0814048:Cytometry [Laboratory Procedure]
   739   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "is"

Phrase: "readily"

Phrase: "killed by FasLigand"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0162388:killed [Social Behavior]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "(K.U.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "B.B.,"

Phrase: "unpublished data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "June 2000"

Phrase: ")."
Processing 00000000.tx.49: The F55B17.2 (F55) cell line represents A20 cells transfected with the empty vector alone (pSV2neo).25 To obtain single-cell suspensions from ex vivo subcutaneous lymphomas, tumors were minced and treated with collagenase and DNase as described.29 Id-specific CD4+ T cells Naive Id-specific T cells were isolated from LNs and spleen of TCR-transgenic or TCR-transgenic SCID mice by magnetic beads as described.17 To obtain T cell helper 1 (Th1) or Th2 cells, LN cells from TCR-transgenic or TCR-transgenic SCID mice were set up in culture (5 x 105/mL) together with BALB/c spleen cells (2.5 x 106/mL), synthetic 91-107 Id-(2315) peptide (1 g/mL), recombinant mouse interleukin 12 (IL-12) (2 ng/mL; R&D Systems, Minneapolis, MN), and antiIL-4 (11B11 mAb, 1 g/mL) for Th1 induction; 

Phrase: "The F55B17.2 (F55) cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "A20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(pSV2neo"

Phrase: ").25 To"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "single-cell suspensions from ex vivo subcutaneous lymphomas,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0038960:Suspensions [Biomedical or Dental Material]
   711 E C1382107:Suspension [Substance]
   711 E C1705537:Suspension [Functional Concept]

Phrase: "tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "minced"

Phrase: "and"

Phrase: "treated with collagenase"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "DNase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "as"

Phrase: "described.29 Id-specific CD4+ T cells Naive Id-specific T cells"

Phrase: "were"

Phrase: "isolated from LNs"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   833   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   799 E C0440747:LYMPH NODE [Tissue]
   799 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   770   C0024202:Lymph [Body Substance]
   770   C0205409:Isolated [Functional Concept]
   770   C0746922:nodes [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1706163:Node [Conceptual Entity]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C2697524:Node [Conceptual Entity]
   737 E C2700445:Node [Plant]

Phrase: "and"

Phrase: "spleen of TCR-transgenic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037993:Spleen [Body Part, Organ, or Organ Component]
   760   C0771377:SPLEEN [Tissue]
   760   C1278932:Spleen [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "TCR-transgenic SCID mice by magnetic beads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   788   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   757   C0025936:Mice, Transgenic [Mammal]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   707   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "as"

Phrase: "described.17 To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1552738:described [Idea or Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "T cell helper 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0018894:t-cell helper [Cell]
   861   C0039194:T-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(Th1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423842:TH1 [Gene or Genome]
  1000   C3540579:TH1 [Gene or Genome]

Phrase: "or"

Phrase: "Th2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0242633:Th2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "LN cells from TCR-transgenic"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0025936:Mice, Transgenic [Mammal]
   859   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   766   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "were"

Phrase: "set up in culture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "(5 x 105/mL) together with BALB/c spleen cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C2699156:Cells/mL [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]

Phrase: "(2.5 x 106/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "synthetic 91-107 Id-(2315"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0600091:ID [Intellectual Product]
   804   C1883254:synthetic [Activity]

Phrase: ")"

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(1 g/mL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "recombinant mouse interleukin 12 (IL-12)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1524115:Recombinant Interleukin-12 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Interleukin 12
   875   C1527200:Recombinant Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
           Interleukin
   861   C0123759:Interleukin-12 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(2 ng/mL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; R&D Systems,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "Minneapolis,"

Phrase: "MN"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "antiIL-4"

Phrase: "(11B11 mAb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "1 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "mL) for Th1 induction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.50: or IL-4 (20 U/mL) for Th2 induction. 

Phrase: "or"

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(20 U/mL) for Th2 induction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.51: T cells were expanded after several days and used after 1 or 2 10-day cycles. 

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "expanded after several days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205229:expanded [Spatial Concept]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "used after 1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "2 10-day cycles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.52: The Id (2315)specific 7A10B2 Th1 clone has been described.18 Complete tissue culture medium was RPMI 1640 with 10% fetal calf serum (FCS; Gibco, Carlsbad, CA) and supplements.30 Antibodies and flow cytometry The following commercially available mAbs were used, conjugated with either fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin, or biotin: CD4 (RM4-5), CD69 (H1.2F3), and CD45R (RA3-6B2) (PharMingen, San Diego, CA). 

Phrase: "The Id (2315"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: "specific 7A10B2 Th1 clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "described.18 Complete tissue culture medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   827   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0040284:Tissue culture [Laboratory Procedure]
   799   C0009458:Medium [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0040300:Tissue [Tissue]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C0439536:Medium [Quantitative Concept]
   799   C1547928:Tissue [Intellectual Product]
   799   C1705217:Medium [Substance]
   799   C2242979:Culture [Laboratory Procedure]
   799   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "RPMI 1640 with 10% fetal calf serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015965:Fetal [Embryonic Structure]
   748   C0229671:Serum [Body Substance]
   748   C0230445:Calf [Body Location or Region]
   748   C0521457:Fetal [Functional Concept]
   748   C1305418:Calf [Body Part, Organ, or Organ Component]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: "(FCS"

Phrase: "; Gibco,"

Phrase: "Carlsbad,"

Phrase: "CA)"

Phrase: "and"

Phrase: "supplements.30 Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "The"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "commercially available mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "conjugated with either fluorescein isothiocyanate (FITC),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0124209:Isothiocyanate [Organic Chemical]
   760   C0206359:isothiocyanate [Organic Chemical]
   760   C0522529:Conjugated [Spatial Concept]
   726 E C0301869:Conjugate [Immunologic Factor]

Phrase: "phycoerythrin (PE),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031789:Phycoerythrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "allophycocyanin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051214:allophycocyanin [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2700256:Biotin [Laboratory Procedure]

Phrase: ":"

Phrase: "CD4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "(RM4-5"

Phrase: ")"

Phrase: ","

Phrase: "CD69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540471:CD69 [Gene or Genome]

Phrase: "(H1.2F3"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CD45R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335285:CD45R [Gene or Genome]

Phrase: "(RA3-6B2"

Phrase: ")"

Phrase: "(PharMingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.53: The various fluorochrome-conjugated, isotype-matched control mAbs were from PharMingen. 

Phrase: "The various fluorochrome-conjugated, isotype-matched control mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were from PharMingen."
Processing 00000000.tx.54: Transgenic-TCRclonotype-specific GB113 mAbs and V8-specific F23.1 mAbs were affinity-purified and biotin and FITC conjugated by standard procedures. 

Phrase: "Transgenic-TCRclonotype-specific GB113 mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "V8-specific F23.1 mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "affinity-purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1998793:Purified [Functional Concept]
   768 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2700256:Biotin [Laboratory Procedure]

Phrase: "and"

Phrase: "FITC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: "conjugated by standard procedures."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0522529:Conjugated [Spatial Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2700391:procedures [Activity]
   770   C2828392:Standard [Intellectual Product]
   737 E C0301869:Conjugate [Immunologic Factor]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.55: Biotinylated Abs were detected with streptavidin (SA)CyChrome or SAperidin-chlorophyll protein (SA-PerCP; PharMingen). 

Phrase: "Biotinylated Abs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected with streptavidin (SA)CyChrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "SAperidin-chlorophyll protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SA-PerCP"

Phrase: "; PharMingen"

Phrase: ")."
Processing 00000000.tx.56: Combinations of the above-listed mAbs were used for double, triple, or quadruple stainings of cells essentially as described earlier.28 Samples were acquired on a FACScalibur (Becton Dickinson, Mountain View, CA) and analyzed by the WinMDI program (http://facs.scripps.edu/software.html). 

Phrase: "Combinations of the above-listed mAbs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0453882:Combinations [Manufactured Object]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "were"

Phrase: "used for double, triple,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0205173:Double [Functional Concept]
   770   C0205174:Triple [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "quadruple stainings of cells essentially"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0487602:Stainings [Laboratory Procedure]
   726 E C1704680:Staining [Finding]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier.28 Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "acquired on a FACScalibur"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439661:Acquired [Temporal Concept]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]

Phrase: "(Becton Dickinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA)"

Phrase: "and"

Phrase: "analyzed by the WinMDI program"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0936012:Analyzed [Research Activity]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//facs.scripps.edu/software.html"

Phrase: ")."
Processing 00000000.tx.57: Immunohistochemistry and microscopy Stainings of tumor sections were performed by embedding organs in optimum cutting temperature (OCT) compound (Tissue-Tek; Miles, Elkhart, IN), and 5-m frozen sections were mounted on L-polylysinecoated glass slides and air-dried overnight. 

Phrase: "Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "microscopy Stainings of tumor sections"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0487602:Stainings [Laboratory Procedure]
   726 E C1704680:Staining [Finding]

Phrase: "were"

Phrase: "performed by embedding organs in optimum cutting temperature (OCT) compound"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C1882161:Optimal Cutting Temperature Compound [Indicator, Reagent, or Diagnostic Aid]
   764   C1550369:Performed By [Qualitative Concept]
   745   C0029215:Organ Temperature [Organism Attribute]
   742   C0005903:temperature [Organism Attribute]
   742   C0039476:*Temperature [Quantitative Concept]
   742   C0152060:Cutting, NOS [Therapeutic or Preventive Procedure]
   742   C0178784:organs [Body Part, Organ, or Organ Component]
   742   C0205198:Compound [Qualitative Concept]
   742   C0884358:Performed [Functional Concept]
   742   C1306235:Cutting [Qualitative Concept]
   742   C1706082:Compound [Chemical]
   742   C1707903:Embedding [Laboratory Procedure]
   742   C2698651:Optimum [Qualitative Concept]
   742   C3496294:Cutting [Functional Concept]
   708 E C0000925:Cut [Injury or Poisoning]
   708 E C1883724:CUT [Phenomenon or Process]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Tissue-Tek"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1336602:TEK [Gene or Genome]
   861   C1705001:TEK [Gene or Genome]

Phrase: "; Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "Elkhart,"

Phrase: "IN"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "5-m frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0016741:Frozen Sections [Tissue]
   827 E C0085188:Frozen Section [Laboratory Procedure]
   812   C0016701:Frozen [Natural Phenomenon or Process]
   812   C0677542:Frozen [Functional Concept]
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted on L-polylysinecoated glass slides"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0017596:Glass [Manufactured Object]
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C0444330:slides [Research Device]
   753   C0449878:mounted [Finding]
   753   C1306462:Light [Functional Concept]
   753   C1881376:Light [Qualitative Concept]
   753   C1947936:Glass [Medical Device]
   719 E C0181909:Mount [Medical Device]
   719 E C1705201:Slide [Manufactured Object]

Phrase: "and"

Phrase: "air-dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.58: The following biotinylated mAbs were added and detected by StreptavidinCy 3 (Amersham, Pittsburgh, PA): GB113,31 antiLy-6G (Gr-1, RB6-8C5; PharMingen), antiThy 1.2, (T24), anti-CD31 (MEC 13.3; PharMingen), and anti-CD11b (TIB128; American Type Culture Collection [ATTC], Manassas, VA). 

Phrase: "The"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "biotinylated mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "detected by StreptavidinCy 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Amersham,"

Phrase: "Pittsburgh,"

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "GB113,"

Phrase: "31 antiLy-6G"

Phrase: "(Gr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "RB6-8C5"

Phrase: "; PharMingen"

Phrase: ")"

Phrase: ","

Phrase: "antiThy 1.2,"

Phrase: "(T24"

Phrase: ")"

Phrase: ","

Phrase: "anti-CD31"

Phrase: "(MEC 13.3"

Phrase: "; PharMingen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-CD11b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541224:CD11B [Laboratory Procedure]

Phrase: "(TIB128"

Phrase: "; American Type Culture Collection [ATTC],"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "Manassas,"

Phrase: "VA)."
Processing 00000000.tx.59: F9 and F55 tumor cells were stained with highly cross-absorbed Alexa Fluor 488 goat antimouse IgG, (Molecular Probes, Eugene, OR). 

Phrase: "F9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1366464:F9 [Gene or Genome]

Phrase: "and"

Phrase: "F55 tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with highly cross-absorbed Alexa Fluor 488 goat antimouse IgG,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C3272928:Alexa Fluor [Indicator, Reagent, or Diagnostic Aid]
   738   C0018019:goat [Mammal]
   738   C0205250:Highly [Qualitative Concept]
   738   C0235665:FLUOR [Pathologic Function]
   738   C1071616:Alexa [Plant]
   738   C1265549:goat [Mammal]
   738   C1510458:Goat [Mammal]
   738   C1979849:Antimouse [Immunologic Factor]
   738   C2828360:Cross [Conceptual Entity]
   738   C2986582:Stained [Qualitative Concept]
   704 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.60: Nuclei were stained with DAPI (4,6-diamino-2-phenylindoldi-hydrochloride; Molecular Probes). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "stained with DAPI (4,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "6-diamino-2-phenylindoldi-hydrochloride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "; Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.61: Pictures were made with a charge-coupled device camera (Hamamatsu, Ichinocho, Japan). 

Phrase: "Pictures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441469:pictures [Manufactured Object]
   966 E C0441468:picture [Manufactured Object]

Phrase: "were"

Phrase: "made with a charge-coupled device camera"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   853   C0598124:charge coupled device camera [Manufactured Object]
   814   C1455741:Charge coupled device [Medical Device]
   778   C0179533:Camera, device [Medical Device]
           Camera
   778   C1706254:Device Camera [Medical Device]
           CAMERA
   748   C0007961:Charge [Quantitative Concept]
   748   C0025080:Device [Medical Device]
   748   C0699733:Device [Manufactured Object]
   748   C1654607:Camera [Eukaryote]
   748   C1706211:Charge [Organism Attribute]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]
   714   C1881534:Make [Functional Concept]

Phrase: "(Hamamatsu,"

Phrase: "Ichinocho,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.62: ELISA The 2315 Ig was measured in a sandwich enzyme-linked immunosorbent assay (ELISA) using 9A8 mAb (anti-V1/V2) as capture antibody and biotinylated 2B6 mAb (anti-C2/C3) as detection antibody. 

Phrase: "ELISA"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "The 2315 Ig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "was"

Phrase: "measured in a sandwich enzyme-linked immunosorbent assay (ELISA)"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   767   C2717977:Enzyme Assay [Laboratory Procedure]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   744   C0243073:assay [Qualitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "9A8 mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "(anti-V1/V2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0457423:V2 [Finding]
   827   C0507237:V2 [Body Part, Organ, or Organ Component]
   827   C1421140:V2 [Gene or Genome]

Phrase: ")"

Phrase: "as"

Phrase: "capture antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "biotinylated 2B6 mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(anti-C2/C3"

Phrase: ")"

Phrase: "as"

Phrase: "detection antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.63: This assay detects free 2315 as well as 2315 associated with an H chain. 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "free 2315"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]

Phrase: "as well as"

Phrase: "2315"

Phrase: "associated with an H chain."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1420192:heavy chain [Gene or Genome]
   760   C0337112:Chain [Manufactured Object]
   760   C0439539:Heavy [Qualitative Concept]
   760   C1524075:Chain [Idea or Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.64: Purified 36.1 mAb (IgG2a 2315) produced by a hybridoma from a 2315 transgenic mouse served as a standard (B.B., unpublished data, October 1999). 

Phrase: "Purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "36.1 mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(IgG2a 2315"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020857:IgG2A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "produced by a hybridoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020204:Hybridoma [Cell]

Phrase: "from a 2315 transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mouse, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "served as a standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]

Phrase: "(B.B.,"

Phrase: "unpublished data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "October 1999"

Phrase: ")."
Processing 00000000.tx.65: Apoptosis assays Apoptosis was measured by a modified JAM assay.32 Tumor cells were cultured in the presence of [methyl-3H] thymidine (3H-TdR) for 24 hours. 

Phrase: "Apoptosis assays Apoptosis"

Phrase: "was"

Phrase: "measured by a modified JAM assay.32 Tumor cells"
Meta Candidates (Total=22; Excluded=6; Pruned=0; Remaining=16)
   764   C0431085:Tumor cells [Cell]
   762   C0205349:Modified By [Qualitative Concept]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0007634:Cells [Cell]
   742   C0022337:JAM [Geographic Area]
   742   C0027651:Tumor [Neoplastic Process]
   742   C0243073:assay [Qualitative Concept]
   742   C0392747:Modified [Functional Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C0453428:Jam [Food]
   742   C1422839:JAM [Gene or Genome]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1578706:Tumor [Intellectual Product]
   742   C3273930:Tumor [Finding]
   742   C3282337:Cells [Cell]
   742   C3541902:MEASURED [Diagnostic Procedure]
   731 E C0597032:Tumor Cell [Cell]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in the presence of [methyl-3H] thymidine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1442460:3H [Temporal Concept]
   711   C0010453:Culture [Idea or Concept]
   711   C0220814:culture [Functional Concept]
   711   C0430400:Culture [Laboratory Procedure]
   711   C2242979:Culture [Laboratory Procedure]

Phrase: "(3H-TdR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:TDR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086126:TdR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "for 24 hours."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.66: Assays were set up with radioactively labeled target cells (104/well) and titrated amounts of cytotoxic T cells. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "set up with radioactively labeled target cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0007634:Cells set [Cell]
   757   C2983663:Set Label [Intellectual Product]
   748   C0036849:Set [Mental Process]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "(104/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "titrated amounts of cytotoxic T cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.67: After overnight culture in 96-well plates, cells were harvested and counted on a TopCount NXT Microplate scintillation and luminescence counter (Packard, Boston, MA). 

Phrase: "After overnight culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "in 96-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "counted on a TopCount NXT Microplate scintillation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0678573:scintillation [Natural Phenomenon or Process]
   748   C1709027:Microplate [Research Device]
   714   C0750480:Count [Activity]
   714   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "luminescence counter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0677601:Counter [Manufactured Object]
   861   C1705206:Counter [Medical Device]

Phrase: "(Packard,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.68: Percent thymidine release was calculated as: (count control target cells) - (count apoptotic target cells) = (count control target cells) x 100. 

Phrase: "Percent thymidine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0439180:percent release [Quantitative Concept]
           % release
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: ":"

Phrase: "(count control target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0221284:Target cells [Cell]
   861   C3272919:Target Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "-"

Phrase: "(count apoptotic target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0221284:Target cells [Cell]
   861   C3272919:Target Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "="

Phrase: "(count control target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0221284:Target cells [Cell]
   861   C3272919:Target Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "x 100."
Processing 00000000.tx.69: Apoptosis was also measured by annexin-V staining using Annexin-VFLUOS Staining Kit (Roche Molecular Biochemicals, Basel, Switzerland).  

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "measured by annexin-V staining"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439828:Variable [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Annexin-VFLUOS Staining Kit (Roche Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0205474:Biochemical [Functional Concept]

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.70: Results Top Abstract Introduction Materials and methods Results Discussion References  Id-specific TCR-transgenic SCID mice are protected against challenges with Id+ B-lymphoma cells The 2315-transfected Id+ A20 cells (F9) express 2315 in their BCRs and secrete small amounts of 2315 Ig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Id-specific TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C0025936:Mice, Transgenic [Mammal]
   831   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   755   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "are"

Phrase: "protected against challenges"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0805586:challenges [Health Care Activity]
   756 E C0798503:Challenge [Clinical Attribute]
   756 E C3274764:Challenge [Conceptual Entity]

Phrase: "with Id+ B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "The 2315-transfected Id+ A20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(F9)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1366464:F9 [Gene or Genome]

Phrase: "express"

Phrase: "2315 in their BCRs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0034789:B cell receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   790   C0004561:B-cell [Cell]
   767   C1514760:Receptor Cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "small amounts of 2315 Ig."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.71: F9 cells spontaneously process 2315 and present Id (2315) peptide bound to I-Ed class II molecules on their cell surface.24,25 In initial experiments, we observed that BALB/c mice were partially resistant to F9 while C.B-17 SCID mice readily developed tumors. 

Phrase: "F9 cells spontaneously process 2315"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   836   C0007613:Cell Process [Cell Function]
   836   C0230625:Cell process [Cell Component]
   804   C0007634:Cells [Cell]
   804   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C1184743:Process [Body Part, Organ, or Organ Component]
   804   C1366464:F9 [Gene or Genome]
   804   C1522240:Process [Phenomenon or Process]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "present Id (2315"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
   827   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "bound to I-Ed class II molecules"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0441886:Class II [Intellectual Product]
   778   C2698968:Class II [Finding]
   774   C0441885:Class I [Classification]
   774   C2698967:Class I [Finding]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332297:bound [Spatial Concept]
   748   C0456387:Class [Intellectual Product]
   748   C0567416:molecules [Substance]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1705943:Class [Classification]
   748   C2349209:Bound [Conceptual Entity]
   748   C3538926:ED [Idea or Concept]

Phrase: "on their cell surface.24,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "25 In initial experiments,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205265:Initial [Temporal Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1279901:Initial [Qualitative Concept]
   770   C1555582:Initial [Idea or Concept]
   770   C1705685:INITIAL [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "partially resistant to F9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "while"

Phrase: "C.B-17 SCID mice readily developed tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0027651:Tumors [Neoplastic Process]
   756 E C1578706:Tumor [Intellectual Product]
   756 E C3273930:Tumor [Finding]
Processing 00000000.tx.72: This difference could be due to the normal B- and T-cell repertoire of BALB/c mice conferring a slight resistance against Id+ F9. 

Phrase: "This difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "could"

Phrase: "be due to the normal B-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "T-cell repertoire of BALB/c mice"

Phrase: "conferring"

Phrase: "a slight resistance against Id+ F9."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
Processing 00000000.tx.73: One possibility is that amino acids (aa's) 106 to 114 of the endogenous H chain of A20, reported to be presented on H-2Kd to CD8+ T cells,33 could induce Id-specific CD8+ T cells in BALB/c mice. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(aa's) 106 to 114 of the endogenous H chain of A20,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C1420192:heavy chain [Gene or Genome]
   738   C0205227:Endogenous [Functional Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C0439539:Heavy [Qualitative Concept]
   738   C1235746:Aa [Plant]
   738   C1524075:Chain [Idea or Concept]
   738   C1882141:aa [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "presented on H-2Kd"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439539:Heavy [Qualitative Concept]
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "to CD8+ T cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "33"

Phrase: "could"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Id-specific CD8+ T cells in BALB/c mice."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0039194:T-Cells [Cell]
   762   C0242629:Cells.CD8 [Cell]
   759   C1522237:Mouse C-Cell [Cell]
   751   C1522131:Mouse T Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.74: Alternatively, expression by F9 cells of the neomycin resistance gene encoding for a foreign phosphotransferase could induce a protective immune response in BALB/c mice. 

Phrase: "Alternatively,"

Phrase: "expression by F9 cells of the neomycin resistance gene encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017262:Gene Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for a foreign phosphotransferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Phosphotransferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a protective immune response in BALB/c mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0301872:Immune response [Organ or Tissue Function]
   744   C0439662:Immune [Functional Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.75: For the reasons above, and in particular to avoid antibodies, we did most of the current experiments in immunodeficient, Id-specific TCR-transgenic SCID mice. 

Phrase: "For the reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:reasons [Idea or Concept]

Phrase: "above,"

Phrase: "and in particular to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "avoid"

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "we"

Phrase: "did"

Phrase: "most of the current experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205393:Most [Quantitative Concept]
   760   C0521116:Current [Temporal Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1705970:Current [Natural Phenomenon or Process]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "in immunodeficient, Id-specific TCR-transgenic SCID mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   874   C1512658:Immunodeficient Mouse [Mammal]
   835   C0025936:Mice, Transgenic [Mammal]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
Processing 00000000.tx.76: Due to their recombination deficiency, TCR-transgenic SCID mice express very few endogenous Ig or TCR genes and contain hardly any B cells or antibodies or CD8+ T cells, whereas Id-specific CD4+ T cells dominate.17 Id+ F9 B-lymphoma cells were injected in titrated amounts subcutaneously between the shoulder blades of mice (Figure 1A). 

Phrase: "Due to their recombination deficiency,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0025936:Mice, Transgenic [Mammal]
   859   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   766   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "express"

Phrase: "very few endogenous Ig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C1621846:immunoglobulin [Molecular Function]

Phrase: "or"

Phrase: "TCR genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1420562:T gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "hardly"

Phrase: "any B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "CD8+ T cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "dominate.17 Id+ F9 B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   818   C0883208:Lymphoma cells [Cell]
   818   C2697951:Lymphoma Cells [Laboratory Procedure]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "injected in titrated amounts subcutaneously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1265611:amounts [Quantitative Concept]
   726   C1720154:Inject [Functional Concept]
   726   C1883350:Titrate [Health Care Activity]

Phrase: "between the shoulder blades"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0036277:Shoulder blade [Body Part, Organ, or Organ Component]
   861   C0037004:Shoulder [Body Location or Region]
   861   C0179323:blades [Medical Device]
   861   C1283792:Shoulder [Body Location or Region]
   827 E C2700402:Blade [Plant]
   827 E C2948008:Blade [Pharmacologic Substance]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.77: TCR-transgenic SCID mice were significantly protected against F9, compared with ordinary SCID mice, the extent of protection being dependent on the number of F9 cells injected. 

Phrase: "TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0025936:Mice, Transgenic [Mammal]
   859   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   766   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "were"

Phrase: "significantly"

Phrase: "protected against F9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1366464:F9 [Gene or Genome]

Phrase: "compared with ordinary SCID mice,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   835   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   814   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   778   C0494261:combined immunodeficiency [Disease or Syndrome]
   748   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205082:Severe [Qualitative Concept]
   748   C0205195:Combined [Qualitative Concept]
   748   C1707455:Compared [Activity]
   726   C1512658:Immunodeficient Mouse [Mammal]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "the extent of protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "being"

Phrase: "dependent on the number of F9 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.78: The protection was Id specific because TCR-transgenic SCID mice readily succumbed to A20 cells transfected with the empty pSV2neo vector (Id- F55 cells) (Figure 1A). 

Phrase: "The protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "TCR-transgenic SCID mice readily"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   850   C0025936:Mice, Transgenic [Mammal]
   843   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]
   760   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "succumbed to A20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the empty pSV2neo vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]

Phrase: "(Id- F55 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C0068319:ID-2 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.79: View larger version (9K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.80: Id-specific TCR-transgenic SCID mice are protected against subcutaneous challenges with Id+ B lymphomas. 

Phrase: "Id-specific TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C0025936:Mice, Transgenic [Mammal]
   831   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   755   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "are"

Phrase: "protected against subcutaneous challenges"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0443315:subcutaneous [Spatial Concept]
   770   C0805586:challenges [Health Care Activity]
   737 E C0798503:Challenge [Clinical Attribute]
   737 E C3274764:Challenge [Conceptual Entity]

Phrase: "with Id+ B lymphomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024299:Lymphomas [Neoplastic Process]
Processing 00000000.tx.81: (A) TCR-transgenic SCID mice and SCID littermates were challenged with the indicated titrated amounts of either A20 cells transfected with the 2315 Ig L chain gene (F9) or A20 cells transfected with the empty pSV2neo vector alone (F55). 

Phrase: "(A) TCR-transgenic SCID mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1522424:A Mouse [Mammal]
   850   C0025936:Mice, Transgenic [Mammal]
   843   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]
   760   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "and"

Phrase: "SCID littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "were"

Phrase: "challenged with the indicated titrated amounts of either A20 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   739   C0007634:Cells [Cell]
   739   C1265611:amounts [Quantitative Concept]
   739   C1444656:Indicated [Finding]
   739   C3282337:Cells [Cell]
   706   C0798503:Challenge [Clinical Attribute]
   706   C0805586:Challenge [Health Care Activity]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706   C1883350:Titrate [Health Care Activity]
   706 E C1948049:Cell [Spatial Concept]
   706   C3274764:Challenge [Conceptual Entity]

Phrase: "transfected with the 2315 Ig L chain gene"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0021038:Immunoglobulin Light-Chain [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0017350:Immunoglobulin gene [Gene or Genome]
   767   C1302674:Immunoglobulin chain [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0017337:Gene [Gene or Genome]
   744   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0337112:Chain [Manufactured Object]
   744   C1306462:Light [Functional Concept]
   744   C1524075:Chain [Idea or Concept]
   744   C1621846:immunoglobulin [Molecular Function]
   744   C1881376:Light [Qualitative Concept]

Phrase: "(F9)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1366464:F9 [Gene or Genome]

Phrase: "or"

Phrase: "A20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the empty pSV2neo vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(F55"

Phrase: ")."
Processing 00000000.tx.82: A palpable tumor of 3 mm was scored as a tumor take. 

Phrase: "A palpable tumor of 3 mm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0027651:Tumor [Neoplastic Process]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]

Phrase: "was"

Phrase: "scored as a tumor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0449820:scored [Quantitative Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "take."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]
Processing 00000000.tx.83: The lowest number of injected F9 cells, 1.25 x 10,3 was not tumorigenic. 

Phrase: "The lowest number of injected F9 cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "1.25 x 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "was"

Phrase: "not tumorigenic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C1519697:Tumorigenicity [Pathologic Function]
Processing 00000000.tx.84: (B) Id+ 2315 Ig in sera of mice injected 12 days earlier with 1.25 x 106 cells. 

Phrase: "(B) Id+ 2315 Ig in sera of mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0063416:immunoglobulin B [Amino Acid, Peptide, or Protein]
   750   C0858451:serum immunoglobulin [Laboratory Procedure]
   744   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C1621846:immunoglobulin [Molecular Function]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "12 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "earlier with 1.25 x 106 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1279919:Early [Temporal Concept]
Processing 00000000.tx.85: Results were statistically significant (P < .0001), Mann-Whitney test.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P < .0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Mann-Whitney test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1708930:Mann-Whitney Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.86: It is well known that B-lymphoma cells, including F9,24,25 secrete minor amounts of Ig. 

Phrase: "It"

Phrase: "is"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that B-lymphoma cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0883208:Lymphoma cells [Cell]
   901   C2697951:Lymphoma Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "F9,24,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1366464:F9 [Gene or Genome]

Phrase: "25"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "minor amounts of Ig."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]
Processing 00000000.tx.87: Because the experiments were performed in antibody-deficient scid-/- mice, it was possible to measure tumor-derived 2315 in serum in the absence of any masking by endogenously produced 2. 

Phrase: "Because"

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in antibody-deficient scid-/- mice,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0085112:SCID Mice [Mammal]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0011155:Deficient [Functional Concept]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0085110:SCID, NOS [Disease or Syndrome]
   753   C0884358:Performed [Functional Concept]
   753   C1636779:% deficient [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "it"

Phrase: "was"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "tumor-derived 2315 in serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1519667:Tumor-Derived [Functional Concept]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0229671:Serum [Body Substance]
   760   C1441547:Derived [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1578706:Tumor [Intellectual Product]
   760   C3245521:derived [Idea or Concept]
   760   C3273930:Tumor [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of any"

Phrase: "masking by endogenously"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0150112:masking [Functional Concept]
   756 E C0024861:Mask [Medical Device]
   756 E C1538279:MASK [Gene or Genome]
   756 E C1845191:MASK [Gene or Genome]

Phrase: "produced"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.88: At day 12, SCID mice injected with 1.25 x 106 F9 cells had an average serum 2315 of about 7500 ng/mL. 

Phrase: "At day 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "injected with 1.25 x 106 F9 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C1366464:F9 [Gene or Genome]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1720154:Inject [Functional Concept]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "an average serum 2315 of about 7500 ng/mL."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0439275:ng/mL [Quantitative Concept]
   742   C0229671:Serum [Body Substance]
   742   C0439526:/mL [Quantitative Concept]
   742   C1510992:Average [Quantitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.89: By comparison, TCR-transgenic SCID mice had much less 2315 Ig in their sera (average 100 ng/mL) and 6 of 14 mice had undetectable levels (Figure 1B). 

Phrase: "By comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0025936:Mice, Transgenic [Mammal]
   859   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   766   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "had"

Phrase: "much less 2315 Ig in their sera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0858451:serum immunoglobulin [Laboratory Procedure]
   748   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1621846:immunoglobulin [Molecular Function]

Phrase: "(average 100 ng/mL)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "6 of 14 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "undetectable levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Figure 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: Thus, the resistance of TCR-transgenic SCID mice against a tumor challenge with F9 (Figure 1A) was paralleled by a significant reduction in amounts of Id+ Ig in serum (Figure 1B). 

Phrase: "Thus,"

Phrase: "the resistance of TCR-transgenic SCID mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0237834:Resistance [Mental Process]
   739   C1514892:Resistance [Physiologic Function]

Phrase: "against a tumor challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "with F9 (Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "was"

Phrase: "paralleled by a significant reduction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0237881:significant [Quantitative Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C2348042:Parallel [Qualitative Concept]
   726   C2826345:PARALLEL [Research Activity]

Phrase: "in amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:amounts [Quantitative Concept]

Phrase: "of Id+ Ig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "(Figure 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: Id-specific TCR-transgenic mice on a nonleaky Rag2-/- background are protected against Id+ B lymphoma SCID mice are known to be leaky; 

Phrase: "Id-specific TCR-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "on a nonleaky Rag2-/- background"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   791   C0011155:Deficient [Functional Concept]
   791   C0017337:Gene [Gene or Genome]
   791   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1636779:% deficient [Quantitative Concept]
   791   C1706907:Background [Conceptual Entity]
   791   C1720176:On [Functional Concept]
   791   C1720294:On [Intellectual Product]
   791   C1879547:activating [Activity]
   758 E C1515877:Activate [Functional Concept]

Phrase: "are"

Phrase: "protected against Id+ B lymphoma SCID mice"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   790   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   764   C0494261:combined immunodeficiency [Disease or Syndrome]
   745   C1522021:Mouse Lymphoma [Neoplastic Process]
   742   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   742   C0024299:Lymphoma [Neoplastic Process]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0205082:Severe [Qualitative Concept]
   742   C0205195:Combined [Qualitative Concept]
   742   C0600091:ID [Intellectual Product]
   712   C1512658:Immunodeficient Mouse [Mammal]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "leaky"

Phrase: ";"
Processing 00000000.tx.92: in our TCR-transgenic SCID colony approximately 25% of adult mice had 10 to 400 g/mL IgM in serum while the remainder were negative.17 We have also detected very low frequencies of endogenous TCR rearrangement and expression in these mice (L.A.N. and B.B., unpublished, December 1998). 

Phrase: "in our TCR-transgenic SCID colony approximately 25%"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   827   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   807   C0494261:combined immunodeficiency [Disease or Syndrome]
   791   C0003069:Transgenic [Animal]
   791   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   791   C0205082:Severe [Qualitative Concept]
   791   C0205195:Combined [Qualitative Concept]
   791   C0332232:Approximately [Qualitative Concept]
   791   C0439158:colony [Quantitative Concept]
   791   C1947989:Colony [Cell]
   791   C2603360:T' [Clinical Attribute]
   758 E C0336789:Combine [Manufactured Object]

Phrase: "of adult mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "10 to 400 g/mL IgM"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "while"

Phrase: "the remainder"

Phrase: "were"

Phrase: "negative.17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "very low frequencies of endogenous TCR rearrangement"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0442811:Very low [Finding]
   744   C0205251:low [Qualitative Concept]
   744   C0439603:Frequencies [Temporal Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1550472:low [Idea or Concept]
   737   C0205213:Low frequency [Temporal Concept]
   711 E C0376249:frequency [Quantitative Concept]
   711 E C0871396:Frequency [Quantitative Concept]
   711 E C1561548:Frequency [Qualitative Concept]
   711 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "expression in these mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(L.A.N."

Phrase: "and"

Phrase: "B.B.,"

Phrase: "unpublished,"

Phrase: "December 1998"

Phrase: ")."
Processing 00000000.tx.93: We therefore repeated the tumor challenge experiment, now injecting 1.25 x 105 cells, with Id-specific TCR-transgenic mice on a nonleaky Rag2-/- BALB/c background. 

Phrase: "We therefore"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "the tumor challenge experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "injecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "1.25 x 105 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "with Id-specific TCR-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "on a nonleaky Rag2-/- BALB/c background."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   801   C0025919:BALB/C [Mammal]
   788   C0011155:Deficient [Functional Concept]
   788   C0017337:Gene [Gene or Genome]
   788   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   788   C1636779:% deficient [Quantitative Concept]
   788   C1706907:Background [Conceptual Entity]
   788   C1720176:On [Functional Concept]
   788   C1720294:On [Intellectual Product]
   788   C1879547:activating [Activity]
   755 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.94: Indeed, TCR-transgenic Rag2-/- mice were protected against F9 (Figure 2A) but not F55 (Figure 2B), while Rag2-/- succumbed to both. 

Phrase: "Indeed,"

Phrase: "TCR-transgenic Rag2-/- mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   866   C0025936:Mice, Transgenic [Mammal]
   866   C1420562:T gene [Gene or Genome]
   791   C0003069:Transgenic [Animal]
   791   C0011155:Deficient [Functional Concept]
   791   C0017337:Gene [Gene or Genome]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1636779:% deficient [Quantitative Concept]
   791   C1879547:activating [Activity]
   791   C2603360:T' [Clinical Attribute]
   758 E C1515877:Activate [Functional Concept]

Phrase: "were"

Phrase: "protected against F9 (Figure 2A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1366464:F9 [Gene or Genome]

Phrase: ")"

Phrase: "but"

Phrase: "not F55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "(Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "Rag2-/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "succumbed to both."
Processing 00000000.tx.95: These experiments exclude the necessity of B cells or antibodies, or endogenous Ig or TCR rearrangements, to protection against Id+ B lymphoma. 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the necessity of B cells"

Phrase: "or"

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "endogenous Ig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "or"

Phrase: "TCR rearrangements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511695:Rearrangements [Genetic Function]

Phrase: "to protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "against Id+ B lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.96: View larger version (12K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.97: Nonleaky Id-specific TCR-transgenic Rag2-/- mice are protected against subcutaneous challenges with Id+ B lymphomas. 

Phrase: "Nonleaky Id-specific TCR-transgenic Rag2-/- mice"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   853   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   844   C0025936:Mice, Transgenic [Mammal]
   787   C0003069:Transgenic [Animal]
   787   C0011155:Deficient [Functional Concept]
   787   C0017337:Gene [Gene or Genome]
   787   C0025914:Mice [Mammal]
   787   C0025929:mice [Mammal]
   787   C0026809:Mice [Mammal]
   787   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   787   C0205369:Specific [Qualitative Concept]
   787   C0600091:ID [Intellectual Product]
   787   C1552740:specific [Intellectual Product]
   787   C1636779:% deficient [Quantitative Concept]
   787   C1879547:activating [Activity]
   754 E C1515877:Activate [Functional Concept]

Phrase: "are"

Phrase: "protected against subcutaneous challenges"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0443315:subcutaneous [Spatial Concept]
   770   C0805586:challenges [Health Care Activity]
   737 E C0798503:Challenge [Clinical Attribute]
   737 E C3274764:Challenge [Conceptual Entity]

Phrase: "with Id+ B lymphomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024299:Lymphomas [Neoplastic Process]
Processing 00000000.tx.98: TCR-transgenic Rag2-/- mice and Rag2-/- littermates were challenged with either (A) Id+ F9 or (B) Id- F55 cells (1.25 x 105).  

Phrase: "TCR-transgenic Rag2-/- mice"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   866   C0025936:Mice, Transgenic [Mammal]
   866   C1420562:T gene [Gene or Genome]
   791   C0003069:Transgenic [Animal]
   791   C0011155:Deficient [Functional Concept]
   791   C0017337:Gene [Gene or Genome]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   791   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1636779:% deficient [Quantitative Concept]
   791   C1879547:activating [Activity]
   791   C2603360:T' [Clinical Attribute]
   758 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "Rag2-/- littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "challenged with either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0798503:Challenge [Clinical Attribute]
   756   C0805586:Challenge [Health Care Activity]
   756   C3274764:Challenge [Conceptual Entity]

Phrase: "(A) Id+ F9 or (B) Id- F55 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   712   C1825406:A-2 [Gene or Genome]
   700   C0068319:ID-2 [Amino Acid, Peptide, or Protein]

Phrase: "(1.25 x 105"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.99: Adoptively transferred Id-specific CD4+ T cells protect SCID mice against challenges with Id+ B-lymphoma cells Although the TCR-transgenic SCID mice predominantly express CD4+ T cells, they have some CD4/CD8 double negative cells, and some very few CD8+ cells, that express the transgenic TCR.17 Albeit unlikely, these cells could have contributed to the tumor protection observed in TCR-transgenic SCID mice (Figure 1A). 

Phrase: "Adoptively transferred Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   829   C0039215:cd4 cells [Cell]
   818   C0039194:T-Cells [Cell]
   813 E C3251824:CD4+ cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "protect"

Phrase: "SCID mice against challenges"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   864   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   737   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "with Id+ B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "Although"

Phrase: "the TCR-transgenic SCID mice predominantly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   850   C0025936:Mice, Transgenic [Mammal]
   843   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]
   760   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "express"

Phrase: "CD4+ T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "they"

Phrase: "have"

Phrase: "some CD4/CD8 double negative cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   897   C0039215:cd4 cells [Cell]
   881 E C3251824:CD4+ cell [Cell]
   875   C0242629:cd8 cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "some very few CD8+ cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0242629:cd8 cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "express"

Phrase: "the transgenic TCR.17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003069:Transgenic [Animal]

Phrase: "Albeit"

Phrase: "unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "have"

Phrase: "contributed to the tumor protection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027651:Tumor [Neoplastic Process]
   760   C1545588:Protection [Finding]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   726   C1880177:Contribute [Activity]

Phrase: "observed in TCR-transgenic SCID mice"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   790   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   764   C0494261:combined immunodeficiency [Disease or Syndrome]
   762   C0025936:Mice, Transgenic [Mammal]
   742   C0003069:Transgenic [Animal]
   742   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0205082:Severe [Qualitative Concept]
   742   C0205195:Combined [Qualitative Concept]
   742   C1441672:Observed [Functional Concept]
   712   C1512658:Immunodeficient Mouse [Mammal]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.100: To test this possibility, we did a number of transfer experiments. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "did"

Phrase: "a number of transfer experiments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.101: In the first set of experiments (Figure 3A-B), we used ordinary TCR-transgenic mice as donors for 2 reasons. 

Phrase: "In the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "set of experiments"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Figure 3A-B"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ordinary TCR-transgenic mice as donors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0025936:Mice, Transgenic [Mammal]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "for 2 reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.102: First, their normal lymphocyte numbers facilitated purification of sufficient amounts of CD4+ T cells for transfer. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "their normal lymphocyte numbers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0332592:Normal number [Qualitative Concept]
   901   C0200635:Lymphocyte Number [Laboratory Procedure]
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "facilitated"

Phrase: "purification of sufficient amounts of CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "for transfer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]
Processing 00000000.tx.103: Second, ordinary TCR-transgenic mice have relatively high numbers of CD8+ and CD4-8- T cells,17 which makes it easy to test any antilymphoma effect of these 2 populations. 

Phrase: "Second, ordinary TCR-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "relatively high numbers of CD8+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "CD4-8- T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   902   C0039215:cd4 cells [Cell]
   886 E C3251824:CD4+ cell [Cell]
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "17"

Phrase: "which"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it easy to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332219:Easy [Qualitative Concept]
   789 E C1331418:Ease [Mental Process]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "any antilymphoma effect of these 2 populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.104: CD4+ T cells were highly purified (> 95%) and injected intravenously into SCID mice (2 x 106 cells per mouse). 

Phrase: "CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "("

Phrase: "> 95%"

Phrase: ")"

Phrase: "and"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously into SCID mice"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   864   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   833   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   790   C0494261:combined immunodeficiency [Disease or Syndrome]
   753   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205082:Severe [Qualitative Concept]
   753   C0205195:Combined [Qualitative Concept]
   737   C1512658:Immunodeficient Mouse [Mammal]
   719 E C0336789:Combine [Manufactured Object]

Phrase: "(2 x 106 cells per mouse"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.105: Another group of mice was injected with the leftover, negatively selected CD4- cells; 

Phrase: "Another group of mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "injected with the leftover, negatively selected CD4- cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0039215:cd4 cells [Cell]
   767 E C3251824:Cells.CD4 [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   744   C3541261:CD4 [Laboratory Procedure]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1707391:Select [Activity]
   711   C1720154:Inject [Functional Concept]
   711 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.106: this population consisted of a mixture of CD8+ and CD4-8- T cells, as well as B cells. 

Phrase: "this population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "consisted of a mixture of CD8+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439962:Mixture [Substance]
   753   C3538720:CD8 [Laboratory Procedure]
   753   C3540595:CD8 [Gene or Genome]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "CD4-8- T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   902   C0039215:cd4 cells [Cell]
   886 E C3251824:CD4+ cell [Cell]
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "as well as"

Phrase: "B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.107: A third group received purified CD4+ T cells from BALB/c mice. 

Phrase: "A third group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "purified CD4+ T cells from BALB/c mice."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0039194:T-Cells [Cell]
   767   C0039215:cd4 cells [Cell]
   767   C1522237:Mouse C-Cell [Cell]
   767   C3251824:Cells.CD4 [Cell]
   760   C1522131:Mouse T Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.108: Three days later the reconstituted mice were challenged with F9 cells. 

Phrase: "Three days later"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "the reconstituted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "challenged with F9 cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0007634:Cells [Cell]
   770   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1366464:F9 [Gene or Genome]
   770   C3282337:Cells [Cell]
   737   C0798503:Challenge [Clinical Attribute]
   737   C0805586:Challenge [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.109: As can be seen in Figure 3A, transgenic Id-specific CD4+ T cells conferred a significant protection against F9 compared with either transgenic CD4- cells or BALB/c CD4+ T cells. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Figure 3A,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "transgenic Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   839   C0039215:cd4 cells [Cell]
   827   C0039194:T-Cells [Cell]
   822 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "conferred"

Phrase: "a significant protection against F9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "compared with either transgenic CD4- cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C0039215:cd4 cells [Cell]
   783 E C3251824:Cells.CD4 [Cell]
   753   C0003069:Transgenic [Animal]
   753   C0007634:Cells [Cell]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   753   C3541261:CD4 [Laboratory Procedure]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "BALB/c CD4+ T cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.110: View larger version (12K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.111: Transfer of Id-specific CD4+ T cells confers tumor protection. 

Phrase: "Transfer of Id-specific CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040671:Transfer [Mental Process]
   748   C1705822:Transfer [Activity]

Phrase: "confers"

Phrase: "tumor protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.112: (A) TCR-transgenic CD4+ cells, but not CD4- cells, protect. 

Phrase: "(A) TCR-transgenic CD4+ cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0039215:cd4 cells [Cell]
   810 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not CD4- cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0039215:cd4 cells [Cell]
   884 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "protect."
Processing 00000000.tx.113: SCID mice were reconstituted with purified TCR-transgenic CD4+ or CD4- cells, or BALB/c CD4+ T cells, injected intravenously (2 x 106). 

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "were"

Phrase: "reconstituted with purified TCR-transgenic CD4+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0003069:Transgenic [Animal]
   748   C1998793:Purified [Functional Concept]
   748   C3541261:CD4 [Laboratory Procedure]

Phrase: "or"

Phrase: "CD4- cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0039215:cd4 cells [Cell]
   983 E C3251824:CD4+ cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "BALB/c CD4+ T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously"

Phrase: "(2 x 106"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.114: Three days later, the mice were challenged with 1.25 x 105 Id+ F9 cells. 

Phrase: "Three days later,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "challenged with 1.25 x 105 Id+ F9 cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   762   C0309276:ID-1 [Pharmacologic Substance]
   742   C0007634:Cells [Cell]
   742   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0600091:ID [Intellectual Product]
   742   C1366464:F9 [Gene or Genome]
   742   C3282337:Cells [Cell]
   708   C0798503:Challenge [Clinical Attribute]
   708   C0805586:Challenge [Health Care Activity]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.115: TCR-transgenic CD4+ cells versus TCR-transgenic CD4- cells: P = .018. 

Phrase: "TCR-transgenic CD4+ cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   897   C0039194:T-Cells [Cell]
   840   C0039215:cd4 cells [Cell]
   823 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "versus"

Phrase: "TCR-transgenic CD4- cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   897   C0039194:T-Cells [Cell]
   840   C0039215:cd4 cells [Cell]
   823 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "P = .018."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.116: TCR-transgenic CD4+ cells versus BALB/c CD4+ cells: P = .0014. 

Phrase: "TCR-transgenic CD4+ cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   897   C0039194:T-Cells [Cell]
   840   C0039215:cd4 cells [Cell]
   823 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "versus"

Phrase: "BALB/c CD4+ cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0039215:cd4 cells [Cell]
   844 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "P = .0014."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.117: TCR transgenic CD4- versus BALB/c: P = 0.59. 

Phrase: "TCR transgenic CD4-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3541261:CD4 [Laboratory Procedure]

Phrase: "versus"

Phrase: "BALB/c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025919:BALB/C [Mammal]

Phrase: ":"

Phrase: "P = 0.59."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.118: (B) Number of Id-specific CD4+ T cells required for transfer of protection. 

Phrase: "(B) Number of Id-specific CD4+ T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "required for transfer of protection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040671:Transfer [Mental Process]
   760   C1514873:Required [Functional Concept]
   760   C1545588:Protection [Finding]
   760   C1705822:Transfer [Activity]
Processing 00000000.tx.119: Groups of Rag2-/- mice were injected intravenously with the indicated titrated amounts of purified TCR-transgenic CD4+ T cells, or left nonreconstituted, and challenged 3 days later with 1.25 x 105 F9 cells. 

Phrase: "Groups of Rag2-/- mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0441865:Group 2 [Intellectual Product]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously with the indicated titrated amounts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1265611:amounts [Quantitative Concept]
   753   C1444656:Indicated [Finding]
   719   C1883350:Titrate [Health Care Activity]

Phrase: "of purified TCR-transgenic CD4+ T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   877   C0039194:T-Cells [Cell]
   829   C0039215:cd4 cells [Cell]
   813 E C3251824:CD4+ cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "left nonreconstituted,"

Phrase: "and"

Phrase: "challenged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0798503:Challenge [Clinical Attribute]
   966   C0805586:Challenge [Health Care Activity]
   966   C3274764:Challenge [Conceptual Entity]

Phrase: "3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "later with 1.25 x 105 F9 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0205087:Late [Temporal Concept]
Processing 00000000.tx.120: (C) Id-specific CD4+ T cells purified from recombination deficient TCR-transgenic SCID mice confer protection. 

Phrase: "(C) Id-specific CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   878   C0229579:C-Cell [Cell]
   839   C0039215:cd4 cells [Cell]
   827   C0039194:T-Cells [Cell]
   822 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "purified from recombination deficient TCR-transgenic SCID mice"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   779   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   775   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   756   C0494261:combined immunodeficiency [Disease or Syndrome]
   754   C0025936:Mice, Transgenic [Mammal]
   738   C0003069:Transgenic [Animal]
   738   C0011155:Deficient [Functional Concept]
   738   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0034865:Recombination [Genetic Function]
   738   C0205082:Severe [Qualitative Concept]
   738   C0205195:Combined [Qualitative Concept]
   738   C1636779:% deficient [Quantitative Concept]
   738   C1998793:Purified [Functional Concept]
   704 E C0336789:Combine [Manufactured Object]
   703   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "confer"

Phrase: "protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]
Processing 00000000.tx.121: Groups of SCID mice were reconstituted with 2.5 x 105 CD4+ cells purified from either TCR-transgenic SCID or BALB/c mice, or left nonreconstituted. 

Phrase: "Groups of SCID mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "reconstituted with 2.5 x 105 CD4+ cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0039215:cd4 cells [Cell]
   767 E C3251824:Cells.CD4 [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   744   C3541261:CD4 [Laboratory Procedure]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "purified from either TCR-transgenic SCID"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   764   C0494261:combined immunodeficiency [Disease or Syndrome]
   742   C0003069:Transgenic [Animal]
   742   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   742   C0205082:Severe [Qualitative Concept]
   742   C0205195:Combined [Qualitative Concept]
   742   C1998793:Purified [Functional Concept]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "or"

Phrase: "BALB/c mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "or"

Phrase: "left nonreconstituted."
Processing 00000000.tx.122: Three days later, the mice were challenged with 1.25 x 105 F9 cells. 

Phrase: "Three days later,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "challenged with 1.25 x 105 F9 cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0007634:Cells [Cell]
   744   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C1366464:F9 [Gene or Genome]
   744   C3282337:Cells [Cell]
   711   C0798503:Challenge [Clinical Attribute]
   711   C0805586:Challenge [Health Care Activity]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.123: TCR-transgenic SCID CD4+ cells versus BALB/c CD4+ cells: P = .014. 

Phrase: "TCR-transgenic SCID CD4+ cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   892   C0039194:T-Cells [Cell]
   812   C0039215:cd4 cells [Cell]
   795 E C3251824:CD4+ cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "versus"

Phrase: "BALB/c CD4+ cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0039215:cd4 cells [Cell]
   844 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "P = .014."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.124: BALB/c CD4+ versus nonreconstituted mice: P = .44.  

Phrase: "BALB/c CD4+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3541261:CD4 [Laboratory Procedure]
   734   C0025919:BALB/C [Mammal]

Phrase: "versus"

Phrase: "nonreconstituted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "P = .44."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.125: To determine the number of T cells needed to protect against Id+ B-lymphoma cells, titrated amounts of TCR-transgenic CD4+ T cells in the range of 2 x 106 to 1.25 x 105 were transferred to SCID recipients prior to challenge with 1.25 x 105 F9 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the number of T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect against Id+ B-lymphoma cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   809   C0079731:cell b lymphoma [Neoplastic Process]
   790   C0883208:Lymphoma cells [Cell]
   790   C2697951:Lymphoma Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0024299:Lymphoma [Neoplastic Process]
   753   C0600091:ID [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "titrated amounts of TCR-transgenic CD4+ T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:amounts [Quantitative Concept]

Phrase: "in the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of 2 x 106"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "to 1.25 x 105"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "were"

Phrase: "transferred to SCID recipients"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   790   C0494261:combined immunodeficiency [Disease or Syndrome]
   753   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   753   C0205082:Severe [Qualitative Concept]
   753   C0205195:Combined [Qualitative Concept]
   753   C0348011:transferred [Functional Concept]
   719 E C0040671:Transfer [Mental Process]
   719 E C0336789:Combine [Manufactured Object]
   719 E C1705822:Transfer [Activity]
   719   C1709854:Recipient [Human]

Phrase: "prior to challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "with 1.25 x 105 F9 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: None of the twelve mice developed tumors, indicating that transfer of more than 1.25 x 105 purified Id-specific CD4+ T cells suffice for complete protection (data not shown). 

Phrase: "None of the twelve mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205458:Twelve [Quantitative Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]

Phrase: "developed"

Phrase: "tumors,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "indicating"

Phrase: "that transfer of more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]

Phrase: "than 1.25 x 105 purified Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   813   C0039215:cd4 cells [Cell]
   804   C0039194:T-Cells [Cell]
   796 E C3251824:CD4+ cell [Cell]
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "suffice for complete protection"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205197:Complete [Qualitative Concept]
   770   C0725685:COMPLEAT [Food]
   770   C1545588:Protection [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: In the next experiment TCR transgenic CD4+ T cells titrated over a wider range were transferred to Rag2-/- recipients (Figure 3B). 

Phrase: "In the next experiment TCR transgenic CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   864   C0039194:T-Cells [Cell]
   822   C0039215:cd4 cells [Cell]
   806 E C3251824:CD4+ cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "titrated over a wider range"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]
   726   C0332464:Wide [Spatial Concept]
   726   C1883350:Titrate [Health Care Activity]

Phrase: "were"

Phrase: "transferred to Rag2-/- recipients"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   750   C1517499:Gene Transfer [Molecular Biology Research Technique]
   744   C0011155:Deficient [Functional Concept]
   744   C0017337:Gene [Gene or Genome]
   744   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0348011:transferred [Functional Concept]
   744   C1636779:% deficient [Quantitative Concept]
   744   C1879547:activating [Activity]
   711 E C0040671:Transfer [Mental Process]
   711 E C1515877:Activate [Functional Concept]
   711 E C1705822:Transfer [Activity]
   711   C1709854:Recipient [Human]

Phrase: "(Figure 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.128: All mice in the nonreconstituted control group acquired tumors within 28 days. 

Phrase: "All mice in the nonreconstituted control group acquired tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "within 28 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.129: Transfer of more than 8 x 103 cells retarded tumor development while partial to complete tumor avoidance required more than 2 x 105 cells. 

Phrase: "Transfer of more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040671:Transfer [Mental Process]
   790   C1705822:Transfer [Activity]

Phrase: "than 8 x 103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "retarded"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:Retarded [Qualitative Concept]
   928 E C0311403:Inhibited [Qualitative Concept]
   928 E C3463820:Inhibiting [Activity]
   907 E C0018790:arrested [Disease or Syndrome]
   907 E C0237477:Arrest [Temporal Concept]
   907 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "tumor development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "while"

Phrase: "partial to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0728938:Partial [Quantitative Concept]
   861   C1550516:partial [Idea or Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "tumor avoidance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870186:Avoidance [Mental Process]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "more than 2 x 105 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C0205172:More [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.130: To exclude any influence of endogenous TCR genes, we repeated the experiment with recombination-deficient TCR-transgenic SCID mice. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "any influence of endogenous TCR genes,"

Phrase: "we"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "with recombination-deficient TCR-transgenic SCID mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C0025936:Mice, Transgenic [Mammal]
   831   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]
   755   C1512658:Immunodeficient Mouse [Mammal]
Processing 00000000.tx.131: Purified CD4+ cells from such SPF-standard mice should be antigen inexperienced and thus naive. 

Phrase: "Purified CD4+ cells from such SPF-standard mice"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0039215:cd4 cells [Cell]
   757 E C3251824:Cells.CD4 [Cell]
   741   C1183428:Free cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "should"

Phrase: "be"

Phrase: "antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "inexperienced"

Phrase: "and"

Phrase: "thus naive."
Processing 00000000.tx.132: As can be seen from Figure 3C, 2.5 x 105 Id-specific CD4+ TCR-transgenic SCID cells conferred a significant protection. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen from Figure 3C,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C0450366:3c [Intellectual Product]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "2.5 x 105 Id-specific CD4+ TCR-transgenic SCID cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   842   C0039215:cd4 cells [Cell]
   825 E C3251824:CD4+ cell [Cell]
   786   C0007634:Cells [Cell]
   786   C3282337:Cells [Cell]
   752 E C1269647:Cell [Cell]
   752 E C1704653:Cell [Medical Device]
   752 E C1948049:Cell [Spatial Concept]

Phrase: "conferred"

Phrase: "a significant protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.133: Hence, transfer of a few hundred thousand Id-specific CD4+ T cells prevent tumor occurrence while smaller amounts may retard development. 

Phrase: "Hence,"

Phrase: "transfer of a few hundred thousand Id-specific CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0040671:Transfer [Mental Process]
   738   C1705822:Transfer [Activity]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "tumor occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243132:occurrence [Functional Concept]
   861   C1554210:occurrence [Idea or Concept]
   861   C2745955:Occurrence [Temporal Concept]

Phrase: "while"

Phrase: "smaller amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "may"

Phrase: "retard"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.134: Immunotherapy with Id-specific CD4+ T cells We next tested the curative potential of Id-specific TCR-transgenic CD4+ T cells in SCID mice previously injected with Id+ F9 cells. 

Phrase: "Immunotherapy with Id-specific CD4+ T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021083:Immunotherapy [Therapeutic or Preventive Procedure]

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the curative potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "of Id-specific TCR-transgenic CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   864   C0039194:T-Cells [Cell]
   822   C0039215:cd4 cells [Cell]
   806 E C3251824:CD4+ cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "in SCID mice previously"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   919   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   787   C1512658:Immunodeficient Mouse [Mammal]
   717   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "injected with Id+ F9 cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0600091:ID [Intellectual Product]
   760   C1366464:F9 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726   C1720154:Inject [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: All nonreconstituted mice developed tumors, 6 of 7 within the first 35 days (Figure 4). 

Phrase: "All nonreconstituted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "tumors,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "6 of 7"

Phrase: "within the first 35 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "(Figure 4"

Phrase: ")."
Processing 00000000.tx.136: By contrast, only 1 of 12 mice reconstituted with Id-specific CD4+ T cells on day 0 or day 3 developed a tumor within 120 days. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "only 1 of 12 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "reconstituted with Id-specific CD4+ T cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0039194:T-Cells [Cell]
   774   C0039215:cd4 cells [Cell]
   774   C3251824:Cells.CD4 [Cell]
   748   C0007634:Cells [Cell]
   748   C0205369:Specific [Qualitative Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1552740:specific [Intellectual Product]
   748   C3282337:Cells [Cell]
   748   C3541261:CD4 [Laboratory Procedure]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "on day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "or"

Phrase: "day 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "developed"

Phrase: "a tumor within 120 days."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
Processing 00000000.tx.137: Protection by transfer on day 6 was less impressive with 2 of 6 mice developing rapidly growing tumors within 30 days (Figure 4). 

Phrase: "Protection by transfer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "on day 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "was"

Phrase: "less impressive with 2 of 6 mice"

Phrase: "developing"

Phrase: "rapidly growing tumors within 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0027651:Tumors [Neoplastic Process]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "(Figure 4"

Phrase: ")."
Processing 00000000.tx.138: When Id-specific CD4+ cell transfer was delayed until days 10, 13, or 17 after F9 injection, a striking phenomenon was observed: within a few days, most mice developed an acute swelling of up to 20 mm that is recorded as tumor occurrence in Figure 4 (bottom row). 

Phrase: "When"

Phrase: "Id-specific CD4+ cell transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0040671:Transfer [Mental Process]
   804   C1705822:Transfer [Activity]

Phrase: "was"

Phrase: "delayed until days 10,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   819   C1547061:10 days [Temporal Concept]
   770   C0205421:Delayed [Temporal Concept]
   770   C0439228:days [Temporal Concept]
   770   C3272602:Delayed [Qualitative Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "13,"

Phrase: "or"

Phrase: "17 after F9 injection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1366464:F9 [Gene or Genome]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "a striking phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ":"

Phrase: "within a few days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "most mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "developed"

Phrase: "an acute swelling of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013604:SWELLING [Pathologic Function]
   770   C0038999:Swelling [Finding]

Phrase: "up to 20 mm"

Phrase: "that"

Phrase: "is"

Phrase: "recorded as tumor occurrence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0243132:occurrence [Functional Concept]
   770   C1554210:occurrence [Idea or Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C2745955:Occurrence [Temporal Concept]
   770   C3273930:Tumor [Finding]
   737   C0034869:Record [Intellectual Product]

Phrase: "in Figure 4"

Phrase: "(bottom row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.139: The swelling did not reflect tumor growth because it increased dramatically in size within a few days and then often receded to be unpalpable within some weeks. 

Phrase: "The swelling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0013604:SWELLING [Pathologic Function]
  1000   C0038999:Swelling [Finding]
   907 E C1709317:Oncosis [Cell Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "tumor growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0598934:tumor growth [Neoplastic Process]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0220844:growth [Physiologic Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   861   C3273930:Tumor [Finding]

Phrase: "because"

Phrase: "it"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "dramatically in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "within a few days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "then often"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332183:Often [Temporal Concept]
   861   C1883708:Then [Temporal Concept]

Phrase: "receded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3264698:Recede [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "unpalpable within some weeks."
Processing 00000000.tx.140: In a considerable number of long-term survivors, a nodule remnant could be palpated, possibly reflecting fibrosis. 

Phrase: "In a considerable number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of long-term survivors,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0206193:Long-Term Survivors [Patient or Disabled Group]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0206194:Survivors [Patient or Disabled Group]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "a nodule remnant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272697:Remnant [Embryonic Structure]

Phrase: "could"

Phrase: "be"

Phrase: "palpated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0013987:feel [Mental Process]
   928   C1527305:Feeling, NOS [Mental Process]

Phrase: ","

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "fibrosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016059:Fibrosis [Pathologic Function]
   928 E C0334129:Fibrotic [Functional Concept]
Processing 00000000.tx.141: In 11 of 18 mice, late tumors (emerging after day 50) developed, marked by asterisks in Figure 4. 

Phrase: "In 11"

Phrase: "of 18 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "late tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "(emerging after day 50"

Phrase: ")"

Phrase: "developed,"

Phrase: "marked by asterisks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   790   C2945706:asterisks [Conceptual Entity]

Phrase: "in Figure 4."
Processing 00000000.tx.142: View larger version (30K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.143: Curative potential of Id-specific CD4+ T cells. 

Phrase: "Curative potential of Id-specific CD4+ T cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.144: Groups of SCID mice (n = 6-7) were injected with 1.25 x 105 F9 cells at day 0 in all graphs. 

Phrase: "Groups of SCID mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "(n = 6-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441922:N+ [Intellectual Product]
   827   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "injected with 1.25 x 105 F9 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C1366464:F9 [Gene or Genome]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1720154:Inject [Functional Concept]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "at day 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "in all graphs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]
Processing 00000000.tx.145: At the indicated time points subsequent to tumor cell injection, mice received 106 CD4+ T cells purified from TCR-transgenic mice. 

Phrase: "At the indicated time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "subsequent to tumor cell injection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "106 CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   875   C0039215:cd4 cells [Cell]
   861   C0039194:T-Cells [Cell]
   858 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "purified from TCR-transgenic mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.146: Percent tumor avoidance (short dashes; tumor  3 mm was defined as tumor take), % survival (long dashes), and tumor size in diameter (solid lines; mm) were recorded (split y-axis). 

Phrase: "Percent tumor avoidance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870186:Avoidance [Mental Process]

Phrase: "(short dashes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827624:DASH [Intellectual Product]

Phrase: "; tumor  3 mm"

Phrase: "was"

Phrase: "defined as tumor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0027651:Tumor [Neoplastic Process]
   790   C1578706:Tumor [Intellectual Product]
   790   C1704788:Defined [Conceptual Entity]
   790   C3273930:Tumor [Finding]
   790   C3539106:Defined [Intellectual Product]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: ")"

Phrase: ","

Phrase: "% survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "(long dashes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827624:DASH [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "tumor size in diameter"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0475440:Tumor size [Spatial Concept]
   819 E C0804677:Size Tumor [Clinical Attribute]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0456389:size [Spatial Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "(solid lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "; mm)"

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "(split y-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0004457:Axis [Body Part, Organ, or Organ Component]
   827   C0999597:Axis [Mammal]
   827   C1522496:Axis [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.147: * indicates late emergence of tumors (survival  60 days). 

Phrase: "*"

Phrase: "indicates"

Phrase: "late emergence of tumors"

Phrase: "(survival  60 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.148: P value in each graph represents comparison with nonreconstituted mice for survival.  

Phrase: "P value in each graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1709380:P-Value [Quantitative Concept]
   760   C1522609:Value [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "comparison with nonreconstituted mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "for survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]
Processing 00000000.tx.149: Id-specific CD4+ T cells accumulate and are activated in Id+ B-lymphoma tumors The results in Figure 4 suggest that Id-specific CD4+ T cells find their way to the tumor and become activated with inflammation and tumor cell eradication as a result. 

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "accumulate"

Phrase: "and"

Phrase: "are"

Phrase: "activated in Id+ B-lymphoma tumors"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0024299:Lymphoma [Neoplastic Process]
   753   C0027651:Tumors [Neoplastic Process]
   753   C0600091:ID [Intellectual Product]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "The results in Figure 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "their way to the tumor"

Phrase: "and"

Phrase: "become"

Phrase: "activated with inflammation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021368:Inflammation [Pathologic Function]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "tumor cell eradication as a result."
Processing 00000000.tx.150: To test this, SCID mice were first injected with F9 or F55 and were 13 days later injected with 106 Id-specific CD4+ T cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this,"

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "injected with F9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1366464:F9 [Gene or Genome]
   756   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "F55"

Phrase: "and"

Phrase: "were"

Phrase: "13 days later"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "injected with 106 Id-specific CD4+ T cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0039194:T-Cells [Cell]
   767   C0039215:cd4 cells [Cell]
   767   C3251824:Cells.CD4 [Cell]
   744   C0007634:Cells [Cell]
   744   C0205369:Specific [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1552740:specific [Intellectual Product]
   744   C3282337:Cells [Cell]
   744   C3541261:CD4 [Laboratory Procedure]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1720154:Inject [Functional Concept]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.151: At this time point, no tumors could be palpated. 

Phrase: "At this time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "no tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "could"

Phrase: "be"

Phrase: "palpated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0013987:feel [Mental Process]
   928   C1527305:Feeling, NOS [Mental Process]
Processing 00000000.tx.152: Five days later, 2 small F55 tumors (each 2 mm diameter, 4.2 mm3 volume, average 13.3 x 106 cells) and 2 larger F9 tumors (8 and 10 mm diameter, 270 and 520 mm3 volume, 28 x 106 and 34 x 106 cells) were observed. 

Phrase: "Five days later,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C1708065:FIVE-DAY [Intellectual Product]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "2 small F55 tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0475277:small tumors [Qualitative Concept]
   804   C0027651:Tumors [Neoplastic Process]
   771 E C1578706:Tumor [Intellectual Product]
   771 E C3273930:Tumor [Finding]

Phrase: "("

Phrase: "each 2 mm diameter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: "4.2 mm3 volume,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "average 13.3 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "2 larger F9 tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C0475278:Large tumor [Qualitative Concept]
   812   C0027651:Tumors [Neoplastic Process]
   779 E C1578706:Tumor [Intellectual Product]
   779 E C3273930:Tumor [Finding]

Phrase: "(8"

Phrase: "and"

Phrase: "10 mm diameter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: "270"

Phrase: "and"

Phrase: "520 mm3 volume,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "28 x 106"

Phrase: "and"

Phrase: "34 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.153: The F9 tumors were apparently inflammatory and edematous because the numbers of cells recovered were much less than that expected from their calculated volumes (F9/F55 cell ratio approximately 2:1; 

Phrase: "The F9 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "apparently inflammatory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333348:Inflammatory [Functional Concept]

Phrase: "and"

Phrase: "edematous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013604:Edematous [Pathologic Function]

Phrase: "because"

Phrase: "the numbers of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "were"

Phrase: "much less than that"

Phrase: "expected from their calculated volumes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0444686:Calculated [Functional Concept]
   760   C0449468:volumes [Quantitative Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1517001:Expected [Idea or Concept]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "(F9/F55 cell ratio approximately 2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   795   C0007634:Cell [Cell]
   795   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C0332232:Approximately [Qualitative Concept]
   795   C0456603:Ratio [Quantitative Concept]
   795   C1269647:Cell [Cell]
   795   C1366464:F9 [Gene or Genome]
   795   C1547037:Ratio [Intellectual Product]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.154: volume ratio approximately 100:1). 

Phrase: "volume ratio approximately 100"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1547056:*Volume Ratio [Quantitative Concept]
   812   C0332232:Approximately [Qualitative Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.155: In single-cell suspensions derived from the tumors, Id-specific CD4+ T cells were more frequent, more activated (CD69+), and had a more blastlike appearance in F9 compared with F55 tumors (Figure 5). 

Phrase: "In single-cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0038960:Suspensions [Biomedical or Dental Material]
   793 E C1382107:Suspension [Substance]
   793 E C1705537:Suspension [Functional Concept]

Phrase: "derived from the tumors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   802   C1519667:Tumor-Derived [Functional Concept]
   770   C0027651:Tumors [Neoplastic Process]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "more frequent, more"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0205172:More [Functional Concept]
   827   C0332183:Frequent [Temporal Concept]
   755 E C0376249:frequency [Quantitative Concept]
   755 E C0439603:Frequencies [Temporal Concept]
   755 E C0871396:Frequency [Quantitative Concept]
   755 E C1561548:Frequency [Qualitative Concept]
   755 E C1705502:Frequency [Quantitative Concept]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "(CD69+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540471:CD69 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "had"

Phrase: "a more blastlike appearance in F9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "compared with F55 tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0027651:Tumors [Neoplastic Process]
   760   C1707455:Compared [Activity]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "(Figure 5"

Phrase: ")."
Processing 00000000.tx.156: View larger version (28K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.157: Id-specific CD4+ T cells accumulate and become activated in Id+ B-lymphoma tumors. 

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "accumulate"

Phrase: "and"

Phrase: "become"

Phrase: "activated in Id+ B-lymphoma tumors."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0024299:Lymphoma [Neoplastic Process]
   753   C0027651:Tumors [Neoplastic Process]
   753   C0600091:ID [Intellectual Product]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]
Processing 00000000.tx.158: SCID mice were injected with 1.25 x 105 F9 or F55 cells and 13 days later received 106 Id-specific CD4+ cells purified from TCR-transgenic mice. 

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "were"

Phrase: "injected with 1.25 x 105 F9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1366464:F9 [Gene or Genome]
   714   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "F55 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "13 days later"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "106 Id-specific CD4+ cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   840   C0039215:cd4 cells [Cell]
   823 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "purified from TCR-transgenic mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.159: At this time point, none of the mice had tumors. 

Phrase: "At this time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "none of the mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "had"

Phrase: "tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]
Processing 00000000.tx.160: Five days later, single-cell suspensions from 2 F55 tumors (2 mm) and 2 F9 tumors (8-10 mm) were analyzed by flow cytometry. 

Phrase: "Five days later,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C1708065:FIVE-DAY [Intellectual Product]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "single-cell suspensions from 2 F55 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0038960:Suspensions [Biomedical or Dental Material]
   711 E C1382107:Suspension [Substance]
   711 E C1705537:Suspension [Functional Concept]

Phrase: "(2 mm)"

Phrase: "and"

Phrase: "2 F9 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "(8-10 mm)"

Phrase: "were"

Phrase: "analyzed by flow cytometry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.161: (A) Number of Id-specific (GB113+) CD4+ T cells per 106 F9 and F55 tumor cells. 

Phrase: "(A) Number of Id-specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(GB113+"

Phrase: ")"

Phrase: "CD4+ T cells per 106 F9"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0039194:T-Cells [Cell]
   783   C0039215:cd4 cells [Cell]
   783   C3251824:Cells.CD4 [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "F55 tumor cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: (B) Number of activated (CD69+ GB113+) CD4+ cells per 106 F9 and F55 tumor cells. 

Phrase: "(B) Number of activated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "(CD69+ GB113+"

Phrase: ")"

Phrase: "CD4+ cells per 106 F9"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0039215:cd4 cells [Cell]
   797 E C3251824:Cells.CD4 [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "F55 tumor cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.163: (C) Gated GB113+ CD4+ T cells in F9 and F55 tumor cell suspensions were analyzed for CD69 expression and size (forward scatter [FSC]).  

Phrase: "(C) Gated GB113+ CD4+ T cells in F9"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0039194:T-Cells [Cell]
   767   C0039215:cd4 cells [Cell]
   767   C3251824:Cells.CD4 [Cell]
   750   C0229579:C-Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "F55 tumor cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0038960:Suspensions [Biomedical or Dental Material]
   771 E C1382107:Suspension [Substance]
   771 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "analyzed for CD69 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C3540471:CD69 [Gene or Genome]

Phrase: "and"

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "(forward scatter [FSC]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439742:scatter [Spatial Concept]
   861   C0439780:Forward [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.164: Infiltration of Id-specific T cells and neutrophils in inflamed Id+ B-lymphoma tumors SCID mice were injected subcutaneously with F9 and F55 cells. 

Phrase: "Infiltration of Id-specific T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332448:Infiltration [Pathologic Function]
   753   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   753   C1523986:Infiltration [Functional Concept]

Phrase: "and"

Phrase: "neutrophils in inflamed Id+ B-lymphoma tumors SCID mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0027950:Neutrophils [Cell]
   721   C1524102:Mouse Neutrophil [Cell]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "subcutaneously with F9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1366464:F9 [Gene or Genome]

Phrase: "and"

Phrase: "F55 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.165: When tumors were barely palpable (approximately 3 mm), mice did or did not receive Id-specific CD4+ T cells, and tumors were analyzed by immunohistochemistry 4 to 5 days later. 

Phrase: "When"

Phrase: "tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "barely palpable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522499:Palpable [Qualitative Concept]

Phrase: "(approximately 3 mm"

Phrase: ")"

Phrase: ","

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "or"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "Id-specific CD4+ T cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "analyzed by immunohistochemistry 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021044:Immunohistochemistry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "to 5 days later."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1442466:5 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.166: For each combination of Id+ or Id- B lymphoma with or without Id-specific T cells, 2 to 4 animals were analyzed with similar results as that shown in Figure 6. 

Phrase: "For each combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "of Id+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "or"

Phrase: "Id- B lymphoma with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024299:Lymphoma [Neoplastic Process]

Phrase: "or without Id-specific T cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0039194:T-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0205369:Specific [Qualitative Concept]
   753   C0600091:ID [Intellectual Product]
   753   C1552740:specific [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "2 to 4 animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003062:Animals [Animal]
   770   C0740116:+2 [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "analyzed with similar results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0936012:Analyzed [Research Activity]
   770   C2348205:Similar [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "as that"

Phrase: "shown in Figure 6."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.167: Acutely inflamed Id+ F9 tumors from SCID mice that had received Id-specific CD4+ T cells were edematous and had perivascular leukocyte infiltrations dominated by polymorph nuclear (PMN) granulocytes (Figure 6A hematoxylin and eosin [H&E] stain). 

Phrase: "Acutely inflamed Id+ F9 tumors from SCID mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0027651:Tumors [Neoplastic Process]
   706 E C1578706:Tumor [Intellectual Product]
   706 E C3273930:Tumor [Finding]

Phrase: "that"

Phrase: "had"

Phrase: "received Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   839   C0039215:cd4 cells [Cell]
   827   C0039194:T-Cells [Cell]
   822 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "edematous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013604:Edematous [Pathologic Function]

Phrase: "and"

Phrase: "had"

Phrase: "perivascular leukocyte infiltrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0702249:Infiltrations [Therapeutic or Preventive Procedure]
   793 E C0332448:Infiltration [Pathologic Function]
   793 E C1523986:Infiltration [Functional Concept]

Phrase: "dominated by polymorph nuclear (PMN) granulocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018183:Granulocytes [Cell]
   760   C0027950:Polymorph [Cell]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0857490:Granulocytes [Laboratory Procedure]

Phrase: "(Figure 6A hematoxylin and eosin [H&E] stain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   858   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   799   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   799   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.168: Immunohistochemistry confirmed the presence of Ly-6G+ PMN granulocytes in proximity to CD31+ vessels (Figure 6B and data not shown). 

Phrase: "Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of Ly-6G+ PMN granulocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514583:Proximity [Spatial Concept]

Phrase: "to CD31+ vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(Figure 6B"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.169: Moreover, the tumor-infiltrating neutrophils were readily found in close contact to surface Ig (sIg)G+ F9 tumor cells (Figure 6B). 

Phrase: "Moreover,"

Phrase: "the tumor-infiltrating neutrophils"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027950:Neutrophils [Cell]
   743 E C0746885:neutrophilic [Cell Function]
   721 E C0151683:Neutrophilia [Finding]

Phrase: "were"

Phrase: "readily"

Phrase: "found in close contact"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0150312:Found [Quantitative Concept]
   770   C0332158:contact [Functional Concept]
   770   C0337611:Contact [Population Group]
   770   C0587267:Close [Functional Concept]
   770   C1705415:Contact [Idea or Concept]
   737 E C0243095:Find [Finding]

Phrase: "to surface Ig (sIg)G+ F9 tumor cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   858   C0524983:G Cells [Cell]
   827   C0431085:Tumor cells [Cell]
   799   C0007634:Cells [Cell]
   799   C0027651:Tumor [Neoplastic Process]
   799   C1578706:Tumor [Intellectual Product]
   799   C3273930:Tumor [Finding]
   799   C3282337:Cells [Cell]
   793 E C0597032:Tumor Cell [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 6B"

Phrase: ")."
Processing 00000000.tx.170: No such infiltrates were found in Id+ F9 tumors in mice that had not received T cells (Figure 6C) or in Id- F55 tumors in recipients of T cells (Figure 6D). 

Phrase: "No"

Phrase: "such infiltrates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:INFILTRATES [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "were"

Phrase: "found in Id+ F9 tumors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0027651:Tumors [Neoplastic Process]
   760   C0150312:Found [Quantitative Concept]
   760   C0600091:ID [Intellectual Product]
   760   C1366464:F9 [Gene or Genome]
   726 E C0243095:Find [Finding]
   726 E C1578706:Tumor [Intellectual Product]
   726 E C3273930:Tumor [Finding]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "had"

Phrase: "not received T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 6C"

Phrase: ")"

Phrase: "or in Id- F55 tumors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   783   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   753   C0027651:Tumors [Neoplastic Process]
   753   C0600091:ID [Intellectual Product]
   719 E C1578706:Tumor [Intellectual Product]
   719 E C3273930:Tumor [Finding]

Phrase: "in recipients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709854:Recipient [Human]

Phrase: "of T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 6D"

Phrase: ")."
Processing 00000000.tx.171: The occurrence of neutrophils as a sign of inflammation was therefore dependent on both injection of Id-specific T cells and Id expression of tumor cells. 

Phrase: "The occurrence of neutrophils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243132:occurrence [Functional Concept]
   770   C1554210:occurrence [Idea or Concept]
   770   C2745955:Occurrence [Temporal Concept]

Phrase: "as a sign"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0311392:Sign [Finding]
  1000   C1547188:Sign [Idea or Concept]

Phrase: "of inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "was"

Phrase: "therefore dependent on both injection of Id-specific T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0851827:Dependent [Qualitative Concept]
   739   C1701901:Dependent [Qualitative Concept]
   739   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Id expression of tumor cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.172: Further, we analyzed if Id-specific CD4+ T cells could be found in F9 tumors in T-cellinjected mice. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "if"

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "found in F9 tumors"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0027651:Tumors [Neoplastic Process]
   770   C0150312:Found [Quantitative Concept]
   770   C1366464:F9 [Gene or Genome]
   737 E C0243095:Find [Finding]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "in T-cellinjected mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.173: Indeed, some few TCR transgenic GB113+ T cells were found infiltrating the F9 tumors, and in some cases they were found to be in direct contact with F9 cells (Figure 6E and data not shown). 

Phrase: "Indeed,"

Phrase: "some few TCR transgenic GB113+ T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   877   C0039194:T-Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "infiltrating"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:Infiltrating [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "the F9 tumors,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "and in some cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "they"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in direct contact"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332158:contact [Functional Concept]
   770   C0337611:Contact [Population Group]
   770   C0439851:Direct [Qualitative Concept]
   770   C1705415:Contact [Idea or Concept]
   770   C1947931:Direct [Qualitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "with F9 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 6E"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: View larger version (92K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(92K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.175: Histologic analysis of inflamed F9 tumors after injection of Id-specific T cells. 

Phrase: "Histologic analysis of inflamed F9 tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of Id-specific T cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.176: SCID mice with barely palpable subcutaneous F9 or F55 tumors were injected intravenously with purified Id-specific CD4+ T cells (1 x 106) and analyzed 4 to 5 days later. 

Phrase: "SCID mice with barely palpable subcutaneous F9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   712   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "or"

Phrase: "F55 tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously with purified Id-specific CD4+ T cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0039194:T-Cells [Cell]
   767   C0039215:cd4 cells [Cell]
   767   C3251824:Cells.CD4 [Cell]
   744   C0007634:Cells [Cell]
   744   C0205369:Specific [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1552740:specific [Intellectual Product]
   744   C1998793:Purified [Functional Concept]
   744   C3282337:Cells [Cell]
   744   C3541261:CD4 [Laboratory Procedure]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(1 x 106"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "4 to 5 days later."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C0450367:4 5 [Quantitative Concept]
   797   C1442765:4 Days [Temporal Concept]
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.177: (A) Hematoxylin and eosinstained section of paraffin-embedded acutely inflamed F9 (15 mm diameter) tumor. 

Phrase: "(A) Hematoxylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "eosinstained section of paraffin-embedded acutely inflamed F9 (15 mm diameter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0205155:Section [Spatial Concept]
   738   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   738   C1522472:Section [Substance]
   738   C1552923:Section [Quantitative Concept]
   738   C1705191:Section [Physical Object]

Phrase: ")"

Phrase: "tumor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027651:Tumor [Neoplastic Process]
  1000   C1578706:Tumor [Intellectual Product]
  1000   C3273930:Tumor [Finding]
Processing 00000000.tx.178: V indicates vessel; 

Phrase: "V"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "indicates"

Phrase: "vessel"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005847:Vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:Vessel [Tissue]
   944 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.179: and T, tumor. 

Phrase: "and"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "tumor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027651:Tumor [Neoplastic Process]
  1000   C1578706:Tumor [Intellectual Product]
  1000   C3273930:Tumor [Finding]
Processing 00000000.tx.180: Arrows mark some of the neutrophils infiltrating the perivascular edematous connective tissue. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "some of the neutrophils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027950:Neutrophils [Cell]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "infiltrating"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332448:Infiltrating [Pathologic Function]
   966 E C1546677:Infiltrate [Intellectual Product]
   966 E C1549537:Infiltrate [Functional Concept]

Phrase: "the perivascular edematous connective tissue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009780:Connective Tissue [Tissue]
   812   C0040300:Tissue [Tissue]
   812   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.181: (B-C) Immunohistochemistry on cryosections of tumor tissue. 

Phrase: "(B-C) Immunohistochemistry on cryosections of tumor tissue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.182: Ly-6G (Gr-1) is shown in red, IgG in green, and nuclei (DAPI) in blue. 

Phrase: "Ly-6G"

Phrase: "(Gr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown in red,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332575:Red [Finding]
   790   C1260956:Red [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "IgG in green,"

Phrase: "and"

Phrase: "nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "(DAPI) in blue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.183: Lymphoma cells express surface IgG2a and are therefore stained green. 

Phrase: "Lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0883208:Lymphoma cells [Cell]
  1000   C2697951:Lymphoma Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "surface IgG2a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2754963:surface IgG2a [Cell Component]
   861   C0020857:IgG2A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "are"

Phrase: "therefore stained green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.184: (B) F9 tumor in mice injected with T cells. 

Phrase: "(B) F9 tumor in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "injected with T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1720154:Inject [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.185: (C) F9 tumor in mice not injected with T cells. 

Phrase: "(C) F9 tumor in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "injected with T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1720154:Inject [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.186: (D) F55 tumor in mice injected with T cells. 

Phrase: "("

Phrase: "D)"

Phrase: "F55 tumor in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "injected with T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039194:T-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1720154:Inject [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.187: (E) Same tumor as in panel B, but stained for detection of Id-specific T cells (GB113, clonotype-specific, red) and IgG+ F9 cells. 

Phrase: "(E) Same tumor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]

Phrase: "as in panel B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441833:Panel [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]

Phrase: "but"

Phrase: "stained for detection of Id-specific T cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0039194:T-Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0205369:Specific [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]
   744   C1552740:specific [Intellectual Product]
   744   C2986582:Stained [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(GB113,"

Phrase: "clonotype-specific, red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "IgG+ F9 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.188: Original magnification, x 60.  

Phrase: "Original magnification,"

Phrase: "x 60."
Processing 00000000.tx.189: Memory but not naive Id-specific CD4+ T cells kill Id+ B-lymphoma cells The experiments described in Figures 1, 2, 3, 4, 5, 6 suggest that Id-specific CD4+ T cells kill Id+ B-lymphoma cells in vivo. 

Phrase: "Memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "but"

Phrase: "not naive Id-specific CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   884   C3641721:Naive T Cells [Cell]
   829   C0039215:cd4 cells [Cell]
   818   C0039194:T-Cells [Cell]
   813 E C3251824:CD4+ cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "Id+ B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "described in Figures 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "Id+ B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.190: We proceeded to test this in vitro. 

Phrase: "We"

Phrase: "proceeded"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.191: F9 (Id+) and F55 (Id-) were tested in a 3H-TdR release assay (JAM assay) for susceptibility to killing by Id-specific CD4+ T cells (Figure 7). 

Phrase: "F9 (Id+)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1366464:F9 [Gene or Genome]

Phrase: "and"

Phrase: "F55"

Phrase: "(Id-)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "were"

Phrase: "tested in a 3H-TdR release assay"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0030685:Release [Health Care Activity]
   748   C0040077:TDR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086126:TdR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243073:assay [Qualitative Concept]
   748   C0391871:Release [Functional Concept]
   748   C0392366:tested [Intellectual Product]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1442460:3H [Temporal Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "(JAM assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: ")"

Phrase: "for susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to"

Phrase: "killing by Id-specific CD4+ T cells"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   778   C0039194:T-Cells [Cell]
   774   C0039215:cd4 cells [Cell]
   774   C0599733:cells killing [Cell Function]
   774   C3251824:Cells.CD4 [Cell]
   748   C0007634:Cells [Cell]
   748   C0162388:Killing [Social Behavior]
   748   C0205369:Specific [Qualitative Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1552740:specific [Intellectual Product]
   748   C3282337:Cells [Cell]
   748   C3541261:CD4 [Laboratory Procedure]
   714 E C0681205:Kill [Idea or Concept]
   714 E C1269647:Cell [Cell]
   714 E C1550555:kill [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 7"

Phrase: ")."
Processing 00000000.tx.192: This assay measures release of 3H-TdRlabeled DNA fragments from cells, due to apoptosis. 

Phrase: "This assay measures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0079809:Measures [Quantitative Concept]
   861   C1879489:Measures [Functional Concept]
   827 E C0242485:Measure [Functional Concept]

Phrase: "release of 3H-TdRlabeled DNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1442460:3H [Temporal Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "fragments from cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0007634:Cells [Cell]
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1708096:Fragment [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "due to apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.193: Previously unstimulated naive T cells from ordinary TCR-transgenic mice were unable to kill lymphoma cells (Figure 7), as were T cells from TCR-transgenic SCID mice or even purified CD4+ T cells from these sources (not shown). 

Phrase: "Previously unstimulated naive T cells from ordinary TCR-transgenic mice"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   775   C3641721:Naive T Cells [Cell]
   756   C0039194:T-Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C1522131:Mouse T Cell [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0883208:Lymphoma cells [Cell]
  1000   C2697951:Lymphoma Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 7"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "were"

Phrase: "T cells from TCR-transgenic SCID mice"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   761   C1274233:T-Cell Immunodeficiency [Disease or Syndrome]
   760   C0039194:T-Cells [Cell]
   744   C1522131:Mouse T Cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "even purified CD4+ T cells from these sources"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0039194:T-Cells [Cell]
   767   C0039215:cd4 cells [Cell]
   767   C3251824:Cells.CD4 [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.194: By contrast, previously stimulated, polarized T cells killed F9 but not F55 cells. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "previously"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: ","

Phrase: "polarized T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0039194:T-Cells [Cell]
   896   C0598102:polarized cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "F9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1366464:F9 [Gene or Genome]

Phrase: "but"

Phrase: "not F55 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: Cytotoxicity of Th1-polarized cells increased with cycles of stimulation while Th2 cells reduced their cytotoxicity with repetitive stimulation. 

Phrase: "Cytotoxicity of Th1-polarized cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   745   C0022686:Cytotoxic cell [Cell]

Phrase: "increased with cycles of stimulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   726   C1511572:Cycle [Temporal Concept]

Phrase: "while"

Phrase: "Th2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0242633:Th2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "their cytotoxicity with repetitive stimulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.196: Similar results were obtained in another assay for apoptosis, annexin-V staining. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in another assay"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C1706701:Obtain [Activity]

Phrase: "for apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "annexin-V staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
Processing 00000000.tx.197: An Id-specific Th1 clone, 7A10B2, induced apoptosis of F9 (Figure 8 arrow) but not F55 cells, whereas unstimulated purified Id-specific CD4+ cells purified ex vivo were unable to kill either (Figure 8). 

Phrase: "An Id-specific Th1 clone,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "7A10B2,"

Phrase: "induced apoptosis of F9 (Figure 8 arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162638:Apoptosis [Cell Function]

Phrase: ")"

Phrase: "but"

Phrase: "not F55 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "unstimulated purified Id-specific CD4+ cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0039215:cd4 cells [Cell]
   810 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "ex vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "either"

Phrase: "(Figure 8"

Phrase: ")."
Processing 00000000.tx.198: View larger version (32K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.199: Memory but not naive Id-specific T cells kill Id+ B-lymphoma cells by apoptosis. 

Phrase: "Memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "but"

Phrase: "not naive Id-specific T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   885   C3641721:Naive T Cells [Cell]
   827   C0039194:T-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "Id+ B-lymphoma cells by apoptosis."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   809   C0079731:cell b lymphoma [Neoplastic Process]
   790   C0883208:Lymphoma cells [Cell]
   790   C2697951:Lymphoma Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.200: Id+ F9 and Id- F55 cells (104) were tested in a 6- or 18-hour 3H-Td release assay (JAM assay) for susceptibility to killing by unstimulated naive or Th1- or Th2-polarized Id-specific TCR-transgenic SCID splenocytes that had been stimulated in vitro for one (x 1) or 2 (x 2) 10-day cycles. 

Phrase: "Id+ F9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1366464:F9 [Gene or Genome]

Phrase: "and"

Phrase: "Id- F55 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C0068319:ID-2 [Amino Acid, Peptide, or Protein]

Phrase: "(104"

Phrase: ")"

Phrase: "were"

Phrase: "tested in a 6-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "or"

Phrase: "18-hour 3H-Td release assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]

Phrase: "(JAM assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: ")"

Phrase: "for susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to"

Phrase: "killing by unstimulated naive"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0162388:Killing [Social Behavior]
   770   C0439819:Unstimulated [Qualitative Concept]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "or"

Phrase: "Th1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423842:TH1 [Gene or Genome]
  1000   C3540579:TH1 [Gene or Genome]

Phrase: "or"

Phrase: "Th2-polarized Id-specific TCR-transgenic SCID splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C1519477:Splenocyte [Cell]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "in vitro for one (x 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(x 2"

Phrase: ")"

Phrase: "10-day cycles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.201: TCR-transgenic lymph node cells served as a source of unstimulated naive CD4+ T cells.  

Phrase: "TCR-transgenic lymph node cells"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   895   C0039194:T-Cells [Cell]
   827   C0024204:Lymph node [Body Part, Organ, or Organ Component]
   827   C0440747:LYMPH NODE [Tissue]
   827   C1269047:Lymph node [Body Part, Organ, or Organ Component]
   822   C0024264:lymph cell [Cell]
   799   C0007634:Cells [Cell]
   799   C0024202:Lymph [Body Substance]
   799   C0746922:Node [Body Part, Organ, or Organ Component]
   799   C1706163:Node [Conceptual Entity]
   799   C2697524:Node [Conceptual Entity]
   799   C2700445:Node [Plant]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0443268:Nodal [Spatial Concept]
   727 E C1417752:NODAL [Gene or Genome]

Phrase: "served as a source of unstimulated naive CD4+ T cells."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   784   C3273372:CD4+ Naive T Cell [Cell]
   777   C3641721:Naive T Cells [Cell]
   760   C0039194:T-Cells [Cell]
   757   C0039215:cd4 cells [Cell]
   757   C3251824:Cells.CD4 [Cell]
   739   C0007634:Cells [Cell]
   739   C0439819:Unstimulated [Qualitative Concept]
   739   C0449416:Source [Finding]
   739   C1705919:Source [Idea or Concept]
   739   C3282337:Cells [Cell]
   739   C3541261:CD4 [Laboratory Procedure]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: View larger version (35K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.203: Id+ B-lymphoma cells become annexin V+ when exposed to cloned Id-specific Th1 cells. 

Phrase: "Id+ B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "become"

Phrase: "annexin V+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "when"

Phrase: "exposed to cloned Id-specific Th1 cells."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   778   C0242632:Th1 Cells [Cell]
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   757   C0009013:Clone Cells [Cell]
           cloned
   748   C0007634:Cells [Cell]
   748   C0205369:Specific [Qualitative Concept]
   748   C0600091:ID [Intellectual Product]
   748   C1423842:TH1 [Gene or Genome]
   748   C1552740:specific [Intellectual Product]
   748   C3282337:Cells [Cell]
   748   C3540579:TH1 [Gene or Genome]
   714 E C1269647:Cell [Cell]
   714 E C1522642:Clone [Tissue]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.204: Id+ F9 and Id- F55 B-lymphoma cells were incubated for 4 hours together with either an Id-specific Th1 cell clone (7A10B2), or magnetic beadpurified naive CD4+ T cells from a TCR-transgenic mouse (effector-target ratio [E/T] 2:1), followed by staining. 

Phrase: "Id+ F9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015491:F9 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1366464:F9 [Gene or Genome]

Phrase: "and"

Phrase: "Id- F55 B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0883208:Lymphoma cells [Cell]
   827   C2697951:Lymphoma Cells [Laboratory Procedure]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 4 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439227:hours [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "together with either"

Phrase: "an Id-specific Th1 cell clone"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   840   C0009013:Cell Clone [Cell]
           Clone
   804   C1522642:Clone [Tissue]
   733 E C1704387:Clonal [Qualitative Concept]
   704 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(7A10B2"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "magnetic beadpurified naive CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   867   C3641721:Naive T Cells [Cell]
   839   C0039215:cd4 cells [Cell]
   827   C0039194:T-Cells [Cell]
   822 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "from a TCR-transgenic mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   897   C1522424:A Mouse [Mammal]
   840   C0025936:Mouse, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]

Phrase: "(effector-target ratio [E/T] 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1521840:Target [Functional Concept]
   812   C1547037:Ratio [Intellectual Product]
   812   C2986546:TARGET [Diagnostic Procedure]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "followed by staining."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.205: Annexin-V staining of gated B220+ propidium iodidenegative lymphoma cells is shown as shaded histograms, open histograms represent annexin-V staining of lymphoma cells in the absence of T cells.   

Phrase: "Annexin-V staining of gated B220+ propidium iodidenegative lymphoma cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0487602:Staining [Laboratory Procedure]
   739   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "shown as shaded histograms,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547282:Show [Intellectual Product]
   737   C2348974:Histogram [Manufactured Object]

Phrase: "open histograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348974:Histogram [Manufactured Object]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "annexin-V staining of lymphoma cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of T cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.206: Discussion Top Abstract Introduction Materials and methods Results Discussion References  This study demonstrates that Id-specific CD4+ T cells protect against B-lymphoma cells in the complete absence of other T cells or antibodies. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "that Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "protect against B-lymphoma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0079731:cell b lymphoma [Neoplastic Process]
   806   C0883208:Lymphoma cells [Cell]
   806   C2697951:Lymphoma Cells [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0024299:Lymphoma [Neoplastic Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the complete absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "of other T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.207: To obtain these results we have used Id-specific TCR-transgenic SCID mice and adoptive transfer of purified Id-specific CD4+ T cells into SCID or Rag2-/- mice. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we"

Phrase: "have"

Phrase: "used Id-specific TCR-transgenic SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0025936:Mice, Transgenic [Mammal]
   822   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   752   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "and"

Phrase: "adoptive transfer of purified Id-specific CD4+ T cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0079613:Adoptive Cell Transfer [Therapeutic or Preventive Procedure]
   770   C0376517:Adoptive Cell Transfer [Therapeutic or Preventive Procedure]
   764   C0376518:Adoptive Transfer [Therapeutic or Preventive Procedure]
   742   C0040671:Transfer [Mental Process]
   742   C1705822:Transfer [Activity]

Phrase: "into SCID"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]
   901   C0494261:combined immunodeficiency [Disease or Syndrome]
   827   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   827   C0205082:Severe [Qualitative Concept]
   827   C0205195:Combined [Qualitative Concept]
   793 E C0336789:Combine [Manufactured Object]

Phrase: "or"

Phrase: "Rag2-/- mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0073020:recombinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.208: A similar strategy was recently taken with success in melanoma patients who first received nonmyeloablative conditioning treatment and then transfer of melanoma-specific T cells that expanded in the lympho-depleted patient.34 Our results let us conclude that transferal of a few hundred thousand Id-specific CD4+ T cells before tumor challenge confer protection against B lymphoma in the absence of other cell types of adaptive immunity. 

Phrase: "A similar strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "taken with success"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0597535:Success [Social Behavior]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
   718 E C1272703:Successful [Qualitative Concept]

Phrase: "in melanoma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "who first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "nonmyeloablative conditioning treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transfer of melanoma-specific T cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0039194:T-Cells [Cell]
   767   C1513095:Melanoma Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0025202:melanoma [Neoplastic Process]
   753   C0040671:Transfer [Mental Process]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1705822:Transfer [Activity]
   753   C2984289:Melanoma [Functional Concept]
   753   C3282337:Cells [Cell]
   753   C3539018:Melanoma [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "expanded in the lympho-depleted patient.34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0205229:expanded [Spatial Concept]
   748   C0333668:Depleted [Functional Concept]

Phrase: "Our results let"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "us"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that transferal of a few hundred thousand Id-specific CD4+ T cells"

Phrase: "before tumor challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "confer"

Phrase: "protection against B lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "of adaptive immunity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0678209:Adaptive Immunity [Physiologic Function]
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.209: On a weight basis, this compares with 2 x 108 Id-specific CD4+ T cells needed for a human patient of about 60 kg. 

Phrase: "On a weight basis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "this"

Phrase: "compares with 2 x 108 Id-specific CD4+ T cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0039194:T-Cells [Cell]
   757   C0039215:cd4 cells [Cell]
   757   C0068319:ID-2 [Amino Acid, Peptide, or Protein]
   757   C3251824:Cells.CD4 [Cell]
   739   C0007634:Cells [Cell]
   739   C0205369:Specific [Qualitative Concept]
   739   C0600091:ID [Intellectual Product]
   739   C1552740:specific [Intellectual Product]
   739   C1707455:Compare [Activity]
   739   C3282337:Cells [Cell]
   739   C3541261:CD4 [Laboratory Procedure]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "needed for a human patient of about 60 kg."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0022718:KG [Geographic Area]
   742   C0027552:Needed [Qualitative Concept]
   742   C0030705:*^patient [Patient or Disabled Group]
   742   C0086418:Human [Human]
   742   C0439209:kg [Quantitative Concept]
   742   C0686904:needed [Functional Concept]
Processing 00000000.tx.210: Taken together with other experiments in less defined but more physiologic systems,8,9,27,30,35-37 the case for an antiB-lymphoma effect of CD4+ cells alone seems strong. 

Phrase: "Taken together with other experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0681814:Experiments [Research Activity]
   760   C1883357:Together [Qualitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "in less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "but"

Phrase: "more physiologic systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "8,"

Phrase: "9,"

Phrase: "27,"

Phrase: "30,"

Phrase: "35-37"

Phrase: "the case for an antiB-lymphoma effect of CD4+ cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0868928:Case [Functional Concept]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "seems"

Phrase: "strong."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442821:Strong [Qualitative Concept]
   928 E C0237897:Strength [Quantitative Concept]
   928 E C0808080:Strength [Idea or Concept]
   928 E C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.211: Accordingly, Id-vaccination protocols should aim at also inducing Id-specific CD4+ T cells. 

Phrase: "Accordingly,"

Phrase: "Id-vaccination protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]

Phrase: "should"

Phrase: "aim at also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1947946:Aim [Idea or Concept]
   790   C2948600:Aim [Pharmacologic Substance]
   790   C3540471:AIM [Gene or Genome]
   790   C3540472:AIM [Functional Concept]

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "Id-specific CD4+ T cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.212: There is increasing evidence for a role of CD4+ T cells also in other types of cancer (reviewed in Pardoll and Topalian38). 

Phrase: "There"

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence for a role of CD4+ T cells also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in other types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332307:Types [Qualitative Concept]
   966 E C1547052:*Type [Quantitative Concept]

Phrase: "of cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "("

Phrase: "reviewed in Pardoll"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "Topalian38"

Phrase: ")."
Processing 00000000.tx.213: Importantly, Id-specific CD4+ T cells could be injected intravenously as late as 17 days after B-lymphoma cell injection and even so, prevent tumor growth in a considerable fraction of mice. 

Phrase: "Importantly,"

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously"

Phrase: "as"

Phrase: "late as 17 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205087:Late [Temporal Concept]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "after B-lymphoma cell injection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0021485:injection [Therapeutic or Preventive Procedure]
   812   C1272883:Injection [Biomedical or Dental Material]
   812   C1533685:Injection [Therapeutic or Preventive Procedure]
   812   C1828121:Injection [Functional Concept]
   708   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "even so,"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "tumor growth in a considerable fraction of mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0598934:tumor growth [Neoplastic Process]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0220844:growth [Physiologic Function]
   744   C1578706:Tumor [Intellectual Product]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   744   C3273930:Tumor [Finding]
Processing 00000000.tx.214: This is remarkable since in the absence of rescuing T cells, most mice had to be killed within 30 days due to large tumor burdens. 

Phrase: "This"

Phrase: "is"

Phrase: "remarkable since in the absence of rescuing T cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0039194:T-Cells [Cell]
   748   C1863243:Absent T cells [Finding]
   742   C0007634:Cells [Cell]
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "most mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "killed within 30 days"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0162388:killed [Social Behavior]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "due to large tumor burdens."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1449699:Tumor Burden [Diagnostic Procedure]
   793   C2828008:Burden [Idea or Concept]
   734   C0475278:Large tumor [Qualitative Concept]
Processing 00000000.tx.215: Clearly, Id-specific CD4+ T cells home to the subcutaneous B-lymphoma injection site, become activated, and induce an acute inflammation with infiltration of neutrophils, resulting in a burst in size from unpalpable to 5 to 20 mm in diameter within 4 to 6 days. 

Phrase: "Clearly,"

Phrase: "Id-specific CD4+ T cells home"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0442519:Home [Conceptual Entity]

Phrase: "to the subcutaneous B-lymphoma injection site,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0221208:Injection site [Injury or Poisoning]
   840   C2700396:Injection site [Spatial Concept]
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   708   C0021499:Subcutaneous injection [Functional Concept]

Phrase: "become"

Phrase: "activated,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an acute inflammation with infiltration of neutrophils,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0333361:Acute inflammation [Finding]
   748   C0021368:Inflammation [Pathologic Function]
   748   C0205178:acute [Temporal Concept]
   721   C0272159:Acute neutrophilia [Disease or Syndrome]

Phrase: "resulting in a burst"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0439818:burst [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1881705:BURST [Phenomenon or Process]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "from unpalpable"

Phrase: "to 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "to 20 mm"

Phrase: "in diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: "within 4"

Phrase: "to 6 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442469:6 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.216: The acute inflammation subsided over a few weeks. 

Phrase: "The acute inflammation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333361:Acute inflammation [Finding]
   861   C0021368:Inflammation [Pathologic Function]
   861   C0205178:acute [Temporal Concept]

Phrase: "subsided over a few weeks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.217: In a fraction ( 30%) of these mice treated with Id-specific CD4+ T cells 10 to 17 days after tumor cell injection, delayed cancer growth occurred with time. 

Phrase: "In a fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "( 30%"

Phrase: ")"

Phrase: "of these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "treated with Id-specific CD4+ T cells 10"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   770   C0039194:T-Cells [Cell]
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   767   C0039215:cd4 cells [Cell]
   767   C3251824:Cells.CD4 [Cell]
   744   C0007634:Cells [Cell]
   744   C0205369:Specific [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1522326:Treated [Functional Concept]
   744   C1552740:specific [Intellectual Product]
   744   C3282337:Cells [Cell]
   744   C3541261:CD4 [Laboratory Procedure]
   711 E C1269647:Cell [Cell]
   711 E C1292734:TREAT [Functional Concept]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "to 17 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "after tumor cell injection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "delayed cancer growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0456070:Delayed growth [Pathologic Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "occurred with time."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0040223:Time [Temporal Concept]
   790   C1709305:Occurred [Activity]
   790   C3541383:Time [Temporal Concept]
   756 E C2745955:OCCUR [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.218: We are currently investigating if these escapee B-lymphoma cells have lost production of the 2315 L chain, or are resistant to cytotoxicity mediated by CD4+ T cells, which would explain why they escape surveillance by Id-specific CD4+ T cells. 

Phrase: "We"

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "if"

Phrase: "these escapee B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "lost production of the 2315 L chain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "or"

Phrase: "are"

Phrase: "resistant to cytotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "mediated by CD4+ T cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0039194:T-Cells [Cell]
   797   C0039215:cd4 cells [Cell]
   797   C3251824:Cells.CD4 [Cell]
   760   C0007634:Cells [Cell]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   760   C3541261:CD4 [Laboratory Procedure]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "would"

Phrase: "explain"

Phrase: "why"

Phrase: "they"

Phrase: "escape"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870509:escape [Mental Process]
  1000   C1880554:ESCAPE [Event]

Phrase: "surveillance by Id-specific CD4+ T cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0220920:surveillance [Functional Concept]
   748   C0733511:Surveillance [Health Care Activity]
Processing 00000000.tx.219: Importantly, the curative potential of Id-specific CD4+ T cells could be of use in the clinic. 

Phrase: "Importantly,"

Phrase: "the curative potential of Id-specific CD4+ T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3245505:Potential [Qualitative Concept]

Phrase: "could"

Phrase: "be of use"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]
   790   C2987476:Be [Conceptual Entity]

Phrase: "in the clinic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
  1000   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   928 E C0205210:Clinical [Qualitative Concept]
Processing 00000000.tx.220: For example, after Id-vaccination of patients with minimal residual disease, patient's Id-specific CD4+ T cells could be expanded in vitro and reinfused in high numbers. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "after"

Phrase: "Id-vaccination of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "with minimal residual disease,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0242596:Minimal Residual Disease [Neoplastic Process]
   901   C0543478:Residual Disease [Neoplastic Process]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0547040:Minimal [Qualitative Concept]
   827   C1524031:MINIMAL [Qualitative Concept]
   827   C1609982:Residual [Qualitative Concept]
   827   C2945599:Minimal [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1552614:minimum [Idea or Concept]
   755 E C2826545:MINIMUM [Quantitative Concept]

Phrase: "patient's Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   839   C0039215:cd4 cells [Cell]
   827   C0039194:T-Cells [Cell]
   822 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "reinfused in high numbers."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205250:High [Qualitative Concept]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.221: In fact, it has recently been demonstrated that transfer of 2 x 1010 to 13 x 1010 melanoma-specific T cells to lympho-depleted melanoma patients resulted in expansion of transferred T cells and objective tumor regression in about half of the patients.34 Probably, lympho-depleted patients and SCID mice are comparable, in the sense that both have empty lymphoid compartments that are readily populated by transferred lymphocytes. 

Phrase: "In fact,"

Phrase: "it"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that transfer of 2 x 1010"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "to 13 x 1010 melanoma-specific T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   829   C1513095:Melanoma Cell [Cell]
   818   C0039194:T-Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "to lympho-depleted melanoma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "resulted in expansion of transferred T cells"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   778   C0039194:T-Cells [Cell]
   757   C0007595:cell expansion [Cell Function]
   748   C0007634:Cells [Cell]
   748   C0348011:transferred [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C0040671:Transfer [Mental Process]
   714 E C1269647:Cell [Cell]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1705822:Transfer [Activity]
   714 E C1948049:Cell [Spatial Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "objective tumor regression in about half of the patients.34 Probably,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1718423:Tumor regression [Organism Attribute]
   738   C0684320:Regression [Pathologic Function]
   738   C0684321:Regression [Mental Process]

Phrase: "lympho-depleted patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "SCID mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   982   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   808   C1512658:Immunodeficient Mouse [Mammal]
   756   C0085110:Severe Combined Immunodeficiency [Disease or Syndrome]

Phrase: "are"

Phrase: "comparable,"

Phrase: "in the sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "that"

Phrase: "both"

Phrase: "have"

Phrase: "empty lymphoid compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "readily"

Phrase: "populated by transferred lymphocytes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0024264:Lymphocytes [Cell]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]
Processing 00000000.tx.222: The number of Id-specific T cells used for obtaining therapeutic results in tumor-bearing SCID mice was about a tenth of the number of melanoma-specific T cells transferred to the melanoma patients on a weight basis. 

Phrase: "The number of Id-specific T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "used for obtaining therapeutic results"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0808233:Therapeutic results [Finding]
   781   C0039795:therapeutic use [Therapeutic or Preventive Procedure]
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0302350:Therapeutic [Functional Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1301820:Obtain [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C1706701:Obtain [Activity]
   726 E C1947944:Use [Intellectual Product]
   726   C2825142:Result [Finding]

Phrase: "in tumor-bearing SCID mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   883   C0085112:Severe Combined Immunodeficient Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   774   C1512658:Immunodeficient Mouse [Mammal]

Phrase: "was"

Phrase: "about"

Phrase: "a tenth of the number of melanoma-specific T cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   760   C0039194:T-Cells [Cell]
   757   C0193959:a t [Therapeutic or Preventive Procedure]
   741   C0007584:Cell Number [Laboratory Procedure]
   741   C1513095:Melanoma Cell [Cell]
   739   C0007634:Cells [Cell]
   739   C0025202:melanoma [Neoplastic Process]
   739   C0205369:Specific [Qualitative Concept]
   739   C0205444:Tenth [Quantitative Concept]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C1552740:specific [Intellectual Product]
   739   C2984289:Melanoma [Functional Concept]
   739   C3282337:Cells [Cell]
   739   C3539018:Melanoma [Intellectual Product]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "transferred to the melanoma patients"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   797   C0030704:patients transferred [Health Care Activity]
   760   C0025202:melanoma [Neoplastic Process]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0348011:transferred [Functional Concept]
   760   C2984289:Melanoma [Functional Concept]
   760   C3539018:Melanoma [Intellectual Product]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "on a weight basis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.223: A concern for application in the clinic is that in vitro expansion of Id-specific CD4+ T cells prior to infusion might create memory phenotype T cells that less efficiently home to sites of B-lymphoma growth. 

Phrase: "A concern for application"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2699424:Concern [Idea or Concept]

Phrase: "in the clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
  1000   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   928 E C0205210:Clinical [Qualitative Concept]

Phrase: "is"

Phrase: "that in vitro expansion of Id-specific CD4+ T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   741   C0007595:cell expansion [Cell Function]

Phrase: "prior to infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0574032:Infusion [Therapeutic or Preventive Procedure]
  1000   C1827465:Infusion [Functional Concept]

Phrase: "might"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "memory phenotype T cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C0682639:Memory T Cells [Cell]
   902   C0312737:Memory cells [Cell]
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "that less efficiently home to sites of B-lymphoma growth."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442519:Home [Conceptual Entity]
Processing 00000000.tx.224: On the other hand, in the melanoma study,34 tumor-infiltrating mixtures of CD4+ and CD8+ lymphocytes were expanded in vitro with high amounts of IL-2 for 4 to 6 weeks. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "in the melanoma study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "34 tumor-infiltrating mixtures of CD4+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:mixtures [Substance]

Phrase: "and"

Phrase: "CD8+ lymphocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C3641617:CD8/Lymphocytes [Laboratory Procedure]
   983 E C0242629:CD8 lymphocyte [Cell]
   861   C0024264:Lymphocytes [Cell]

Phrase: "were"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "in vitro with high amounts of IL-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]

Phrase: "for 4"

Phrase: "to 6 weeks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.225: Nevertheless, such in vitroexpanded and injected tumor infiltrating lymphocytes (TIL) could readily be identified in cutaneous and subcutaneous tumor nodules. 

Phrase: "Nevertheless,"

Phrase: "such in vitroexpanded"

Phrase: "and"

Phrase: "injected tumor infiltrating lymphocytes (TIL)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   923   C0079722:Lymphocytes, Tumor-Infiltrating [Cell]
   923   C1515408:Tumor Infiltrating Lymphocytes [Pharmacologic Substance]
   812   C0024264:Lymphocytes [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0332448:Infiltrating [Pathologic Function]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   779 E C1546677:Infiltrate [Intellectual Product]
   779 E C1549537:Infiltrate [Functional Concept]

Phrase: "could"

Phrase: "readily"

Phrase: "be"

Phrase: "identified in cutaneous"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0205396:Identified [Qualitative Concept]
   790   C0221912:Cutaneous [Spatial Concept]
   790   C1522447:Cutaneous [Functional Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   734 E C0444099:Skin [Body Substance]
   734 E C1123023:Skin [Body System]
   734 E C1278993:Skin [Body System]
   706 E C0221928:Dermal [Qualitative Concept]

Phrase: "and"

Phrase: "subcutaneous tumor nodules."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0151811:Subcutaneous nodules [Pathologic Function]
   871 E C0443316:Subcutaneous nodular [Spatial Concept]
   827   C0028259:Nodules [Acquired Abnormality]
   827   C0228505:nodules [Body Part, Organ, or Organ Component]
   793 E C2700389:Nodule [Plant]
   743 E C0205297:Nodular [Qualitative Concept]
   734   C0241279:SUBCUTANEOUS TUMOR [Finding]
   721 E C0449579:Nodularity [Qualitative Concept]
Processing 00000000.tx.226: In this context, it is relevant to point out that memory T cells may be divided into central memory (CCR7+) and effector memory T cells (CCR7-) based on their expression of CCR7, the receptor for the secondary lymphoid tissue chemokine (SLC).39 While the former recirculates between lymphoid organs by diapedesis through high endothelial venules, the latter may traverse (inflamed) flat endothelium in nonlymphoid sites. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "relevant to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that memory T cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0682639:Memory T Cells [Cell]
   913   C0312737:Memory cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "divided into central memory"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0025260:Memory [Mental Process]
   770   C0205099:Central [Spatial Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   770   C1879652:Central - [Laboratory Procedure]
   715 E C0679055:mnemonic [Mental Process]

Phrase: "(CCR7+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413191:CCR7 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "effector memory T cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   923   C0682639:Memory T Cells [Cell]
   923   C3641722:Effector T Cells [Cell]
   886   C0312740:Effector Cell [Cell]
   875   C0312737:Memory cells [Cell]
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0025260:Memory [Mental Process]
   812   C0700327:memory [Finding]
   812   C1706377:Memory [Manufactured Object]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C0679055:mnemonic [Mental Process]

Phrase: "(CCR7-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413191:CCR7 [Gene or Genome]

Phrase: ")"

Phrase: "based on their expression of CCR7,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1413191:CCR7 [Gene or Genome]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the receptor for the secondary lymphoid tissue chemokine (SLC).39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0524914:chemokine receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "While"

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "recirculates between lymphoid organs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0502330:lymphoid organs [Body Part, Organ, or Organ Component]
   816 E C1283883:Lymphoid organ [Body Part, Organ, or Organ Component]
   770   C0178784:organs [Body Part, Organ, or Organ Component]
   770   C1518071:Lymphoid [Qualitative Concept]

Phrase: "by diapedesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0277921:Diapedesis [Cell Function]

Phrase: "through high endothelial venules,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C0596700:High Endothelial Venule [Body Part, Organ, or Organ Component]
   827   C0014257:Endothelial [Tissue]
   827   C0042520:Venules [Body Part, Organ, or Organ Component]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   793 E C1282854:Venule [Body Part, Organ, or Organ Component]

Phrase: "the latter"

Phrase: "may"

Phrase: "traverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Traverse [Conceptual Entity]

Phrase: "(inflamed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333348:Inflamed [Functional Concept]

Phrase: ")"

Phrase: "flat endothelium in nonlymphoid sites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014257:Endothelium [Tissue]
Processing 00000000.tx.227: Thus, a mixture of central and effector memory cells might home to most sites where lymphomas usually grow. 

Phrase: "Thus,"

Phrase: "a mixture of central"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "effector memory cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   901   C0312737:Memory cells [Cell]
   896   C0312740:Effector Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0025260:Memory [Mental Process]
   827   C0700327:memory [Finding]
   827   C1706377:Memory [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0679055:mnemonic [Mental Process]

Phrase: "might"

Phrase: "home to most sites where lymphomas usually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442519:Home [Conceptual Entity]

Phrase: "grow."
Processing 00000000.tx.228: How do Id-specific CD4+ T cells kill the B-lymphoma cells? 

Phrase: "How"

Phrase: "do"

Phrase: "Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "the B-lymphoma cells?"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0883208:Lymphoma cells [Cell]
   901   C2697951:Lymphoma Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.229: They could do so directly or indirectly. 

Phrase: "They"

Phrase: "could"

Phrase: "do"

Phrase: "so directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly."
Processing 00000000.tx.230: As concerns direct killing, immunohistochemistry analysis revealed proximity of Id-specific T cells and Id+ tumor cells, but whether this reflects direct killing of B-lymphoma cells by T cells in vivo in the tumor remains to be demonstrated. 

Phrase: "As concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concerns [Idea or Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: ","

Phrase: "immunohistochemistry analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "proximity of Id-specific T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514583:Proximity [Spatial Concept]

Phrase: "and"

Phrase: "Id+ tumor cells,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "whether"

Phrase: "this"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "killing of B-lymphoma cells"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   833   C0079731:cell b lymphoma [Neoplastic Process]
   806   C0883208:Lymphoma cells [Cell]
   806   C2697951:Lymphoma Cells [Laboratory Procedure]
   797   C0599733:cells killing [Cell Function]
   760   C0007634:Cells [Cell]
   760   C0024299:Lymphoma [Neoplastic Process]
   760   C0162388:Killing [Social Behavior]
   760   C3282337:Cells [Cell]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1550555:kill [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo in the tumor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "demonstrated."
Processing 00000000.tx.231: In vitro, more conclusive data suggest that naive T cells are incapable of inducing tumor cell apoptosis of B-lymphoma cells but that previously stimulated T cells can do so. 

Phrase: "In vitro, more conclusive data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that naive T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C3641721:Naive T Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "incapable of inducing tumor cell apoptosis of B-lymphoma cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1550518:incapable [Idea or Concept]

Phrase: "but"

Phrase: "that previously stimulated T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "do"

Phrase: "so."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]
Processing 00000000.tx.232: Surprisingly, not only Th1 cells were effective killers but so were Th2 cells, although the latter reduced their cytotoxicity with repetitious restimulation. 

Phrase: "Surprisingly,"

Phrase: "not only Th1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0242632:Th1 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "effective killers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1336644:KILLER [Gene or Genome]
   827   C1705132:KILLER [Gene or Genome]

Phrase: "but"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "were"

Phrase: "Th2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0242633:Th2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "the latter"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "their cytotoxicity with repetitious restimulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
Processing 00000000.tx.233: Possibly, the cytotoxicity of Th2-polarized cells could be due to contaminating Th1 cells that gradually are lost on repetitive stimulation under Th2 conditions. 

Phrase: "Possibly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the cytotoxicity of Th2-polarized cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   731   C0022686:Cytotoxic cell [Cell]

Phrase: "could"

Phrase: "be due to contaminating Th1 cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0242632:Th1 Cells [Cell]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0007634:Cells [Cell]
   753   C1423842:TH1 [Gene or Genome]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]
   753   C3282337:Cells [Cell]
   753   C3540579:TH1 [Gene or Genome]
   719   C0205279:contaminate [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "that gradually"

Phrase: "are"

Phrase: "lost on repetitive stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0745777:Lost [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "under Th2 conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.234: Alternatively, Id-specific Th2 cells may be cytotoxic to B-lymphoma cells.6 In any case, the in vitro data suggest that in vivo, naive Id-specific CD4+ T cells require stimulation in order to attain cytotoxicity toward B-lymphoma cells. 

Phrase: "Alternatively,"

Phrase: "Id-specific Th2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0242633:Th2 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "cytotoxic to B-lymphoma cells.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0022686:Cytotoxic cell [Cell]
   753   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   753   C1511636:cytotoxic [Functional Concept]

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the in vitro data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in vivo, naive Id-specific CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   869   C3641721:Naive T Cells [Cell]
   822   C0039215:cd4 cells [Cell]
   812   C0039194:T-Cells [Cell]
   806 E C3251824:CD4+ cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "require"

Phrase: "stimulation in order to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "attain"

Phrase: "cytotoxicity toward B-lymphoma cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   745   C0022686:Cytotoxic cell [Cell]
Processing 00000000.tx.235: At least 2 possibilities exist for initial stimulation of naive Id-specific CD4+ T cells. 

Phrase: "At least 2 possibilities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   743   C0332149:Possible [Qualitative Concept]
   743   C1705910:Possible [Qualitative Concept]
   743   C2362652:Possible [Qualitative Concept]

Phrase: "exist for initial stimulation of naive Id-specific CD4+ T cells."
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   777   C3273372:CD4+ Naive T Cell [Cell]
   772   C3641721:Naive T Cells [Cell]
   756   C0039194:T-Cells [Cell]
   754   C0039215:cd4 cells [Cell]
   754   C3251824:Cells.CD4 [Cell]
   738   C0007634:Cells [Cell]
   738   C0205265:Initial [Temporal Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0600091:ID [Intellectual Product]
   738   C1279901:Initial [Qualitative Concept]
   738   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   738   C1552740:specific [Intellectual Product]
   738   C1555582:Initial [Idea or Concept]
   738   C1705685:INITIAL [Functional Concept]
   738   C1948023:Stimulation [Natural Phenomenon or Process]
   738   C2987476:Exist [Conceptual Entity]
   738   C3282337:Cells [Cell]
   738   C3541261:CD4 [Laboratory Procedure]
   737   C0017471:initial cell [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.236: First, Id+ B-lymphoma cells could directly stimulate Id-specific CD4+ T cells. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "Id+ B-lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "stimulate"

Phrase: "Id-specific CD4+ T cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.237: Second, Id-primed dendritic cells at the tumor site and in draining lymph nodes could have this function, as described for a subcutaneous mouse plasmacytoma.29,40 We find the latter possibility most likely, because Id-specific TCR-transgenic mice are not protected against lymphoma cells and myeloma cells that do not secrete Id+ Ig, but retain it intracellularly. 

Phrase: "Second, Id-primed dendritic cells at the tumor site"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   767   C1301364:Dendritic Cell Tumor, Not Otherwise Specified [Neoplastic Process]
   764   C0011306:Dendritic Cells [Cell]
   762   C0431085:Tumor cells [Cell]
   745 E C0597032:Tumor Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C0011305:Dendritic [Cell Component]
   742   C0439640:Dendritic [Qualitative Concept]
   742   C3282337:Cells [Cell]
   731 E C0003315:Dendritic cell [Cell]
   731 E C1511762:Dendritic Cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and in draining lymph nodes"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   773 E C0440747:LYMPH NODE [Tissue]
   773 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   760   C0024202:Lymph [Body Substance]
   760   C0746922:nodes [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   726   C0013103:drain [Therapeutic or Preventive Procedure]
   726   C0180499:Drain [Medical Device]
   726 E C1706163:Node [Conceptual Entity]
   726 E C2697524:Node [Conceptual Entity]
   726 E C2700445:Node [Plant]

Phrase: "could"

Phrase: "have"

Phrase: "this function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "as"

Phrase: "described for a subcutaneous mouse plasmacytoma.29,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1522685:Mouse Plasmacytoma [Neoplastic Process]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0032131:Plasmacytoma [Neoplastic Process]
   748   C0443315:subcutaneous [Spatial Concept]
   748   C1552738:described [Idea or Concept]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "the latter possibility most likely,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0332148:Likely [Qualitative Concept]
   812   C0750492:Likely [Idea or Concept]
   741   C0332149:Possible [Qualitative Concept]
   741   C1705910:Possible [Qualitative Concept]
   741   C2362652:Possible [Qualitative Concept]

Phrase: "because"

Phrase: "Id-specific TCR-transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "protected against lymphoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0883208:Lymphoma cells [Cell]
   833   C2697951:Lymphoma Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0024299:Lymphoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "Id+ Ig,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "but"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "it intracellularly."
Processing 00000000.tx.238: In fact, purified dendritic cells (DCs) from Id+ F9 subcutaneous tumors are far superior at stimulating Id-specific T cells than Id+ F9 lymphoma cells themselves (K.U.L. and B.B., unpublished data, May 2000). 

Phrase: "In fact,"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "dendritic cells (DCs) from Id+ F9 subcutaneous tumors"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   778   C0011306:Dendritic Cells [Cell]
   771   C1301364:Dendritic Cell Tumor, Not Otherwise Specified [Neoplastic Process]
   757   C0431085:Tumor cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0011305:Dendritic [Cell Component]
   748   C0439640:Dendritic [Qualitative Concept]
   748   C3282337:Cells [Cell]
   745 E C0003315:Dendritic cell [Cell]
   745 E C1511762:Dendritic Cell [Cell]
   741 E C0597032:Tumor Cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "far superior at stimulating Id-specific T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1282910:Superior [Spatial Concept]

Phrase: "than Id+ F9 lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0883208:Lymphoma cells [Cell]
   861   C2697951:Lymphoma Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "themselves"

Phrase: "(K.U.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "B.B.,"

Phrase: "unpublished data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "May 2000"

Phrase: ")."
Processing 00000000.tx.239: The molecular mechanism by which Id-specific effector memory CD4+ T cells could directly kill B-lymphoma cells remains to be elucidated. 

Phrase: "The molecular mechanism by which Id-specific effector memory CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0441712:Mechanism [Functional Concept]
   736   C1706376:Mechanism [Manufactured Object]

Phrase: "could"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "B-lymphoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0883208:Lymphoma cells [Cell]
   901   C2697951:Lymphoma Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.240: One possibility is that FasLigand expressed on activated CD4+ T cells could bind Fas on B-lymphoma cells and induce apoptosis. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that FasLigand"

Phrase: "expressed on activated CD4+ T cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0039194:T-Cells [Cell]
   783   C0039215:cd4 cells [Cell]
   783   C3251824:Cells.CD4 [Cell]
   753   C0007634:Cells [Cell]
   753   C1879547:Activated [Activity]
   753   C3282337:Cells [Cell]
   753   C3541261:CD4 [Laboratory Procedure]
   719 E C1269647:Cell [Cell]
   719 E C1515877:Activate [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Fas on B-lymphoma cells"

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.241: Indeed, F9 cells express Fas, and we have obtained evidence that this is an important mechanism in vitro but less so in vivo (K.U.L. and B.B., unpublished data, November 2000). 

Phrase: "Indeed,"

Phrase: "F9 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "Fas,"

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "obtained evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "an important mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "but"

Phrase: "less so in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(K.U.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "B.B.,"

Phrase: "unpublished data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "November 2000"

Phrase: ")."
Processing 00000000.tx.242: As concerns indirect killing of B-lymphoma cells, it has been described that interferon (IFN) produced by CD4+ T cells could inhibit tumor growth by destroying tumor vasculature.41 Consistent with this possibility, we have observed that activated Id-specific T cells in MOPC315 myeloma tumors produce IFN (A.C., B.B., unpublished data, January 2002). 

Phrase: "As"

Phrase: "concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concern [Idea or Concept]

Phrase: "indirect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439852:Indirect [Qualitative Concept]

Phrase: "killing of B-lymphoma cells,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   833   C0079731:cell b lymphoma [Neoplastic Process]
   806   C0883208:Lymphoma cells [Cell]
   806   C2697951:Lymphoma Cells [Laboratory Procedure]
   797   C0599733:cells killing [Cell Function]
   760   C0007634:Cells [Cell]
   760   C0024299:Lymphoma [Neoplastic Process]
   760   C0162388:Killing [Social Behavior]
   760   C3282337:Cells [Cell]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1550555:kill [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "that interferon (IFN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced by CD4+ T cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0039194:T-Cells [Cell]
   797   C0039215:cd4 cells [Cell]
   797   C3251824:Cells.CD4 [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   760   C3541261:CD4 [Laboratory Procedure]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "tumor growth by destroying tumor vasculature.41 Consistent"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0598934:tumor growth [Neoplastic Process]
   767   C1658953:tumor vasculature [Neoplastic Process]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0220844:growth [Physiologic Function]
   744   C1578706:Tumor [Intellectual Product]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   744   C3273930:Tumor [Finding]

Phrase: "with this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that activated Id-specific T cells in MOPC315 myeloma tumors"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0039194:T-Cells [Cell]
   757   C0333843:cells myeloma [Cell]
   741   C0431085:Tumor cells [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   724 E C0597032:Tumor Cell [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "produce"

Phrase: "IFN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(A.C., B.B.,"

Phrase: "unpublished data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "January 2002"

Phrase: ")."
Processing 00000000.tx.243: It has also been described that activated CD4+ T cells can recruit nonadaptive arms of immunity such as cytotoxic macrophages and eosinophils.42 Herein we describe that Id-specific CD4+ T cells induce inflammation and infiltration of neutrophils in Id+ B lymphomas. 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "that activated CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   875   C0039215:cd4 cells [Cell]
   861   C0039194:T-Cells [Cell]
   858 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "recruit"

Phrase: "nonadaptive arms of immunity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0206655:ARMS [Neoplastic Process]
   770   C0446516:Arm [Body Location or Region]
   770   C1269078:Arm [Body Part, Organ, or Organ Component]
   770   C1269612:Arm [Body Location or Region]
   770   C2681631:ARMS [Gene or Genome]
   715 E C0445456:Brachial [Spatial Concept]

Phrase: "such as cytotoxic macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024432:Macrophages [Cell]
   861   C1546706:Macrophages [Intellectual Product]
   861   C1550652:Macrophages [Body Substance]

Phrase: "and"

Phrase: "eosinophils.42 Herein"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0014467:Eosinophils [Cell]
   827   C0200638:Eosinophils [Laboratory Procedure]
   743 E C0333930:Eosinophilic [Functional Concept]
   721 E C0014457:EOSINOPHILIAS [Disease or Syndrome]
   721 E C1306759:Eosinophilia [Disease or Syndrome]
   721 E C1636667:Eosinophilia [Disease or Syndrome]
   721 E C2240374:Eosinophilia [Finding]

Phrase: "we"

Phrase: "describe"

Phrase: "that Id-specific CD4+ T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   853   C0039215:cd4 cells [Cell]
   840   C0039194:T-Cells [Cell]
   836 E C3251824:CD4+ cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "infiltration of neutrophils"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   841   C0751982:Neutrophil Infiltration [Physiologic Function]
   816 E C0333361:Neutrophilic infiltration [Finding]
   790   C0332448:Infiltration [Pathologic Function]
   790   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   790   C1523986:Infiltration [Functional Concept]

Phrase: "in Id+ B lymphomas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024299:Lymphomas [Neoplastic Process]
Processing 00000000.tx.244: It might be that such an inflammatory reaction causes tumor cell death and explains the observed cure of B lymphoma. 

Phrase: "It"

Phrase: "might"

Phrase: "be"

Phrase: "that"

Phrase: "such an inflammatory reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021368:Inflammatory reaction [Pathologic Function]
   861   C0333348:Inflammatory [Functional Concept]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "tumor cell death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007587:Cell Death [Cell Function]
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "and"

Phrase: "explains"

Phrase: "the observed cure of B lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880198:Cure [Conceptual Entity]
Processing 00000000.tx.245: In summary, we find it likely that Id-specific T cells kill Id+ B-lymphoma cells by several mechanisms, some of them being direct and others indirect. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "it likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that Id-specific T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "Id+ B-lymphoma cells by several mechanisms,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   793   C0079731:cell b lymphoma [Neoplastic Process]
   778   C0883208:Lymphoma cells [Cell]
   778   C2697951:Lymphoma Cells [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "some of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "being"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "indirect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439852:Indirect [Qualitative Concept]
Processing 00000000.tx.246: CD4+ cells in TCR-transgenic SCID mice have a naive phenotype that should make them extravasate through high endothelial venules (HEVs) and thus presumably recirculate between LNs. 

Phrase: "CD4+ cells in TCR-transgenic SCID mice"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0039215:cd4 cells [Cell]
   757 E C3251824:Cells.CD4 [Cell]
   753   C1522131:Mouse T Cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a naive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "that"

Phrase: "should"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "them"

Phrase: "extravasate through high endothelial venules (HEVs)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   828   C0596700:High Endothelial Venule [Body Part, Organ, or Organ Component]
   760   C0014257:Endothelial [Tissue]
   760   C0042520:Venules [Body Part, Organ, or Organ Component]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   745   C1179026:Venule endothelium [Tissue]
   726 E C1282854:Venule [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "thus presumably"

Phrase: "recirculate between LNs."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   833   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   799 E C0440747:LYMPH NODE [Tissue]
   799 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   770   C0024202:Lymph [Body Substance]
   770   C0746922:nodes [Body Part, Organ, or Organ Component]
   737 E C1706163:Node [Conceptual Entity]
   737 E C2697524:Node [Conceptual Entity]
   737 E C2700445:Node [Plant]
Processing 00000000.tx.247: This raises a problem: how do naive T cells get in contact with B-lymphoma cells that are injected subcutaneously? 

Phrase: "This"

Phrase: "raises"

Phrase: "a problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: ":"

Phrase: "how"

Phrase: "do"

Phrase: "naive T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C3641721:Naive T Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "get in contact with B-lymphoma cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   793   C0079731:cell b lymphoma [Neoplastic Process]
   778   C0332158:Contact with [Functional Concept]
           contact
   778   C0883208:Lymphoma cells [Cell]
   778   C2697951:Lymphoma Cells [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0024299:Lymphoma [Neoplastic Process]
   748   C0337611:Contact [Population Group]
   748   C1705415:Contact [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "subcutaneously?"
Processing 00000000.tx.248: One explanation could be that the B-lymphoma cells metastasize to draining LNs and activate naive T cells. 

Phrase: "One explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "that"

Phrase: "the B-lymphoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0883208:Lymphoma cells [Cell]
   901   C2697951:Lymphoma Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "metastasize to draining LNs"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   773 E C0440747:LYMPH NODE [Tissue]
   773 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   760   C0024202:Lymph [Body Substance]
   760   C0027627:Metastasize [Neoplastic Process]
   760   C0746922:nodes [Body Part, Organ, or Organ Component]
   760   C2939420:metastasize [Neoplastic Process]
   726   C0013103:drain [Therapeutic or Preventive Procedure]
   726   C0180499:Drain [Medical Device]
   726 E C1706163:Node [Conceptual Entity]
   726 E C2697524:Node [Conceptual Entity]
   726 E C2700445:Node [Plant]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "naive T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C3641721:Naive T Cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.249: An alternative explanation is that dendritic cells in the tumor pick up Id's from the locally secreted monoclonal Ig or from necrotic or apoptotic lymphoma cells, and that these Id-primed dendritic cells travel with afferent lymphatics to draining LNs and stimulate Id-specific naive T cells. 

Phrase: "An alternative explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that dendritic cells in the tumor pick up Id's"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   767   C1301364:Dendritic Cell Tumor, Not Otherwise Specified [Neoplastic Process]
   764   C0011306:Dendritic Cells [Cell]
   762   C0431085:Tumor cells [Cell]
   745   C0333842:Pick's cell [Cell]
   745 E C0597032:Tumor Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C0011305:Dendritic [Cell Component]
   742   C0439640:Dendritic [Qualitative Concept]
   742   C3282337:Cells [Cell]
   731 E C0003315:Dendritic cell [Cell]
   731 E C1511762:Dendritic Cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "from the locally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517927:Locally [Spatial Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "monoclonal Ig"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0443737:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0700271:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "or from necrotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027540:Necrotic [Organ or Tissue Function]
   718 E C1334928:Necrosis [Finding]

Phrase: "or"

Phrase: "apoptotic lymphoma cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0883208:Lymphoma cells [Cell]
   901   C2697951:Lymphoma Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "these Id-primed dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "travel with afferent lymphatics"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0934891:Afferent lymphatics [Body Part, Organ, or Organ Component]
   770   C0024235:Lymphatics [Body System]
   770   C0040802:travel [Daily or Recreational Activity]
   770   C0205115:Afferent [Spatial Concept]
   770   C0229889:Lymphatics [Body Part, Organ, or Organ Component]
   770   C1555670:travel [Idea or Concept]
   770   C1557119:LYMPHATICS [Finding]
   737 E C1522604:Lymphatic [Qualitative Concept]

Phrase: "to draining LNs"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   901   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   867 E C0440747:LYMPH NODE [Tissue]
   867 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   827   C0024202:Lymph [Body Substance]
   827   C0746922:nodes [Body Part, Organ, or Organ Component]
   793 E C1706163:Node [Conceptual Entity]
   793 E C2697524:Node [Conceptual Entity]
   793 E C2700445:Node [Plant]
   743 E C0443268:Nodal [Spatial Concept]
   743 E C1417752:NODAL [Gene or Genome]
   721 E C0449725:Nodality [Spatial Concept]

Phrase: "and"

Phrase: "stimulate"

Phrase: "Id-specific naive T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C3641721:Naive T Cells [Cell]
   840   C0039194:T-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.250: Relevant to this, Id-primed dendritic cells have recently been demonstrated in subcutaneous plasmacytoma,29 and we also have data suggesting their existence in B-cell lymphoma (K.U.L., B.B., unpublished data, May 2000). 

Phrase: "Relevant to this,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347946:Relevant [Qualitative Concept]

Phrase: "Id-primed dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "demonstrated in subcutaneous plasmacytoma,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0032131:Plasmacytoma [Neoplastic Process]
   770   C0443315:subcutaneous [Spatial Concept]
   715 E C1136084:PLASMA CELL TUMOR [Neoplastic Process]
   715 E C1959632:Plasma Cell Tumor [Neoplastic Process]

Phrase: "29"

Phrase: "and"

Phrase: "we also"

Phrase: "have"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "their existence in B-cell lymphoma"

Phrase: "(K.U.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "B.B.,"

Phrase: "unpublished data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "May 2000"

Phrase: ")."
Processing 00000000.tx.251: In either case, stimulated Id-specific CD4+ LN T cells could become effector memory cells with a changed recirculation pattern43 so that they now might traverse flat endothelium of the subcutaneous tumor and kill the lymphoma cells. 

Phrase: "In either case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "stimulated Id-specific CD4+ LN T cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   845   C0039215:cd4 cells [Cell]
   829 E C3251824:CD4+ cell [Cell]
   818   C0039194:T-Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "become"

Phrase: "effector memory cells with a changed recirculation pattern43"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0312737:Memory cells [Cell]
   750   C0312740:Effector Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0025260:Memory [Mental Process]
   744   C0700327:memory [Finding]
   744   C1706377:Memory [Manufactured Object]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "they now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "might"

Phrase: "traverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Traverse [Conceptual Entity]

Phrase: "flat endothelium of the subcutaneous tumor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014257:Endothelium [Tissue]

Phrase: "and"

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "the lymphoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0883208:Lymphoma cells [Cell]
  1000   C2697951:Lymphoma Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.252: The finding that antibodies and CD8+ cells are dispensable for protection against subcutaneous B-cell lymphoma in this model does in no way exclude an importance of CD8+ and B cells. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "CD8+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0242629:cd8 cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "dispensable for protection"

Phrase: "against subcutaneous B-cell lymphoma"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   861   C0004561:B-cell [Cell]
   861   C0883208:cell lymphoma [Cell]
   812   C0007634:Cell [Cell]
   812   C0024299:Lymphoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "does in no way"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272751:Does [Finding]
   770   C2828361:Does [Activity]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "an importance of CD8+"

Phrase: "and"

Phrase: "B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.253: In fact, in the 38C13 B-lymphoma model, anti-Id antibodies alone were sufficient for protection.16 Most likely, the different arms of adaptive immunity may contribute to Id-specific protection against B-cell lymphomas and in many instances work in synergy. 

Phrase: "In fact,"

Phrase: "in the 38C13 B-lymphoma model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "anti-Id antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0600091:ID [Intellectual Product]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "were"

Phrase: "sufficient for protection.16 Most likely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "the different arms of adaptive immunity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0206655:ARMS [Neoplastic Process]
   753   C0446516:Arm [Body Location or Region]
   753   C1269078:Arm [Body Part, Organ, or Organ Component]
   753   C1269612:Arm [Body Location or Region]
   753   C2681631:ARMS [Gene or Genome]

Phrase: "may"

Phrase: "contribute to Id-specific protection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205369:Specific [Qualitative Concept]
   760   C0600091:ID [Intellectual Product]
   760   C1545588:Protection [Finding]
   760   C1552740:specific [Intellectual Product]
   760   C1880177:Contribute [Activity]

Phrase: "against B-cell lymphomas"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0079731:B-Cell Lymphomas [Neoplastic Process]
   901   C0004561:B-cell [Cell]
   884   C0883208:cell lymphoma [Cell]
   827   C0007634:Cell [Cell]
   827   C0024299:Lymphomas [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and in many instances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   737   C1550608:Instance [Idea or Concept]

Phrase: "work in synergy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043227:Work [Occupational Activity]
Processing 00000000.tx.254: However, the relative importance of Id-specific CD4+ T cells, CD8+ T cells, and antibodies (B cells) could differ for each individual tumor, depending on whether the BCR's V-region sequences fit MHC class I or class II molecules of that individual and on the susceptibility of the tumor cells to various killing mechanisms employed by T-cell subsets and antibodies.  

Phrase: "However,"

Phrase: "the relative importance of Id-specific CD4+ T cells,"

Phrase: "CD8+ T cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "could"

Phrase: "differ for each individual tumor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027361:Individual [Population Group]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0237401:Individual [Human]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "depending on"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0725813:depend [Medical Device]

Phrase: "whether"

Phrase: "the BCR's V-region sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "MHC class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "or"

Phrase: "class II molecules of that individual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0567416:molecules [Substance]

Phrase: "and on the susceptibility of the tumor cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   770   C0431085:Tumor cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0012655:Susceptibility [Clinical Attribute]
   744   C0027651:Tumor [Neoplastic Process]
   744   C0220898:Susceptibility [Organism Attribute]
   744   C1264642:Susceptibility [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1547045:*Susceptibility [Quantitative Concept]
   744   C1578706:Tumor [Intellectual Product]
   744   C3273930:Tumor [Finding]
   744   C3282337:Cells [Cell]
   737 E C0597032:Tumor Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "to various"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "employed by T-cell subsets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0080202:T-Cell Subsets [Cell]
   862   C2362651:T cell subsets [Finding]
   806   C0039194:T-cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0557351:Employed [Finding]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0457083:Employ [Functional Concept]
   726   C1515021:Subset [Classification]

Phrase: "and"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.255: Acknowledgements  Suzanne Garman-Vik expertly prepared the manuscript. 

Phrase: "Acknowledgements  Suzanne Garman-Vik expertly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1538223:VIK [Gene or Genome]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.256: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.257: U. 

Phrase: "U."
Processing 00000000.tx.258: Lundin and A. 

Phrase: "Lundin"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.259: Corthay are fellows of the Norwegian Cancer Society.  

Phrase: "Corthay"

Phrase: "are"

Phrase: "fellows of the Norwegian Cancer Society."
Processing 00000000.tx.260: Footnotes  Submitted November 7, 2002; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted November 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "2002"

Phrase: ";"
Processing 00000000.tx.261: accepted March 17, 2003. 

Phrase: "accepted March 17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.262: Prepublished online as Blood First Edition Paper, March 20, 2003; 

Phrase: "Prepublished online as Blood First Edition Paper,"

Phrase: "March 20,"

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.263: DOI 10.1182/blood-2002-11-3381. 

Phrase: "DOI 10.1182/blood-2002-11-3381."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   795   C0005767:Blood [Tissue]
   795   C0005768:blood [Body Substance]
   795   C0229664:Blood [Body Substance]
   795   C2348291:DOI [Classification]
   724 E C0333275:Bloody [Qualitative Concept]
   712 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   712 E C0392895:Bloods [Population Group]
   712 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   712 E C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.264: Supported by grants from The Norwegian Cancer Society and the Research Council of Norway. 

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from The Norwegian Cancer Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037455:society [Organization]

Phrase: "and"

Phrase: "the Research Council of Norway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1551807:Council [Population Group]
Processing 00000000.tx.265: The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.266: Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. 

Phrase: "Therefore,"

Phrase: "and"

Phrase: "solely to"

Phrase: "indicate"

Phrase: "this fact,"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C. section 1734."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0041703:U S [Geographic Area]
   799   C0205155:Section [Spatial Concept]
   799   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   799   C1522472:Section [Substance]
   799   C1552923:Section [Quantitative Concept]
   799   C1705191:Section [Physical Object]
Processing 00000000.tx.267: Reprints: Katrin Lundin or Bjarne Bogen, Institute of Immunology, University of Oslo, The National Hospital, N-0027 Oslo, Norway; 

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Katrin Lundin"

Phrase: "or"

Phrase: "Bjarne Bogen,"

Phrase: "Institute of Immunology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "University of Oslo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "The National Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "N-0027 Oslo,"

Phrase: "Norway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028423:Norway [Geographic Area]

Phrase: ";"
Processing 00000000.tx.268: e-mail: k.u.lundin{at}labmed.uio.no or b.bogen{at}labmed.uio.no .  References Top Abstract Introduction Materials and methods Results Discussion References  Sirisinha S, Eisen HN. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "k.u.lundin{at}labmed.uio."

Phrase: "no"

Phrase: "or"

Phrase: "b.bogen{at}labmed.uio."

Phrase: "no ."

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Sirisinha S,"

Phrase: "Eisen HN."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019905:HN [Geographic Area]
   861   C1537997:HN [Gene or Genome]
   861   C1853668:HN [Gene or Genome]
Processing 00000000.tx.269: Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. 

Phrase: "Autoimmune-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443146:Autoimmune [Pathologic Function]

Phrase: "like antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to the ligand-binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0005456:Binding Sites [Receptor]
   901   C1517880:Ligand Binding [Molecular Function]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0023688:Ligand [Chemical]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "of myeloma proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027015:Myeloma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.270: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.271: 1971;68: 3130-3135.[Abstract] Jorgensen T, Hannestad K. 

Phrase: "1971"

Phrase: ";68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "3130-3135."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jorgensen T,"

Phrase: "Hannestad K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.272: Specificity of T and B lymphocytes for myeloma protein 315. 

Phrase: "Specificity of T"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "B lymphocytes for myeloma protein 315."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004561:B-Lymphocytes [Cell]
   783   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   753   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.273: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.274: 1977;7: 426-431.[Medline] [OrderarticleviaInfotrieve] George AJ, Tutt AL, Stevenson FK. 

Phrase: "1977"

Phrase: ";7"

Phrase: ":"

Phrase: "426-431."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] George AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Tutt AL,"

Phrase: "Stevenson FK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349396:FK [Geographic Area]
   861   C1150640:FK [Molecular Function]
Processing 00000000.tx.275: Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. 

Phrase: "Anti-idiotypic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in suppression of a mouse B cell lymphoma,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   790   C1522109:Mouse B Cell [Cell]
   764   C0004561:B-cell [Cell]
   764   C0883208:cell lymphoma [Cell]
   762   C1522021:Mouse Lymphoma [Neoplastic Process]
   742   C0007634:Cell [Cell]
   742   C0024299:Lymphoma [Neoplastic Process]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]
   742   C1269647:Cell [Cell]
   742   C1314939:Involved [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "BCL1."
Processing 00000000.tx.276: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.277: 1987;138: 628-634.[Abstract/Free FullText] Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. 

Phrase: "1987"

Phrase: ";138"

Phrase: ":"

Phrase: "628-634."

Phrase: "[Abstract/Free FullText"

Phrase: "] Campbell MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Esserman L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "Byars NE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:NE [Gene or Genome]

Phrase: "Allison AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Levy R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.278: Idiotype vaccination against murine B cell lymphoma: humoral and cellular requirements for the full expression of antitumor immunity. 

Phrase: "Idiotype vaccination against murine B cell lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "humoral"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   928   C0020168:Humor [Intellectual Product]
   928   C0597811:humor [Therapeutic or Preventive Procedure]
   884 E C0683242:humorousness [Individual Behavior]

Phrase: "and"

Phrase: "cellular requirements for the full expression of antitumor immunity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.279: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.280: 1990;145: 1029-1036.[Abstract/Free FullText] Ghosh SK, White LM, Ghosh R, Bankert RB. 

Phrase: "1990"

Phrase: ";145"

Phrase: ":"

Phrase: "1029-1036."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghosh SK,"

Phrase: "White LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Ghosh R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bankert RB."
Processing 00000000.tx.281: Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype. 

Phrase: "Vaccination with membrane-associated idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "and"

Phrase: "more prolonged protection of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "from tumor challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "than the soluble form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of idiotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.282: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.283: 1990;145: 365-370.[Abstract/Free FullText] Lauritzsen GF, Weiss S, Bogen B. 

Phrase: "1990"

Phrase: ";145"

Phrase: ":"

Phrase: "365-370."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lauritzsen GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Weiss S,"

Phrase: "Bogen B."
Processing 00000000.tx.284: Anti-tumour activity of idiotype-specific, MHC-restricted Th1 and Th2 clones in vitro and in vivo. 

Phrase: "Anti-tumour activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "of idiotype-specific, MHC-restricted Th1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1423842:TH1 [Gene or Genome]
   795   C3540579:TH1 [Gene or Genome]

Phrase: "and"

Phrase: "Th2"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.285: Scand J Immunol. 

Phrase: "Scand J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.286: 1993;37: 77-85.[Medline] [OrderarticleviaInfotrieve] Flamand V, Sornasse T, Thielemans K, et al. 

Phrase: "1993"

Phrase: ";37"

Phrase: ":"

Phrase: "77-85."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Flamand V,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "Sornasse T,"

Phrase: "Thielemans K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.287: Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. 

Phrase: "Murine dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1947910:Pulsed [Phenomenon or Process]
   966 E C0232117:PULSE [Clinical Attribute]
   966 E C0391850:Pulse [Physiologic Function]

Phrase: "in vitro with tumor antigen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "tumor resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.288: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.289: 1994;24: 605-610.[Medline] [OrderarticleviaInfotrieve] Kwak LW, Young HA, Pennington RW, Weeks SD. 

Phrase: "1994"

Phrase: ";24"

Phrase: ":"

Phrase: "605-610."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kwak LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Young HA,"

Phrase: "Pennington RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Weeks SD."
Processing 00000000.tx.290: Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. 

Phrase: "Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "combined with granulocyte/macrophage colony-stimulating factor"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   897   C0079460:Granulocyte-Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Colony-Stimulating Factor
   897   C0376563:Colony-Stimulating Factor, Granulocyte-Macrophage [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   897   C1149401:granulocyte macrophage colony-stimulating factor [Molecular Function]
   897   C1332791:GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [Gene or Genome]
   853   C0079784:Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0079459:Granulocyte Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   814   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018183:granulocyte [Cell]
   748   C0024432:macrophage [Cell]
   748   C0205195:Combined [Qualitative Concept]
   748   C0439158:colony [Quantitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1947989:Colony [Cell]
   748   C1948023:Stimulating [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "primes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "mice for a protective T-cell response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   788   C1522131:Mouse T Cell [Cell]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
Processing 00000000.tx.291: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.292: 1996;93: 10972-10977.[Abstract/Free FullText] Levitsky HI, Montgomery J, Ahmadzadeh M, et al. 

Phrase: "1996"

Phrase: ";93"

Phrase: ":"

Phrase: "10972-10977."

Phrase: "[Abstract/Free FullText"

Phrase: "] Levitsky HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "Montgomery J,"

Phrase: "Ahmadzadeh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.293: Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B71-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. 

Phrase: "Immunization with granulocyte-macrophage colony-stimulating factor-transduced,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   744   C0042196:immunisation [Therapeutic or Preventive Procedure]
   744   C3244291:immunization [Functional Concept]
   703   C0079460:Granulocyte-Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   703   C0376563:Colony-Stimulating Factor, Granulocyte-Macrophage [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   703   C1149401:granulocyte macrophage colony-stimulating factor [Molecular Function]
   703   C1332791:GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [Gene or Genome]

Phrase: "but"

Phrase: "not B71-transduced, lymphoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0883208:Lymphoma cells [Cell]
   840   C2697951:Lymphoma Cells [Laboratory Procedure]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "primes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "idiotype-specific T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "generates"

Phrase: "potent systemic antitumor immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0020964:Immunity [Physiologic Function]
   741 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.294: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.295: 1996;156: 3858-3865.[Abstract] Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW. 

Phrase: "1996"

Phrase: ";156"

Phrase: ":"

Phrase: "3858-3865."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Biragyn A,"

Phrase: "Tani K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grimm MC,"

Phrase: "Weeks S,"

Phrase: "Kwak LW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]
Processing 00000000.tx.296: Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. 

Phrase: "Genetic fusion of chemokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332466:Fusion [Functional Concept]
   770   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "to a self tumor antigen"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C0004359:self antigen [Immunologic Factor]
   901   C0041361:Tumor antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "protective, T-cell dependent antitumor immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0020964:Immunity [Physiologic Function]
   727 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.297: Nat Biotechnol. 

Phrase: "Nat Biotechnol."
Processing 00000000.tx.298: 1999;17: 253-258.[CrossRef][Medline] [OrderarticleviaInfotrieve] Hsu FJ, Benike C, Fagnoni F, et al. 

Phrase: "1999"

Phrase: ";17"

Phrase: ":"

Phrase: "253-258."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hsu FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Benike C,"

Phrase: "Fagnoni F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.299: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. 

Phrase: "Vaccination of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "with B-cell lymphoma"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   901   C0004561:B-cell [Cell]
   901   C0883208:cell lymphoma [Cell]
   827   C0007634:Cell [Cell]
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "autologous antigen-pulsed dendritic cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   911   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.300: Nat Med. 

Phrase: "Nat Med."
Processing 00000000.tx.301: 1996;2: 52-58.[Medline] [OrderarticleviaInfotrieve] Bendandi M, Gocke CD, Kobrin CB, et al. 

Phrase: "1996"

Phrase: ";2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "52-58."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bendandi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gocke CD,"

Phrase: "Kobrin CB,"

Phrase: "et al."
Processing 00000000.tx.302: Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. 

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "molecular remissions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0544452:remissions [Finding]
   861   C0687702:remissions [Neoplastic Process]

Phrase: "induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   820   C0314597:Colony-stimulating factor, granulocyte-monocyte [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   792   C0079459:Granulocyte Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   775   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0440740:Granulocyte-specific [Cell]
   738   C0018183:granulocyte [Cell]
   738   C0026473:Monocyte [Cell]
   738   C0030705:*^patient [Patient or Disabled Group]
   738   C0042196:Vaccination [Therapeutic or Preventive Procedure]
   738   C0205263:Induced [Functional Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0332287:Plus [Qualitative Concept]
   738   C0439158:colony [Quantitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1552740:specific [Intellectual Product]
   738   C1947989:Colony [Cell]
   738   C1948023:Stimulating [Natural Phenomenon or Process]
   738   C2827422:Factor [Conceptual Entity]

Phrase: "against lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.303: Nat Med. 

Phrase: "Nat Med."
Processing 00000000.tx.304: 1999;5: 1171-1177.[CrossRef][Medline] [OrderarticleviaInfotrieve] Timmerman JM, Czerwinski DK, Davis TA, et al. 

Phrase: "1999"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "1171-1177."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Timmerman JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Czerwinski DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Davis TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.305: Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. 

Phrase: "Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "immune responses in 35 patients."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0301872:immune responses [Organ or Tissue Function]
   760   C0439662:Immune [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.306: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.307: 2002;99: 1517-1526.[Abstract/Free FullText] Miller RA, Maloney DG, Warnke R, Levy R. 

Phrase: "2002"

Phrase: ";99"

Phrase: ":"

Phrase: "1517-1526."

Phrase: "[Abstract/Free FullText"

Phrase: "] Miller RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Maloney DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Warnke R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Levy R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.308: Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. 

Phrase: "Treatment of B-cell lymphoma"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with monoclonal anti-idiotype antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0003242:Anti-Idiotype Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           anti antibody
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.309: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.310: 1982;306: 517-522.[Medline] [OrderarticleviaInfotrieve] Vuist WM, Levy R, Maloney DG. 

Phrase: "1982"

Phrase: ";306"

Phrase: ":"

Phrase: "517-522."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vuist WM,"

Phrase: "Levy R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Maloney DG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]
Processing 00000000.tx.311: Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein. 

Phrase: "Lymphoma regression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "induced by monoclonal anti-idiotypic antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0003242:Antibodies, Anti-Idiotypic [Amino Acid, Peptide, or Protein,Immunologic Factor]
       E   anti antibody
   783   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0205263:Induced [Functional Concept]
   753   C0746619:monoclonal [Finding]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "correlates with their ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Ig signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevented by tumor expression of high levels of bcl-2 protein."
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   775   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0376515:Bcl-2 [Gene or Genome]
   754   C0260034:protein tumor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1171362:expression protein [Genetic Function]
   738   C0027651:Tumor [Neoplastic Process]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205250:High [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C1299351:High [Qualitative Concept]
   738   C1578706:Tumor [Intellectual Product]
   738   C2700149:HIGH [Intellectual Product]
   738   C3273930:Tumor [Finding]
   737   C0428479:Protein level [Laboratory or Test Result]
   737   C0456948:Level 2 [Intellectual Product]
   737   C3244092:expression level [Idea or Concept]
   704   C0309872:PREVENT [Pharmacologic Substance]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.312: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.313: 1994;83: 899-906.[Abstract/Free FullText] Syrengelas AD, Levy R. 

Phrase: "1994"

Phrase: ";83"

Phrase: ":"

Phrase: "899-906."

Phrase: "[Abstract/Free FullText"

Phrase: "] Syrengelas AD,"

Phrase: "Levy R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.314: DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection. 

Phrase: "DNA vaccination against the idiotype of a murine B cell lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "mechanism of tumor protection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.315: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.316: 1999;162: 4790-4795.[Abstract/Free FullText] Bogen B, Munthe L, Sollien A, et al. 

Phrase: "1999"

Phrase: ";162"

Phrase: ":"

Phrase: "4790-4795."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bogen B,"

Phrase: "Munthe L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "Sollien A,"

Phrase: "et al."
Processing 00000000.tx.317: Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies. 

Phrase: "Naive CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   923   C3641721:Naive T Cells [Cell]
   875   C0039215:cd4 cells [Cell]
   861   C0039194:T-Cells [Cell]
   858 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "confer"

Phrase: "idiotype-specific tumor resistance in the absence of antibodies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237834:Resistance [Mental Process]
   742   C1514892:Resistance [Physiologic Function]
Processing 00000000.tx.318: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.319: 1995;25: 3079-3086.[Medline] [OrderarticleviaInfotrieve] Bogen B, Malissen B, Haas W. 

Phrase: "1995"

Phrase: ";25"

Phrase: ":"

Phrase: "3079-3086."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bogen B,"

Phrase: "Malissen B,"

Phrase: "Haas W."
Processing 00000000.tx.320: Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. 

Phrase: "Idiotope-specific T cell clones"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0009013:cell clones [Cell]
           Clones
   840   C0039194:T-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "that"

Phrase: "recognize"

Phrase: "syngeneic immunoglobulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "fragments in the context of class II molecules."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0441886:Class II [Intellectual Product]
   770   C2698968:Class II [Finding]
   744   C0332255:fragment [Functional Concept]
   744   C0449255:Context [Finding]
   744   C0456387:Class [Intellectual Product]
   744   C0486805:Fragments [Body Substance]
   744   C0542559:Context [Functional Concept]
   744   C0567416:molecules [Substance]
   744   C1705943:Class [Classification]
   744   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.321: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.322: 1986;16: 1373-1378.[Medline] [OrderarticleviaInfotrieve] Eyerman MC, Zhang X, Wysocki LJ. 

Phrase: "1986"

Phrase: ";16"

Phrase: ":"

Phrase: "1373-1378."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Eyerman MC,"

Phrase: "Zhang X,"

Phrase: "Wysocki LJ."
Processing 00000000.tx.323: T cell recognition and tolerance of antibody diversity. 

Phrase: "T cell recognition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0678836:cell recognition [Cell Function]
   827   C0524637:Recognition [Mental Process]
   734   C0039194:T-cell [Cell]

Phrase: "and"

Phrase: "tolerance of antibody diversity."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0013220:Tolerance [Finding]
   770   C0020963:Tolerance [Pathologic Function]
   770   C0220929:tolerance [Mental Process]
   770   C0231197:Tolerance [Physiologic Function]
   770   C1704410:Tolerance [Qualitative Concept]
   715 E C0680282:toleration [Social Behavior]
Processing 00000000.tx.324: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.325: 1996;157: 1037-1046.[Abstract] Yamamoto H, Araki K, Bitoh S, et al. 

Phrase: "1996"

Phrase: ";157"

Phrase: ":"

Phrase: "1037-1046."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yamamoto H, Araki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: "Bitoh S,"

Phrase: "et al."
Processing 00000000.tx.326: Cytotoxic T lymphocyte clone recognizing self idiotype: its regulatory role in antibody production. 

Phrase: "Cytotoxic T lymphocyte clone recognizing self idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "its regulatory role in antibody production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.327: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.328: 1987;17: 719-722.[Medline] [OrderarticleviaInfotrieve] Trojan A, Schultze JL, Witzens M, et al. 

Phrase: "1987"

Phrase: ";17"

Phrase: ":"

Phrase: "719-722."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Trojan A,"

Phrase: "Schultze JL,"

Phrase: "Witzens M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.329: Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. 

Phrase: "Immunoglobulin framework-derived peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "function as cytotoxic T-cell epitopes commonly"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0039195:Cytotoxic T cell [Cell]
   814   C0282580:T-Cell Epitopes [Immunologic Factor]
   778   C0039194:T-cell [Cell]
   774   C0007613:Cell Function [Cell Function]
   774   C0022686:Cytotoxic cell [Cell]
   748   C0003316:Epitopes [Immunologic Factor]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1511636:cytotoxic [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]

Phrase: "expressed in B-cell malignancies."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0004561:B-cell [Cell]
   760   C0006826:MALIGNANCIES [Neoplastic Process]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   756   C0334227:Malignant Cell [Cell]
   726 E C1306459:Malignancy [Finding]
Processing 00000000.tx.330: Nat Med. 

Phrase: "Nat Med."
Processing 00000000.tx.331: 2000;6: 667-672.[CrossRef][Medline] [OrderarticleviaInfotrieve] Bogen B, Snodgrass R, Briand JP, Hannestad K. 

Phrase: "2000"

Phrase: ";6"

Phrase: ":"

Phrase: "667-672."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bogen B,"

Phrase: "Snodgrass R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Briand JP,"

Phrase: "Hannestad K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.332: Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. 

Phrase: "Synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "and"

Phrase: "beta-chain gene rearrangements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017287:Rearrangements, Gene [Genetic Function]
   812   C1511695:Rearrangements [Genetic Function]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a diversified T cell repertoire for a lambda light chain third hypervariable region."
Processing 00000000.tx.333: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.334: 1986;16: 1379-1384.[Medline] [OrderarticleviaInfotrieve] Bogen B, Lambris JD. 

Phrase: "1986"

Phrase: ";16"

Phrase: ":"

Phrase: "1379-1384."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bogen B,"

Phrase: "Lambris JD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]
Processing 00000000.tx.335: Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. 

Phrase: "Minimum length of an idiotypic peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "a model for its binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "to a major histocompatibility complex class II molecule."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0567416:Molecule [Substance]
   780   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]
   727 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.336: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.337: 1989;8: 1947-1952.[Abstract] Weiss S, Bogen B. 

Phrase: "1989"

Phrase: ";8"

Phrase: ":"

Phrase: "1947-1952."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weiss S,"

Phrase: "Bogen B."
Processing 00000000.tx.338: B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. 

Phrase: "B-lymphoma cells process"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0007613:Cell Process [Cell Function]
   844   C0230625:Cell process [Cell Component]
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]
   708   C0004561:B-Cells [Cell]

Phrase: "and"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "their endogenous immunoglobulin to major histocompatibility complex-restricted T cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1167408:immunoglobulin complex [Cell Component]
   739   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C1621846:immunoglobulin [Molecular Function]
Processing 00000000.tx.339: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.340: 1989;86: 282-286.[Abstract] Weiss S, Bogen B. 

Phrase: "1989"

Phrase: ";86"

Phrase: ":"

Phrase: "282-286."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weiss S,"

Phrase: "Bogen B."
Processing 00000000.tx.341: MHC class II-restricted presentation of intracellular antigen. 

Phrase: "MHC class II-restricted presentation of intracellular antigen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0206431:Antigen Presentation [Cell Function]
   739   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.342: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.343: 1991;64: 767-776.[Medline] [OrderarticleviaInfotrieve] Rudensky AY, Preston-Hurlburt P, al Ramadi BK, Rothbard J, Janeway CA Jr. 

Phrase: "1991"

Phrase: ";64"

Phrase: ":"

Phrase: "767-776."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rudensky AY,"

Phrase: "Preston-Hurlburt P,"

Phrase: "al Ramadi BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C1537501:BK [Gene or Genome]

Phrase: "Rothbard J,"

Phrase: "Janeway CA Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.344: Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. 

Phrase: "Truncation variants of peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variants [Qualitative Concept]

Phrase: "isolated from MHC class II molecules"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   869   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]
   800   C0024518:Major Histocompatibility Complex [Gene or Genome]
   800   C1753349:Major histocompatibility complex [Cell Component]
   770   C0441886:Class II [Intellectual Product]
   770   C2698968:Class II [Finding]
   767   C2263441:complex II [Molecular Function]
   744   C0019627:Histocompatibility [Qualitative Concept]
   744   C0205164:Major [Qualitative Concept]
   744   C0205409:Isolated [Functional Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0456387:Class [Intellectual Product]
   744   C0567416:molecules [Substance]
   744   C1548221:Isolated [Idea or Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1705943:Class [Classification]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "sequence motifs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.345: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.346: 1992;359: 429-431.[CrossRef][Medline] [OrderarticleviaInfotrieve] Lauritzsen GF, Weiss S, Dembic Z, Bogen B. 

Phrase: "1992"

Phrase: ";359"

Phrase: ":"

Phrase: "429-431."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lauritzsen GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Weiss S,"

Phrase: "Dembic Z,"

Phrase: "Bogen B."
Processing 00000000.tx.347: Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. 

Phrase: "Naive idiotype-specific CD4+ T cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   904   C3641721:Naive T Cells [Cell]
   839   C0039215:cd4 cells [Cell]
   827   C0039194:T-Cells [Cell]
   822 E C3251824:CD4+ cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "immunosurveillance of B-cell tumors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026428:Immunosurveillance [Health Care Activity]
Processing 00000000.tx.348: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.349: 1994;91: 5700-5704.[Abstract] Bogen B, Gleditsch L, Weiss S, Dembic Z. 

Phrase: "1994"

Phrase: ";91"

Phrase: ":"

Phrase: "5700-5704."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bogen B,"

Phrase: "Gleditsch L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "Weiss S,"

Phrase: "Dembic Z."
Processing 00000000.tx.350: Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities. 

Phrase: "Weak positive selection of transgenic T cell receptor-bearing thymocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C1621775:positive T cell selection [Cell Function]
   777   C1159918:T cell selection [Cell Function]
   760   C2347644:Positive Selection [Laboratory Procedure]
   741   C1515433:Thymocyte Selection [Cell Function]
   739   C0036576:selection [Genetic Function]

Phrase: ":"

Phrase: "importance of major histocompatibility complex class II,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   731   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "T cell receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034790:T-Cell Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C0039194:T-cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "CD4 surface molecule densities."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0178587:densities [Quantitative Concept]
   729 E C0439794:Dense [Qualitative Concept]
   708   C0003323:CD4 Molecule [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   708   C1332714:CD4 molecule [Gene or Genome]
Processing 00000000.tx.351: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.352: 1992;22: 703-709.[Medline] [OrderarticleviaInfotrieve] Dembic Z, Schenck K, Bogen B. 

Phrase: "1992"

Phrase: ";22"

Phrase: ":"

Phrase: "703-709."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dembic Z,"

Phrase: "Schenck K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bogen B."
Processing 00000000.tx.353: Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. 

Phrase: "Dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "purified from myeloma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0026764:Myeloma [Neoplastic Process]
   790   C1998793:Purified [Functional Concept]
   790   C3538749:Myeloma [Intellectual Product]

Phrase: "are"

Phrase: "primed with tumor-specific antigen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0041361:tumor-specific antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumor antigen
   806   C0456981:Specific antigen [Immunologic Factor]
   760   C0003320:Antigen [Immunologic Factor]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0205369:Specific [Qualitative Concept]
   760   C0871133:primed [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "(idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "CD4+ T cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0039215:cd4 cells [Cell]
   901   C0039194:T-Cells [Cell]
   896 E C3251824:CD4+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.354: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.355: 2000;97: 2697-2702.[Abstract/Free FullText] Lauritzsen GF, Bogen B. 

Phrase: "2000"

Phrase: ";97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "2697-2702."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lauritzsen GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Bogen B."
Processing 00000000.tx.356: The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. 

Phrase: "The role of idiotype-specific, CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in tumor resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "against major histocompatibility complex class II molecule negative plasmacytoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   707   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.357: Cell Immunol. 

Phrase: "Cell Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.358: 1993;148: 177-188.[CrossRef][Medline] [OrderarticleviaInfotrieve] Bogen B, Lauritzsen GF, Weiss S. 

Phrase: "1993"

Phrase: ";148"

Phrase: ":"

Phrase: "177-188."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bogen B,"

Phrase: "Lauritzsen GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Weiss S."
Processing 00000000.tx.359: A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones. 

Phrase: "A stimulatory monoclonal antibody detecting T cell receptor diversity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   864   C0003259:Antibody Diversity [Molecular Function]
   793   C1880371:Diversity [Qualitative Concept]

Phrase: "among idiotype-specific, major histocompatibility complex-restricted T cell clones."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   807   C0009013:cell clones [Cell]
           Clones
   807   C0039194:T-cell [Cell]
   791   C0007634:Cell [Cell]
   791   C1269647:Cell [Cell]
   791   C1704653:Cell [Medical Device]
   791   C1948049:Cell [Spatial Concept]
   758 E C1522642:Clone [Tissue]
   708 E C1704387:Clonal [Qualitative Concept]
Processing 00000000.tx.360: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.361: 1990;20: 2359-2362.[Medline] [OrderarticleviaInfotrieve] Matzinger P. 

Phrase: "1990"

Phrase: ";20"

Phrase: ":"

Phrase: "2359-2362."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matzinger P."
Processing 00000000.tx.362: The JAM test: a simple assay for DNA fragmentation and cell death. 

Phrase: "The JAM test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: ":"

Phrase: "a simple assay for DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.363: J Immunol Methods. 

Phrase: "J Immunol Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.364: 1991;145: 185-192.[CrossRef][Medline] [OrderarticleviaInfotrieve] Armstrong AC, Dermime S, Allinson CG, et al. 

Phrase: "1991"

Phrase: ";145"

Phrase: ":"

Phrase: "185-192."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Armstrong AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Dermime S,"

Phrase: "Allinson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.365: Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope. 

Phrase: "Immunization with a recombinant adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C3244291:immunization [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a lymphoma idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "induction of tumor-protective immunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "identification of an idiotype-specific T cell epitope."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.366: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.367: 2002;168: 3983-3991.[Abstract/Free FullText] Dudley ME, Wunderlich JR, Robbins PF, et al. 

Phrase: "2002"

Phrase: ";168"

Phrase: ":"

Phrase: "3983-3991."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dudley"

Phrase: "ME,"

Phrase: "Wunderlich JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Robbins PF,"

Phrase: "et al."
Processing 00000000.tx.368: Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. 

Phrase: "Cancer regression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0920421:cancer regression [Neoplastic Process]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]

Phrase: "and"

Phrase: "autoimmunity in patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0004368:Autoimmunity [Pathologic Function]
   718 E C0443146:Autoimmune [Pathologic Function]

Phrase: "after clonal repopulation"

Phrase: "with antitumor lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.369: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.370: 2002;298: 850-854.[Abstract/Free FullText] Kwak LW, Pennington R, Boni L, et al. 

Phrase: "2002"

Phrase: ";298"

Phrase: ":"

Phrase: "850-854."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kwak LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Pennington R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boni L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "et al."
Processing 00000000.tx.371: Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity. 

Phrase: "Liposomal formulation of a self lymphoma antigen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524527:Formulation [Research Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "potent protective antitumor immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0020964:Immunity [Physiologic Function]
   741 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.372: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.373: 1998;160: 3637-3641.[Abstract/Free FullText] King CA, Spellerberg MB, Zhu D, et al. 

Phrase: "1998"

Phrase: ";160"

Phrase: ":"

Phrase: "3637-3641."

Phrase: "[Abstract/Free FullText"

Phrase: "] King CA,"

Phrase: "Spellerberg MB,"

Phrase: "Zhu D,"

Phrase: "et al."
Processing 00000000.tx.374: DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. 

Phrase: "DNA vaccines with single-chain Fv"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0376613:Vaccines, DNA [Immunologic Factor,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   719 E C1552558:Vaccine [Intellectual Product]

Phrase: "fused"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "C of tetanus toxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "protective immunity against lymphoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020964:Immunity [Physiologic Function]

Phrase: "and"

Phrase: "myeloma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026764:Myeloma [Neoplastic Process]
  1000   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.375: Nat Med. 

Phrase: "Nat Med."
Processing 00000000.tx.376: 1998;4: 1281-1286.[CrossRef][Medline] [OrderarticleviaInfotrieve] Stevenson FK, Zhu D, King CA, et al. 

Phrase: "1998"

Phrase: ";4"

Phrase: ":"

Phrase: "1281-1286."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stevenson FK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349396:FK [Geographic Area]
   861   C1150640:FK [Molecular Function]

Phrase: "Zhu D,"

Phrase: "King"

Phrase: "CA,"

Phrase: "et al."
Processing 00000000.tx.377: Idiotypic DNA vaccines against B-cell lymphoma. 

Phrase: "Idiotypic DNA vaccines against B-cell lymphoma."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0376613:Vaccines, DNA [Immunologic Factor,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   714 E C1552558:Vaccine [Intellectual Product]
Processing 00000000.tx.378: Immunol Rev. 

Phrase: "Immunol Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.379: 1995;145: 211-228.[Medline] [OrderarticleviaInfotrieve] Pardoll DM, Topalian SL. 

Phrase: "1995"

Phrase: ";145"

Phrase: ":"

Phrase: "211-228."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pardoll DM,"

Phrase: "Topalian SL."
Processing 00000000.tx.380: The role of CD4+ T cell responses in antitumor immunity. 

Phrase: "The role of CD4+ T cell responses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in antitumor immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.381: Curr Opin Immunol. 

Phrase: "Curr Opin Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.382: 1998;10: 588-594.[CrossRef][Medline] [OrderarticleviaInfotrieve] Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 

Phrase: "1998"

Phrase: ";10"

Phrase: ":"

Phrase: "588-594."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sallusto F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lenig D,"

Phrase: "Forster R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lipp M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lanzavecchia A."
Processing 00000000.tx.383: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. 

Phrase: "Two subsets of memory T lymphocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0080202:T-Lymphocyte Subsets [Cell]
   767   C0079720:Lymphocyte Subsets [Classification]
   767   C1304884:Lymphocyte subsets [Laboratory Procedure]
   719   C1515021:Subset [Classification]

Phrase: "with distinct homing potentials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3245505:potentials [Qualitative Concept]

Phrase: "and"

Phrase: "effector functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.384: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.385: 1999;401: 708-712.[CrossRef][Medline] [OrderarticleviaInfotrieve] Dembic Z, Rottingen JA, Dellacasagrande J, Schenck K, Bogen B. 

Phrase: "1999"

Phrase: ";401"

Phrase: ":"

Phrase: "708-712."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dembic Z,"

Phrase: "Rottingen JA,"

Phrase: "Dellacasagrande J,"

Phrase: "Schenck K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bogen B."
Processing 00000000.tx.386: Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level. 

Phrase: "Phagocytic dendritic cells from myelomas"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C0011306:Dendritic Cells [Cell]
   797   C0031307:Phagocytic Cells [Cell]
   781   C0333843:cells myeloma [Cell]
   773 E C0003315:Dendritic cell [Cell]
   773 E C1511762:Dendritic Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0011305:Dendritic [Cell Component]
   760   C0439640:Dendritic [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "tumor-specific T cells at a single cell level."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   764   C0039194:T-Cells [Cell]
   762   C0431085:Tumor cells [Cell]
   745 E C0597032:Tumor Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.387: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.388: 2001;97: 2808-2814.[Abstract/Free FullText] Qin Z, Blankenstein T. 

Phrase: "2001"

Phrase: ";97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "2808-2814."

Phrase: "[Abstract/Free FullText"

Phrase: "] Qin Z,"

Phrase: "Blankenstein T."
Processing 00000000.tx.389: CD4+ T cellmediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. 

Phrase: "CD4+ T cellmediated tumor rejection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0035015:Rejection [Social Behavior]
   804   C1548437:Rejection [Idea or Concept]
   804   C1882923:REJECTION [Phenomenon or Process]
   804   C2700401:Rejection [Activity]

Phrase: "involves"

Phrase: "inhibition of angiogenesis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1510884:inhibition of angiogenesis [Cell Function]
           Angiogenesis Inhibition
   858   C0281318:Angiogenesis Inhibition [Therapeutic or Preventive Procedure]
   858   C2267119:Angiogenesis Inhibition [Molecular Function]
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "dependent on IFN gamma receptor expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "by nonhematopoietic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.390: Immunity. 

Phrase: "Immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.391: 2000;12: 677-686.[Medline] [OrderarticleviaInfotrieve] Hung K, Hayashi R, Lafond-Walker A, et al. 

Phrase: "2000"

Phrase: ";12"

Phrase: ":"

Phrase: "677-686."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hung K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hayashi R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lafond-Walker A,"

Phrase: "et al."
Processing 00000000.tx.392: The central role of CD4(+) T cells in the antitumor immune response. 

Phrase: "The central role of CD4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(+"

Phrase: ")"

Phrase: "T cells in the antitumor immune response."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0039194:T-Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.393: J Exp Med. 

Phrase: "J Exp Med."
Processing 00000000.tx.394: 1998;188: 2357-2368.[Abstract/Free FullText] Tietz W, Hamann A. 

Phrase: "1998"

Phrase: ";188"

Phrase: ":"

Phrase: "2357-2368."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tietz W,"

Phrase: "Hamann A."
Processing 00000000.tx.395: The migratory behavior of murine CD4+ cells of memory phenotype. 

Phrase: "The migratory behavior of murine CD4+ cells of memory phenotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0004927:Behavior [Individual Behavior]
   739   C2707008:Behavior [Clinical Attribute]
   722   C1321146:Behavioral phenotype [Behavior]
Processing 00000000.tx.396: Eur J Immunol. 

Phrase: "Eur J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.397: 1997;27: 2225-2232.[Medline] [OrderarticleviaInfotrieve] This Article Abstract Full Text (PDF) All Versions of this Article: 2002-11-3381v1 102/2/605 most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Google Scholar Articles by Lundin, K. 

Phrase: "1997"

Phrase: ";27"

Phrase: ":"

Phrase: "2225-2232."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "2002-11-3381v1 102/2/605 most recent Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Rights"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035621:Rights [Qualitative Concept]
   827   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Google Scholar Articles by Lundin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.398: U. 

Phrase: "U."
Processing 00000000.tx.399: Articles by Bogen, B. 

Phrase: "Articles by Bogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.400: Articles citing this Article PubMed PubMed Citation Articles by Lundin, K. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Lundin,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.401: U. 

Phrase: "U."
Processing 00000000.tx.402: Articles by Bogen, B. 

Phrase: "Articles by Bogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.403: Related Collections Immunotherapy Immunobiology Neoplasia Blood Online is supported in part by Genentech BioOncology Copyright  2003 by American Society of Hematology.

Phrase: "Related Collections Immunotherapy Immunobiology Neoplasia Blood"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   799   C0005767:Blood [Tissue]
   799   C0005768:blood [Body Substance]
   799   C0229664:Blood [Body Substance]
   727 E C0333275:Bloody [Qualitative Concept]
   716 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   716 E C0392895:Bloods [Population Group]
   716 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   716 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "Online"

Phrase: "is"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by Genentech BioOncology Copyright  2003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0009993:Copyright [Intellectual Product]
   812   C0331820:Genentech [Health Care Related Organization]
   812   C1552856:copyright [Idea or Concept]

Phrase: "by American Society of Hematology."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1515949:American Society of Hematology [Professional Society]
   812   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   812   C0037455:society [Organization]
   812   C0200627:HEMATOLOGY [Laboratory Procedure]
   812   C0596070:American [Population Group]
   741 E C0205488:Haematologic [Functional Concept]

